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Foreword
Asbestos has been a highly visible issue in public health for over three decades. 
During the mid- to late-20th century, many advances were made in the scientific 
understanding of worker health effects from exposure to asbestos fibers and other 
elongate mineral particles (EMPs). It is now well documented that asbestos fibers, 
when inhaled, can cause serious diseases in exposed workers. However, many ques-
tions and areas of confusion and scientific uncertainty remain. 
The National Institute for Occupational Safety and Health (NIOSH) has determined 
that exposure to asbestos fibers causes cancer and asbestosis in humans on the ba-
sis of evidence of respiratory disease observed in workers exposed to asbestos, and 
recommends that exposures be reduced to the lowest feasible concentration.  As the 
federal agency responsible for conducting research and making recommendations 
for the prevention of worker injury and illness, NIOSH has undertaken a reappraisal 
of how to ensure optimal protection of workers from exposure to asbestos fibers and 
other EMPs. As a first step in this effort, NIOSH convened an internal work group 
to develop a framework for future scientific research and policy development. The 
NIOSH Mineral Fibers Work Group prepared a first draft of this State of the Science 
and Roadmap for Scientific Research (herein referred to as the Roadmap), summariz-
ing NIOSH’s understanding of occupational exposure and toxicity issues concern-
ing asbestos fibers and other EMPs. 
NIOSH invited comments on the occupational health issues identified and the 
framework for research suggested in the first draft Roadmap. NIOSH sought oth-
er views about additional key issues that should be identified, additional research 
that should be conducted, and methods for conducting the research. In particular, 
NIOSH sought input from stakeholders concerning study designs, techniques for 
generating size-selected fibers, analytic approaches, sources of particular types of 
EMPs suitable for experimental studies, and worker populations suitable for epide-
miological study. On the basis of comments received during the public and expert 
peer review process, NIOSH revised the Roadmap and invited public review of the 
revised version by stakeholders. After further revision and public comment, a re-
vised draft Roadmap was submitted for review by the National Academies of Science 
in early 2009. Based on the National Academies assessment of the draft Roadmap, 
revisions were made, and NIOSH disseminated a fourth draft version of the docu-
ment for final public comment in early 2010. After considering these comments, 
NIOSH has developed this final revision of the Roadmap.
The purpose of this Roadmap is to outline a research agenda that will guide the de-
velopment of specific research programs and projects that will lead to a broader and 
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clearer understanding of the important determinants of toxicity for asbestos fibers 
and other EMPs. NIOSH recognizes that results from such research may impact en-
vironmental as well as occupational health policies and practices. Many of the issues 
that are important in the workplace are also important to communities and to the 
general population. Therefore, NIOSH envisions that the planning and conduct of 
the research will be a collaborative effort involving active participation of multiple 
federal agencies, including the Agency for Toxic Substances and Disease Registry 
(ATSDR), the Consumer Product Safety Commission (CPSC), the Environmental 
Protection Agency (EPA), the Mine Safety and Health Administration (MSHA), the 
National Institute of Environmental Health Sciences (NIEHS), the National Institute 
of Standards and Technology (NIST), the National Toxicology Program (NTP), the 
Occupational Safety and Health Administration (OSHA), and the United States Geo-
logical Survey (USGS), as well as labor, industry, academia, health and safety practi-
tioners, and other interested parties, including international groups. This collabora-
tion will help to focus the scope of the research, to fund and conduct the research, 
and to develop and disseminate informational materials describing research results 
and their implications for establishing new occupational and public health policies. 
This Roadmap also includes a clarified rewording of the NIOSH recommended ex-
posure limit (REL) for airborne asbestos fibers. This clarification is not intended to 
establish a new NIOSH occupational health policy for asbestos, and no regulatory 
response by OSHA or MSHA is requested or expected. 
John Howard, MD
Director, National Institute for 
Occupational Safety and Health
Centers for Disease Control and Prevention 
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Executive Summary 
In the 1970s, NIOSH determined that exposure to asbestos fibers causes cancer and 
asbestosis in humans on the basis of evidence of respiratory disease observed in 
workers exposed to asbestos. Consequently, it made recommendations to the fed-
eral enforcement agencies on how to reduce workplace exposures. The enforcement 
agencies developed occupational regulatory definitions and standards for exposure 
to airborne asbestos fibers based on these recommendations. Since the promulga-
tion of these standards, which apply to occupational exposures to the six commer-
cially used asbestos minerals—the serpentine mineral chrysotile, and the amphibole 
minerals cummingtonite-grunerite asbestos (amosite), riebeckite asbestos (crocido-
lite), actinolite asbestos, anthophyllite asbestos, and tremolite asbestos—the use of 
asbestos in the United States has declined substantially and mining of asbestos in the 
United States ceased in 2002. Nevertheless, many asbestos products remain in use 
and new asbestos-containing products continue to be manufactured in or imported 
into the United States.
As more information became available on the relationship between the dimensions 
of asbestos fibers and their ability to cause nonmalignant respiratory disease and 
cancer, interest increased in exposure to other “mineral fibers.” The term “mineral 
fiber” has been frequently used by nonmineralogists to encompass thoracic-size 
elongate mineral particles (EMPs) occurring either in an asbestiform habit (e.g., as-
bestos fibers) or in a nonasbestiform habit (e.g., as needle-like [acicular] or prismat-
ic crystals), as well as EMPs that result from the crushing or fracturing of  nonfibrous 
minerals (e.g., cleavage fragments). Asbestos fibers are clearly of substantial health 
concern. Further research is needed to better understand health risks associated 
with exposure to other thoracic-size EMPs, including those with mineralogical 
compositions identical or similar to the asbestos minerals and those that have al-
ready been documented to cause asbestos-like disease, as well as the physicochemi-
cal characteristics that determine their toxicity. 
Imprecise terminology and mineralogical complexity have affected progress in re-
search. “Asbestos” and “asbestiform” are two commonly used terms that lack miner-
alogical precision. “Asbestos” is a term used for certain minerals that have crystallized 
in a particular macroscopic habit with certain commercially useful properties. These 
properties are less obvious on microscopic scales, and so a different definition of as-
bestos may be necessary at the scale of the light microscope or electron microscope, 
involving characteristics such as chemical composition and crystallography. “Asbesti-
form” is a term applied to minerals with a macroscopic habit similar to that of asbes-
tos. The lack of precision in these terms and the difficulty in translating macroscopic 
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properties to microscopically identifiable characteristics contribute to miscommuni-
cation and uncertainty in identifying toxicity associated with various forms of miner-
als. Deposits may have more than one mineral habit and transitional minerals may be 
present, which make it difficult to clearly and simply describe the mineralogy.
In 1990, NIOSH revised its recommendation concerning occupational exposure to 
airborne asbestos fibers. At issue were concerns about potential health risks associated 
with worker exposures to the analogs of the asbestos minerals that occur in a differ-
ent habit—so-called cleavage fragments—and the inability of the analytical method 
routinely used for characterizing airborne exposures (i.e., phase contrast microscopy 
[PCM]) to differentiate nonasbestiform analogs from asbestos fibers on the basis of 
physical appearance. This problem was further compounded by the lack of more sensi-
tive analytical methods that could distinguish asbestos fibers from other EMPs having 
the same elemental composition. To address these concerns and ensure that workers 
are protected, NIOSH defined “airborne asbestos fibers” to encompass not only fibers 
from the six previously listed asbestos minerals (chrysotile, crocidolite, amosite, an-
thophyllite asbestos, tremolite asbestos, and actinolite asbestos) but also EMPs from 
their nonasbestiform analogs. NIOSH retained the use of PCM for measuring air-
borne fiber concentrations and counting those EMPs having: (1) an aspect ratio of 3:1 
or greater and (2) a length greater than 5 µm. NIOSH also retained its recommended 
exposure limit (REL) of 0.1 airborne asbestos fiber per cubic centimeter (f/cm3). 
Since 1990, several persistent concerns have been raised about the revised NIOSH 
recommendation. These concerns include the following:
 • NIOSH’s explicit inclusion of EMPs from nonasbestiform amphiboles in its 
1990 revised definition of airborne asbestos fibers is based on inconclusive sci-
ence and contrasts with the regulatory approach subsequently taken by OSHA 
and by MSHA. 
 • The revised definition of airborne asbestos fibers does not explicitly encompass 
EMPs from asbestiform amphiboles that formerly had been mineralogically de-
fined as tremolite (e.g., winchite and richterite) or other asbestiform minerals 
that are known to be (e.g., erionite and fluoro-edenite) or may be (e.g., some 
forms of talc) associated with health effects similar to those caused by asbestos. 
 • The specified dimensional criteria (length and aspect ratio) for EMPs covered 
by the revised definition of airborne asbestos fibers may not be optimal for 
protecting the health of exposed workers because they are not based solely on 
health concerns.
 • Other physicochemical parameters, such as durability and surface activity, 
may be important toxicological parameters but are not reflected in the revised 
definition of airborne asbestos fibers.
 • NIOSH’s use of the term “airborne asbestos fibers” to describe all airborne 
EMPs covered by the REL differs from the way mineralogists use the term and 
this inconsistency leads to confusion about the toxicity of EMPs. 
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NIOSH recognizes that its 1990 description of the particles covered by the REL for 
airborne asbestos fibers has created confusion, causing many to infer that the non-
asbestiform minerals included in the NIOSH definition are “asbestos.” Therefore, 
in this Roadmap, NIOSH makes clear that such nonasbestiform minerals are not 
“asbestos” or “asbestos minerals,” and clarifies which particles are included in the 
REL. This clarification also provides a basis for a better understanding of the need 
for the proposed research. Clarification of the REL in this way does not change the 
existing NIOSH occupational health policy for asbestos, and no regulatory response 
by OSHA or MSHA is requested or expected. The REL remains subject to revision 
based on findings of ongoing and future research.
PCM, the primary method specified by NIOSH, OSHA, and MSHA for analysis of 
air samples for asbestos fibers, has several limitations, including limited ability to 
resolve very thin fibers and to differentiate various types of EMPs. Occupational 
exposure limits for asbestos derive from lung cancer risk estimates from exposure of 
workers to airborne asbestos fibers in commercial processes. These risk assessments 
are based on fiber concentrations determined from a combination of PCM-based 
fiber counts on membrane filter samples and fiber counts estimated from impinger 
samples. The standard PCM method counts only fibers longer than 5 µm. Moreover, 
some fibers longer than 5 µm may be too thin to be detected by PCM. Thus, an un-
determined number of fibers collected on each sample remain uncounted by PCM. 
More sensitive analytical methods are currently available, but standardization and 
validation of these methods will be required before they can be recommended for 
routine analysis. However, unlike PCM, these methods are substantially more ex-
pensive, and field instruments are not available. In addition, any substantive change 
in analytical techniques used to evaluate exposures to asbestos and/or the criteria 
for determining exposure concentrations will necessitate a reassessment of current 
risk estimates, which are based on PCM-derived fiber concentrations.
Epidemiological evidence clearly indicates a causal relationship between exposure 
to fibers from the asbestos minerals and various adverse health outcomes, including 
asbestosis, lung cancer, and mesothelioma. However, NIOSH has viewed as incon-
clusive the results from epidemiological studies of workers exposed to EMPs from 
the nonasbestiform analogs of the asbestos minerals. Populations of interest for 
possible epidemiological studies include workers at talc mines in upstate New York 
and workers at taconite mines in northeastern Minnesota. Others include popula-
tions exposed to other EMPs, such as winchite and richterite fibers (asbestiform 
EMPs identified in vermiculite from a former mine near Libby, Montana), zeolites 
(such as asbestiform erionite), and other minerals (such as fluoro-edenite). Future 
studies should include detailed characterizations of the particles to which workers 
are or have been exposed.
There is considerable potential for experimental animal and in vitro studies to ad-
dress specific scientific questions relating to the toxicity of EMPs. Short-term in 
vivo animal studies and in vitro studies have been conducted to examine cellular 
and tissue responses to EMPs, identify pathogenic mechanisms involved in those 
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responses, and understand morphological and/or physicochemical EMP properties 
controlling those mechanisms. Long-term studies of animals exposed to EMPs have 
been conducted to assess the risk for adverse health outcomes (primarily lung can-
cer, mesothelioma, and lung fibrosis) associated with various types and dimensions 
of EMPs. Such studies have produced evidence demonstrating the importance of 
dimensional characteristics of mineral particles for determining carcinogenic po-
tential of durable EMPs. Although in vitro studies and animal studies are subject to 
uncertainties with respect to how their findings apply to humans, such studies are 
warranted to systematically assess and better understand the impacts of dimension, 
morphology, chemistry, and biopersistence of EMPs on malignant and nonmalig-
nant respiratory disease outcomes.
To reduce existing scientific uncertainties and to help resolve current policy con-
troversies, a strategic research program is needed that encompasses endeavors in 
toxicology, exposure assessment, epidemiology, mineralogy, and analytical meth-
ods. The findings of such research can contribute to the development of new policies 
for exposures to airborne asbestos fibers and other EMPs with recommendations 
for exposure indices that are not only more effective in protecting workers’ health 
but firmly based on quantitative estimates of health risk. To bridge existing scien-
tific uncertainties, this Roadmap proposes that interdisciplinary research address 
the following three strategic goals: (1) develop a broader and clearer understand-
ing of the important determinants of toxicity for EMPs, (2) develop information 
on occupational exposures to various EMPs and health risks associated with such 
exposures, and (3) develop improved sampling and analytical methods for asbestos 
fibers and other EMPs. 
Developing a broader and clearer understanding of the important determinants of 
toxicity for EMPs will involve building on what is known by systematically con-
ducting in vitro studies and in vivo animal studies to ascertain which physical and 
chemical properties of EMPs influence their toxicity and their underlying mecha-
nisms of action in causing disease. The in vitro studies could provide information on 
membranolytic, cytotoxic, and genotoxic activities as well as signaling mechanisms. 
The in vivo animal studies should involve a multispecies testing approach for short-
term assays to develop information for designing chronic inhalation studies and to 
develop information on biomarkers and mechanisms of disease. Chronic animal 
inhalation studies are required to address the impacts of dimension, morphology, 
chemistry, and biopersistence on critical disease endpoints, including cancer and 
nonmalignant respiratory disease. Chronic inhalation studies should be designed 
to provide solid scientific evidence on which to base human risk assessments for 
a variety of EMPs. The results of toxicity studies should be assessed in the context 
of results of epidemiologic studies to provide a basis for understanding the human 
health effects of exposure to EMPs for which epidemiologic studies are not available. 
Developing information and knowledge on occupational exposures to various 
EMPs and potential health outcomes will involve (1) collecting and analyzing avail-
able occupational exposure information to ascertain the characteristics and extent 
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of exposure to various types of EMPs; (2) collecting and analyzing available infor-
mation on health outcomes associated with exposures  to various types of EMPs; 
(3) conducting epidemiological studies of workers exposed to various types of EMPs 
to better define the association between exposure and health effects; and (4) devel-
oping and validating methods for screening, diagnosis, and secondary prevention 
for diseases caused by exposure to asbestos fibers and other EMPs. 
Developing improved sampling and analytical methods for EMPs will involve (1) re-
ducing interoperator and interlaboratory variability of currently used analytical 
methods; (2) developing a practical analytical method that will permit the counting, 
sizing, and identification of EMPs; (3) developing a practical analytical method that 
can assess the potential durability of EMPs as one determinant of biopersistence 
in the lung; and (4) developing and validating size-selective sampling methods for 
collecting and quantifying airborne thoracic-size asbestos fibers and other EMPs.
A primary anticipated outcome of the research that is broadly outlined in this Road-
map will be the identification of the physicochemical parameters such as chemical 
composition, dimensional attributes (e.g., ranges of length, width, and aspect ratio), 
and durability as predictors of biopersistence, as well as particle surface character-
istics or activities (e.g., generation reactive oxygen species [ROS]) as determinants 
of toxicity of asbestos fibers and other EMPs. The results of the research will also 
help define the sampling and analytical methods that closely measure the important 
toxic characteristics and need to be developed. These results can then inform devel-
opment of appropriate recommendations for worker protection.
Another outcome of the research that is broadly outlined in this Roadmap might be the 
development of criteria that could be used to predict, on the basis of results of in vitro 
testing and/or short-term in vivo testing, the potential risk associated with exposure 
to any particular type of EMP. This could reduce the need for comprehensive toxicity 
testing with long-term in vivo animal studies and/or epidemiological evaluation of each 
type of EMP. Ultimately, the results from such studies could be used to fill in knowledge 
gaps beyond EMPs to encompass predictions of relative toxicities and adverse health 
outcomes associated with exposure to other elongate particles (EPs), including inor-
ganic and organic manufactured particles. A coherent risk management approach that 
fully incorporates an understanding of the toxicity of particles could then be developed 
to minimize the potential for disease in exposed individuals and populations. 
This Roadmap is intended to outline the scientific and technical research issues that 
need to be addressed to ensure that workers are optimally protected from health 
risks posed by exposures to asbestos fibers and other EMPs. Achievement of the 
research goals framed in this Roadmap will require a significant investment of time, 
scientific talent, and resources by NIOSH and others. This investment, however, can 
result in a sound scientific basis for better occupational health protection policies 
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Many workers are exposed to a broad spec-
trum of inhalable particles in their places 
of work. These particles vary in origin, size, 
shape, chemistry, and surface properties. Con-
siderable research over many years has been 
undertaken to understand the potential health 
effects of these particles and the particle char-
acteristics that are most important in confer-
ring their toxicity. Elongate particles* (EPs) 
have been the subject of much research, and 
the major focus of research on EPs has related 
to asbestos fibers, a group of elongate miner-
al particles (EMPs) that have long been known 
to cause serious disease when inhaled. Because 
of the demonstrated health effects of asbestos, 
research attention has also been extended not 
only to other EMPs, but also to synthetic vitre-
ous fibers which have dimensions similar to as-
bestos fibers and, more recently, to engineered 
carbon nanotubes and carbon nanofibers. Al-
though nonmineral EPs are of interest, they are 
not the subject of this Roadmap, which focus-
es on EMPs. 
Occupational health policies and associat-
ed federal regulations controlling occupation-
al exposure to airborne asbestos fibers have 
* A glossary of technical terms is provided in Section 6. It in-
cludes definitions of terms from several standard sources 
in Tables 1 and 2. In general, where a term is used in this 
Roadmap the definitions in Tables 1 and 2 under the col-
umn “NIOSH 1990” are intended unless otherwise spec-
ified. Readers should be aware that, in reviewing publi-
cations cited in this Roadmap, it was not always possible 
to know the meaning of technical terms as used by the 
authors of those publications. Thus, some imprecision of 
terminology carries over into the literature review con-
tained in this Roadmap.
been in existence for decades. Current regula-
tions have been based on studies of the health 
effects of exposures encountered in the com-
mercial exploitation and use of asbestos fibers. 
Nevertheless, important uncertainties remain 
to be resolved to fully inform possible revision 
of existing federal policies and/or development 
of new federal policies to protect workers from 
health effects caused by occupational exposure 
to airborne asbestos fibers. 
Health effects caused by other exposures to 
EMPs have not been studied as thoroughly as 
health effects caused by exposures in the com-
mercial exploitation and use of asbestos fibers. 
Miners and others exposed to asbestiform am-
phibole fibers associated with vermiculite from 
a mine near Libby, Montana, may not have 
been exposed to commercial asbestos fibers, 
but the adverse health outcomes they have ex-
perienced as a result of their exposure have in-
dicated that those EMPs are similarly toxic. 
Other hardrock miner populations face un-
certain but potential risk associated with ex-
posures to EMPs that could be generated dur-
ing mining and processing of nonasbestiform 
amphiboles. Studies of human populations ex-
posed to airborne fibers of erionite, a fibrous 
mineral that is neither asbestos nor amphibole, 
have documented high rates of malignant me-
sothelioma (a cancer most commonly asso-
ciated with exposure to asbestos fibers). Fur-
ther research is warranted to understand how 
properties of EMPs determine toxicity so that 
the nature and magnitude of any potential tox-
icity associated with an EMP to which work-
ers are exposed can be readily predicted and 
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controlled, even when exhaustive long-term 
studies of that particular EMP have not been 
carried out.
This Roadmap has been prepared and is be-
ing disseminated with the intent of motivating 
eventual development and implementation of 
a coordinated, interdisciplinary research pro-
gram that can effectively address key remaining 
issues relating to health hazards associated with 
exposure to asbestos fibers and other EMPs. 
Section 2, Overview of Current Issues, provides 
an overview of available scientific information 
and identifies important issues that need to be 
resolved before recommendations for occupa-
tional exposure to airborne asbestos fibers and 
related EMPs can be improved and before rec-
ommendations for occupational exposure to 
other EMPs can be developed. The nature of oc-
cupational exposures to asbestos has changed 
over the last several decades. Once dominated 
by chronic exposures in asbestos textile mills, 
friction product manufacturing, cement pipe 
fabrication, and insulation manufacture and 
installation, occupational exposures to asbestos 
in the United States now primarily occur dur-
ing maintenance activities or remediation of 
buildings containing asbestos. OSHA has esti-
mated that 1.3 million workers in general in-
dustry continue to be exposed to asbestos. In 
2002 NIOSH estimated that about 44,000 mine 
workers might be exposed to asbestos fibers or 
amphibole cleavage fragments during the min-
ing of some mineral commodities. These cur-
rent occupational exposure scenarios frequent-
ly involve short-term, intermittent exposures, 
and proportionately fewer long fibers than 
workers were exposed to in the past. The gen-
erally lower current exposures and predomi-
nance of short fibers give added significance to 
the question of whether or not there are thresh-
olds for EMP exposure level and EMP length 
below which workers would incur no demon-
strable risk of material health impairment. The 
large number of potentially exposed workers 
and these changed exposure scenarios also give 
rise to the need to better understand whether 
appropriate protection is provided by the cur-
rent occupational exposure recommendations 
and regulations. In addition, limited informa-
tion is currently available on exposures to, and 
health effects of, other EMPs. 
Section 3, Framework for Research, provides a 
general framework for research needed to ad-
dress the key issues. NIOSH envisions that this 
general framework will serve as a basis for a 
future interdisciplinary research program car-
ried out by a variety of organizations to (1) elu-
cidate exposures to EMPs, (2) identify any ad-
verse health effects caused by these exposures, 
and (3) determine the influence of size, shape, 
and other physical and chemical characteris-
tics of EMPs on human health. Findings from 
this research would provide a basis for deter-
mining which EMPs should be included in 
recommendations to protect workers from 
hazardous occupational exposures along with 
appropriate exposure limits. A fully informed 
strategy for prioritizing research on EMPs will 
be based on a systematic collection and evalu-
ation of available information on occupational 
exposures to EMPs. 
Section 4, The Path Forward, broadly outlines a 
proposed structure for development and over-
sight of a comprehensive, interdisciplinary re-
search program. Key to this approach will be 
(1) the active involvement of stakeholders rep-
resenting parties with differing views, (2) ex-
pert study groups specifying and guiding vari-
ous components of the research program, and 
(3) a multidisciplinary group providing care-
ful ongoing review and oversight to ensure rel-
evance, coordination, and impact of the overall 
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research program. NIOSH does not intend this 
(or any other) section of this Roadmap to be 
prescriptive, so detailed research aims, specific 
research priorities, and funding considerations 
have intentionally not been specified. Rather, it 
is expected that these more detailed aspects of 
the program will be most effectively developed 
with collaborative input from scientists, policy 
experts, and managers from various agencies, 
as well as from other interested stakeholders. 
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2 Overview of Current Issues
2.1 Background
Prior to the 1970s, concern about the health ef-
fects of occupational exposure to airborne fi-
bers was focused on six commercially exploit-
ed minerals termed “asbestos:” the serpentine 
mineral chrysotile and the amphibole minerals 
cummingtonite-grunerite asbestos (amosite), 
riebeckite asbestos (crocidolite), actinolite as-
bestos, anthophyllite asbestos, and tremolite as-
bestos. The realization that dimensional char-
acteristics of asbestos fibers were important 
physical parameters in the initiation of respi-
ratory disease led to studies of other elongate 
mineral particles (EMPs) of similar dimensions 
[Stanton et al. 1981].
To date, occupational health interest in EMPs 
other than asbestos fibers has been focused pri-
marily on fibrous minerals exploited commer-
cially (e.g., wollastonite, sepiolite, and attapulgite) 
and mineral commodities that contain (e.g., 
Libby vermiculite) or may contain (e.g., upstate 
New York talc) asbestiform minerals. Exposure 
to airborne thoracic-size EMPs generated from 
the crushing and fracturing of nonasbestiform 
amphibole minerals has also garnered sub-
stantial interest. The asbestos minerals, as well 
as other types of fibrous minerals, are typical-
ly associated with other minerals in geologic 
formations at various locations in the United 
States [Van Gosen 2007]. The biological sig-
nificance of occupational exposure to airborne 
particles remains unknown for some of these 
minerals and can be difficult to ascertain, given 
the mixed and sporadic nature of exposure in 
many work environments and the general lack 
of well-characterized exposure information.
The complex and evolving terminology used to 
name and describe the various minerals from 
which airborne EMPs are generated has led to 
much confusion and uncertainty in scientif-
ic and lay discourse related to asbestos fibers 
and other EMPs. To help reduce such confu-
sion and uncertainty about the content of this 
Roadmap, several new terms are used in this 
Roadmap and defined in the Glossary (Sec-
tion 6). The Glossary also lists definitions from 
a variety of sources for many other mineral-
ogical and other scientific terms used in this 
Roadmap. Definitions from these sources of-
ten vary, and many demonstrate a lack of stan-
dardization and sometimes rigor that should 
be addressed by the scientific community.
To address current controversies and uncer-
tainties concerning exposure assessment and 
health effects relating to asbestos fibers and 
other EMPs, strategic research endeavors are 
needed in toxicology, exposure assessment, ep-
idemiology, mineralogy, and analytical meth-
ods. The results of such research might inform 
new risk assessments and the potential devel-
opment of new policies for asbestos fibers and 
other EMPs, with recommendations for ex-
posure limits that are firmly based on well-
established risk estimates and that effectively 
protect workers’ health. To support the devel-
opment of these policies, efforts are needed to 
establish a common set of mineral terms that 
unambiguously describe EMPs and are rele-
vant for toxicological assessments. What fol-
lows in the remainder of Section 2 is an over-
view of (1)  definitions and terms relevant to 
asbestos fibers and other EMPs; (2)  trends in 
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production and use of asbestos; (3)  occupa-
tional exposures to asbestos and asbestos-relat-
ed diseases; (4) sampling and analytical issues; 
and (5) physicochemical properties associated 
with EMP toxicity.
2.2 Minerals and Mineral 
Morphology
Minerals are naturally occurring inorganic 
compounds with a specific crystalline struc-
ture and elemental composition. Asbestos is a 
term applied to several silicate minerals from 
the serpentine and amphibole groups that oc-
cur in a particular type of fibrous habit and 
have properties that have made them commer-
cially valuable. The fibers of all varieties of as-
bestos are long, thin, and usually flexible when 
separated. One variety of asbestos, chrysotile, 
is a mineral in the serpentine group of sheet 
silicates. Five varieties of asbestos are miner-
als in the amphibole group of double-chain 
silicates—riebeckite asbestos (crocidolite), 
cummingtonite-grunerite asbestos (amosite), 
anthophyllite asbestos, tremolite asbestos, and 
actinolite asbestos [Virta 2002].
Although a large amount of health informa-
tion has been generated on workers occupa-
tionally exposed to asbestos, limited miner-
al characterization information and the use of 
nonmineralogical names for asbestos have re-
sulted in uncertainty and confusion about the 
specific nature of exposures described in many 
published studies. Trade names for mined as-
bestos minerals predated the development of 
rigorous scientific nomenclature. For exam-
ple, amosite is the trade name for asbestiform 
cummingtonite-grunerite and crocidolite is 
the trade name for asbestiform riebeckite. A 
changing mineralogical nomenclature for am-
phiboles has also contributed to uncertainty in 
the specific identification of minerals reported 
in the literature. Over the past 50 years, several 
systems for naming amphibole minerals have 
been used. The current mineralogical nomen-
clature was unified by the International Miner-
alogical Association (IMA) under a single sys-
tem in 1978 [Leake 1978] and later modified in 
1997 [Leake et al. 1997]. For some amphibole 
minerals, the name assigned under the 1997 
IMA system is different than the name used 
prior to 1978, but the mineral names specified 
in regulations have not been updated to corre-
late with the new IMA system names.
Adding to the complexity of the nomencla-
ture, serpentine and amphibole minerals typ-
ically develop through the alteration of other 
minerals. Consequently, they may exist as par-
tially altered minerals having variations in el-
emental compositions. For example, the mi-
croscopic analysis of an elongate amphibole 
particle using energy dispersive X-ray spec-
troscopy (EDS) can reveal variations in ele-
mental composition along the particle’s length, 
making it difficult to identify the particle as a 
single specific amphibole mineral. In addition, 
a mineral may occur in different growth forms, 
or “habits,” so different particles may have dif-
ferent morphologies. However, because they 
share the same range of elemental composition 
and chemical structure and belong to the same 
crystal system, they are the same mineral. Dif-
ferent habits are not recognized as having dif-
ferent mineral names.
Mineral habit results from the environmental 
conditions present during a mineral’s formation. 
The mineralogical terms applied to habits are 
generally descriptive (e.g., fibrous, asbestiform, 
massive, prismatic, acicular, asbestiform, tab-
ular, and platy). Both asbestiform (a specif-
ic fibrous type) and nonasbestiform versions 
(i.e., analogs) of the same mineral can occur in 
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juxtaposition or matrixed together, so that both 
analogs of the same mineral can occur within a 
narrow geological formation.
The habits of amphibole minerals vary, from 
prismatic crystals of hornblende through pris-
matic or acicular crystals of riebeckite, actinolite, 
tremolite, and others, to asbestiform habits of 
grunerite (amosite), anthophyllite, tremolite- 
actinolite, and riebeckite (crocidolite). The pris-
matic and acicular crystal habits occur more 
commonly, and asbestiform habit is rela-
tively rare. Some of the amphiboles, such as 
hornblendes, are not known to occur in an 
asbestiform habit. The asbestiform varieties 
range from finer (flexible) to coarser (more 
brittle) and often are found in a mixture of fine 
and coarse fibrils. In addition, properties vary—
e.g., density of (010) defects—even within an 
apparently homogeneous specimen [Dorling 
and Zussman 1987].
In the scientific literature, the term “miner-
al fibers” has often been used to refer not only 
to particles that occur in an asbestiform habit 
but also to particles that occur in other fibrous 
habits or as needle-like (acicular) single crys-
tals. The term “mineral fibers” has sometimes 
also encompassed other prismatic crystals and 
cleavage fragments that meet specified dimen-
sional criteria. Cleavage fragments are gener-
ated by crushing and fracturing minerals, in-
cluding the nonasbestiform analogs of the 
asbestos minerals. Although the substantial 
hazards of inhalational exposure to airborne 
asbestos fibers have been well documented, 
there is ongoing debate about whether expo-
sure to thoracic-size EMPs (EMPs of a size that 
can enter the thoracic airways when inhaled) 
from nonasbestiform analogs of the asbestos 
minerals is also hazardous.
2.3 Terminology
The use of nonstandard terminology or terms 
with imprecise definitions when reporting 
studies makes it difficult to fully understand 
the implications of these studies or to compare 
the results to those of other studies. For the 
health community, this ultimately hampers re-
search efforts, leads to ambiguity in exposure-
response relationships, and could also lead to 
imprecise recommendations to protect human 
health. Terms are often interpreted differently 
between disciplines. The situation is complicat-
ed by further different usage of the same terms 
by stakeholders outside of the scientific com-
munity. NIOSH has carefully reviewed numer-
ous resources and has not found any current 
reference for standard terminology and defi-
nitions in several disciplines that is complete 
and unambiguous. An earlier tabulation of as-
bestos-related terminology by the USGS dem-
onstrated similar issues [Lowers and Meeker 
2002]. The terms “asbestos” and “asbestiform” 
exemplify this issue. They are commonly used 
terms but lack mineralogical precision. “As-
bestos” is a term used for certain minerals that 
have crystallized in a particular macroscopic 
habit with certain commercially useful proper-
ties. These properties are less obvious on mi-
croscopic scales, and so a different definition of 
“asbestos” may be necessary at the scale of the 
light microscope or electron microscope, in-
volving characteristics such as chemical com-
position and crystallography. “Asbestiform” is 
a term applied to minerals with a macroscopic 
habit similar to that of asbestos. The lack of pre-
cision in these terms and the difficulty in trans-
lating macroscopic properties to microscopi-
cally identifiable characteristics contribute to 
miscommunication and uncertainty in iden-
tifying toxicity associated with various forms 
of minerals. Some deposits may contain more 
than one habit or transitional particles may be 
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present, which make it difficult to clearly and 
simply describe the mineralogy. Furthermore, 
the minerals included in the term asbestos 
vary between federal agencies and sometimes 
within an agency. 
NIOSH supports the development of standard 
terminology and definitions relevant to the is-
sues of asbestos and other EMPs that are based 
on objective criteria and are acceptable to the 
majority of scientists. NIOSH also supports 
the dissemination of standard terminology 
and definitions to the community of interest-
ed nonscientists and encourages adoption and 
use by this community. The need for the devel-
opment and standardization of unambiguous 
terminology and definitions warrants a prior-
ity effort of the greater scientific community 
that should precede, or at least be concurrent 
with, further research efforts.
2.3.1 Mineralogical Definitions
The minerals of primary concern are the 
asbestiform minerals that have been regulated 
as asbestos (chrysotile, amosite,† crocidolite,‡ 
tremolite asbestos, actinolite asbestos, and 
anthophyllite asbestos). In addition, there is in-
terest in closely related minerals to which work-
ers might be exposed that (1) were not commer-
cially used but would have been mineralogically 
identified as regulated asbestos minerals at the 
time the asbestos regulations were promulgat-
ed (e.g., asbestiform winchite and richterite); 
(2)  are other asbestiform amphiboles (e.g., 
fluoro-edenite); (3)  might resemble asbes-
tos (e.g., fibrous antigorite); (4)  are unrelated 
EMPs (e.g., the zeolites erionite and mordenite, 
fibrous talc, and the clay minerals sepiolite and 
palygorskite); and (5)  are individual particles 
†Amosite is not recognized as a proper mineral name.
‡Crocidolite is not recognized as a proper mineral name.
or fragments of the nonasbestiform analogs of 
asbestos minerals. Minerals are precisely de-
fined by their chemical composition and crys-
tallography. Ionic substitutions occur in miner-
als, especially for metal cations of similar ionic 
charge or size. Such substitution can result in 
an isomorphous series (also referred to as solid-
solution or mixed crystal) consisting of miner-
als of varying composition between end-mem-
bers with a specific chemical composition. The 
differences in chemical composition within an 
isomorphous series can result in different prop-
erties such as color and hardness, as well as dif-
ferences in crystal properties by alteration of 
unit-cell dimensions. It is sometimes possible 
to differentiate mineral species on the basis of 
distinctive changes through an isomorphous se-
ries. However, in general, classification occurs 
by an arbitrary division based on chemistry, 
and this can be complicated by having multiple 
sites of possible substitution (e.g., in a specific 
mineral, calcium may exchange for magnesium 
in one position whereas sodium and potassium 
may be exchanged in another position). These 
allocations are open to reevaluation and re-
classification over time (e.g., the mineral now 
named richterite was called soda-tremolite in 
pre-1978 IMA nomenclature).
When certain minerals were marketed or regu-
lated as asbestos, the mineral names had defini-
tions that might have been imprecise at the time 
and might have changed over time. In particu-
lar, the mineral name amosite was a commercial 
term for a mineral that was not well defined at 
first. The definitions of amosite in the Dictionary 
of Mining, Mineral, and Related Terms [USBOM 
1996] and in the Glossary of Geology [American 
Geological Institute 2005] allow for the possibil-
ity that amosite might be anthophyllite asbes-
tos, although it is now known to be a mineral in 
the cummingtonite-grunerite series. This is one 
source of confusion in the literature.
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A further source of confusion comes from the 
use of the geological terms for a mineral habit. 
Minerals of the same chemistry differing only 
in the expression of their crystallinity (e.g., mas-
sive, fibrous, asbestiform, or prismatic) are not 
differentiated in geology as independent spe-
cies. Thus, tremolite in an asbestiform crystal 
habit is not given a separate name (either chem-
ical or common) from tremolite in a massive 
habit. It has been suggested that crystals grown 
in an “asbestiform” habit can be distinguished 
by certain characteristics, such as parallel or ra-
diating growth of very thin and elongate crys-
tals that are to some degree flexible, the pres-
ence of bundles of fibrils, and, for amphiboles, 
a particular combination of twinning, stacking 
faults, and defects [Chisholm 1973]. The geo-
logical conditions necessary for the formation 
of asbestiform crystals are not as common as 
those that produce other crystal habits. These 
other habits may occur without any accompa-
nying asbestiform crystals. However, amphi-
bole asbestos may also include additional am-
phiboles that, if separated, are not asbestiform 
[Brown and Gunter 2003]. The mineralogi-
cal community uses many terms, including fi-
bril, fiber, fibrous, acicular, needlelike, prismat-
ic, and columnar, to denote crystals that are 
elongate. In contrast, in sedimentology, similar 
terms have been more narrowly defined with 
specific axial ratios.
Thus it is not clear, even from a single reference 
source, exactly what range of morphologies are 
described by these terms and the degree of 
overlap, if any. For example, the Dictionary of 
Mining, Mineral, and Related Terms defines fi-
bril as “a single fiber, which cannot be separat-
ed into smaller components without losing its 
fibrous properties or appearance,” but also de-
fines a fiber as “the smallest single strand of as-
bestos or other fibrous material.”
2.3.2 Other Terms and Definitions
Health-related professions also employ termi-
nology that can be used imprecisely. For exam-
ple, the terms “inhalable” and “respirable” have 
different meanings but are sometimes used in-
terchangeably. Also, each of these terms is de-
fined somewhat differently by various profes-
sional organizations and agencies. Particles can 
enter the human airways, but the aspiration ef-
ficiency, the degree of penetration to different 
parts of the airways, and the extent of deposi-
tion depend on particle aerodynamics, as well 
as on the geometry and flow dynamics within 
the airways. In addition to obvious differences 
between species (e.g., mouse, rat, dog, primate, 
human), there is a significant range of variation 
within a species based on, for example, age, sex, 
body mass, and work-rate. Thus, these terms 
may mean different things to a toxicologist en-
gaging in animal inhalation experiments, an 
environmental specialist concerned with child-
hood exposure, and an industrial hygienist 
concerned with adult, mostly male, workers.
2.4 Trends in Asbestos Use, 
Occupational Exposures, 
and Disease
2.4.1 Trends in Asbestos Use
Over recent decades, mining and use of as-
bestos have declined in the United States. The 
mining of asbestos in the United States ceased 
in 2002. Consumption of raw asbestos contin-
ues to decline from a peak of 803,000 metric 
tons in 1973 [USGS 2006]. In 2006, 2000 met-
ric tons of raw asbestos were imported, down 
from an estimated 35,000 metric tons in 1991 
(see Figure 1) and a peak of 718,000 metric 
tons in 1973. Unlike information on the im-
portation of raw asbestos, information is not 
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readily available on the importation of asbestos-
containing products. The primary recent uses 
for asbestos materials in the United States are 
estimated as 55% for roofing products, 26% for 
coatings and compounds, and 19% for other 
applications [USGS 2007], and more recently 
as 84% for roofing products and 16% for other 
applications [USGS 2008]. 
Worldwide, the use of asbestos has declined. 
Using the amount of asbestos mined as a sur-
rogate for the amount used, worldwide annu-
al use has declined from about 5 million met-
ric tons in 1975 to about 2 million metric tons 
since 1999 [Taylor et al. 2006]. The European 
Union has banned imports and the use of as-
bestos with very limited exceptions. In oth-
er regions of the world, there is a continued 
demand for inexpensive, durable construc-
tion materials. Consequently, markets remain 
strong in some countries for asbestos-cement 
products, such as asbestos-cement panels for 
construction of buildings and asbestos-cement 
pipe for water-supply lines. Currently over 70% 
of all mined asbestos is used in Eastern Europe 
and Asia [Tossavainen 2005].
Historically, chrysotile accounted for more 
than 90% of the world’s mined asbestos; it 
presently accounts for over 99% [Ross and 
Virta 2001; USGS 2008]. Mining of crocidolite 
(asbestiform riebeckite) and amosite (asbesti-
form cummingtonite-grunerite) deposits have 
accounted for most of the remaining asbestos. 
Mining of amosite is thought to have ceased in 
1992 and mining of crocidolite is thought to 
have ended in 1997, although it is not possible 
to be certain. Small amounts of anthophyllite 
asbestos have been mined in Finland [Ross and 
Virta 2001] and are currently being mined in 
India [Ansari et al. 2007].
2.4.2 Trends in Occupational Exposure
Since 1986, the annual geometric mean concen-
trations of occupational exposures to asbestos in 
the United States, as reported in the Integrated 
Management Information System (IMIS) of the 
Occupational Safety and Health Administration 
Figure 1. U.S. asbestos production and imports, 1991–2007. Source of data: USGS [2008].
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(OSHA) and the database of the Mine Safety 
and Health Administration (MSHA), have been 
consistently below the NIOSH recommend-
ed exposure limit (REL) of 0.1 fibers per cubic 
centimeter of air (f/cm3) for all major indus-
try divisions (Figure 2). The number of occu-
pational asbestos exposures that were measured 
and reported in IMIS decreased from an aver-
age of 890 per year during the 8-year period of 
1987–1994 to 241 per year during the 5-year pe-
riod of 1995–1999 and 135 for the 4-year peri-
od of 2000–2003. The percentage exceeding the 
NIOSH REL decreased from 6.3% in 1987–1994 
to 0.9% in 1995–1999, but it increased to 4.3% in 
2000–2003. During the same three periods, the 
number of exposures measured and reported in 
MSHA’s database decreased from an average of 
47 per year during 1987–1994 to an average of 
23 per year during 1995–1999, but it increased 
to 84 during 2000–2003 (most of which were 
collected in 2000). The percentage exceeding 
the NIOSH REL decreased from 11.1% in 1987–
1994 to 2.6% in 1995–1999, but it increased to 
9.8% in 2000–2003 [NIOSH 2007a]. 
The preceding summary of occupational ex-
posures to asbestos is based on the OSHA and 
MSHA regulatory definitions relating to asbestos. 
Because NIOSH includes nonasbestiform ana-
logs of the asbestos minerals in the REL that may 
have, at least from some samples, been excluded 
by OSHA and MSHA in performing differential 
counting, the reported percentages of exposures 
exceeding the REL should be interpreted as low-
er limits. Because of analytical limitations of the 
phase contrast microscopy (PCM) method and 
the variety of workplaces from which the data 
were obtained, it is unclear what portions of these 
exposures were to EMPs from nonasbestiform 
analogs of the asbestos minerals, which have 
been explicitly encompassed by the NIOSH REL 
for airborne asbestos fibers since 1990.
Figure 2. Asbestos: Annual geometric mean exposure concentrations by major industry division, 
MSHA and OSHA samples, 1979–2003. Source of data: NIOSH [2007a]. Note: the MSHA PEL for 
this time period was 2 f/cm3.
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Very limited information is available on the 
number of workers still exposed to asbestos. 
On the basis of mine employment data [MSHA 
2002], NIOSH estimated that 44,000 miners 
and other mine workers may be exposed to as-
bestos or amphibole cleavage fragments dur-
ing the mining of some mineral commodities 
[NIOSH 2002]. OSHA estimated in 1990 that 
about 568,000 workers in production and ser-
vices industries and 114,000 in construction 
industries may be exposed to asbestos in the 
workplace [OSHA 1990]. More recently, OSHA 
has estimated that 1.3 million employees in con-
struction and general industry face significant 
asbestos exposure on the job [OSHA 2008].
In addition to evidence from OSHA and MSHA 
that indicates a reduction in occupational ex-
posures in the United States over the last sev-
eral decades of the 1900s, other information 
compiled on workplace exposures to asbes-
tos indicates that the nature of occupational 
exposures to asbestos has changed [Rice and 
Heineman 2003]. Once dominated by chron-
ic exposures in manufacturing processes such 
as those used in textile mills, friction product 
manufacturing, and cement pipe fabrication, 
current occupational exposures to asbestos in 
the United States primarily occur during main-
tenance activities or remediation of buildings 
containing asbestos. These current occupa-
tional exposure scenarios frequently involve 
short-term, intermittent exposures.
2.4.3 Trends in Asbestos-related 
Disease
Evidence that asbestos causes lung cancer and 
mesothelioma in humans is well documented 
[NIOSH 1976; IARC 1977, 1987a,b; EPA 1986; 
ATSDR 2001; HHS 2005a]. Epidemiological 
studies of workers occupationally exposed to 
asbestos have clearly documented a substantial 
increase in risk of several nonmalignant respi-
ratory diseases, including diffuse fibrosis of the 
lung (i.e., asbestosis) and nonmalignant pleu-
ral abnormalities including acute pleuritis and 
chronic diffuse and localized thickening of the 
pleura [ATS 2004]. In addition, it has been de-
termined that laryngeal cancer [IOM 2006] and 
ovarian cancer [Straif et al. 2009] can be caused 
by exposure to asbestos, and evidence suggests 
that asbestos may also cause other diseases (e.g., 
pharyngeal, stomach, and colorectal cancers 
[IOM 2006] and immune disorders [ATSDR 
2001]).
National surveillance data, showing trends over 
time, are available for two diseases with rather 
specific mineral fiber etiologies—asbestosis and 
malignant mesothelioma (see following subsec-
tions). Lung cancer is known to be caused in 
part by asbestos fiber exposure but has multi-
ple etiologies. Ongoing national surveillance for 
lung cancer caused by asbestos exposure has not 
been done. However, using various assumptions 
and methods, several researchers have projected 
the number of U.S. lung cancer deaths caused by 
asbestos. Examples of the projected number of 
asbestos-caused lung cancer deaths in the Unit-
ed States include 55,100 [Walker et al. 1983] and 
76,700 [Lilienfeld et al. 1988]; each of these pro-
jections represent the 30-year period from 1980 
through 2009. However, in the absence of spe-
cific diagnostic criteria and a specific disease 
code for the subset of lung cancers caused by as-
bestos, ongoing surveillance cannot be done for 
lung cancer caused by asbestos.
 2.4.3.1 Asbestosis
NIOSH has annually tracked U.S. deaths due to 
asbestosis since 1968 and deaths due to malig-
nant mesothelioma since 1999, using death cer-
tificate data in the National Occupational Re-
spiratory Mortality System (NORMS). NORMS 
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data, representing all deaths among U.S. resi-
dents, show that asbestosis deaths increased al-
most 20-fold from the late 1960s to the late 1990s 
(Figure 3) [NIOSH 2007b]. Asbestosis mortality 
trends are expected to substantially trail trends 
in asbestos exposures (see Section 2.4.2) for two 
primary reasons: (1) the latency period between 
asbestos exposure and asbestosis onset is typi-
cally long, commonly one or two decades or 
more; and (2) asbestosis is a chronic disease, so 
affected individuals can live for many years with 
the disease before succumbing. In fact, asbesto-
sis deaths have apparently plateaued (at nearly 
1,500 per year) since 2000 (Figure 3) [NIOSH 
2007b]. Ultimately, it is anticipated that the an-
nual number of asbestosis deaths in the United 
States will decrease substantially as a result of 
documented reductions in exposure. However, 
asbestos use has not been completely eliminat-
ed, and because asbestos-containing materials 
remain in structural materials and machinery, 
the potential for exposure continues. Thus, 
asbestosis deaths in the United States are antici-
pated to continue for several decades.
2.4.3.2 Malignant Mesothelioma
Malignant mesothelioma, an aggressive disease 
that is nearly always fatal, is known to be caused 
by exposure to asbestos and some other min-
eral fibers [IOM 2006]. The occurrence of 
mesothelioma has been strongly linked with 
occupational exposures to asbestos [Bang et 
al. 2006]. There had been no discrete Interna-
tional Classification of Disease (ICD) code for 
mesothelioma until its most recent 10th revision. 
Thus, only seven years of NORMS data are avail-
able with a specific ICD code for mesothelioma 
(Figure 4); during this period, there was a 9% 
increase in annual mesothelioma deaths, from 
2,484 in 1999 to 2,704 in 2005 [NIOSH 2007b]. 
A later peak for mesothelioma deaths than 
for asbestosis deaths would be entirely expect-
ed, given the longer latency for mesothelioma 
Figure 3. Number of asbestosis deaths, U.S. residents aged ≥15 years, 1968–2004. Source of data: 
NIOSH [2007b].
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[Järvholm et al. 1999]. One analysis of malig-
nant mesothelioma incidence based on the Na-
tional Cancer Institute’s Surveillance, Epidemi-
ology, and End Results (SEER) Program data 
found that an earlier steep increase in inci-
dence had moderated and that mesothelioma 
incidence may have actually peaked sometime 
in the 1990s in SEER-covered areas [Weill et al. 
2004]. In contrast to NORMS data, which rep-
resents a census of all deaths in the entire Unit-
ed States, the analyzed SEER data were from ar-
eas in which a total of only about 15% of the U.S. 
population resides.
2.5 Workers’ Home 
Contamination 
In addition to workers’ exposures, their families 
also have the potential for exposure to asbestos 
[NIOSH 1995]. Families have been exposed to 
asbestos when workers were engaged in min-
ing, shipbuilding, insulating, maintenance and 
repair of boilers and vehicles, and asbestos re-
moval operations. Occupants of homes where 
asbestos workers live may be exposed while 
house cleaning and laundering; these activities 
can result in hazardous exposure for the per-
son performing the tasks, as well as for others 
in the household. 
As the understanding of the effects of second-
hand exposure to asbestos has increased, health 
effects among families of asbestos- exposed 
workers have been identified. Most document-
ed cases of asbestos-related disease among 
workers’ family members have occurred in 
households where women were exposed during 
home laundering of contaminated work cloth-
ing. In addition, children have been exposed 
Figure 4. Number of deaths due to malignant mesothelioma, U.S. residents aged ≥15 years, 1999–
2005. Source of data: NIOSH [2007b].
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at home by playing in areas where asbestos- 
contaminated shoes and work clothes were lo-
cated, or where asbestos-containing materials 
were stored [NIOSH 1995]. As a result of these 
exposures, family members have been found to 
be at increased risk of malignant mesothelioma, 
lung cancer, cancer of the gastrointestinal tract, 
asbestosis, and nonmalignant pleural abnor-
malities [NIOSH 1995].
Because of the long latency periods between 
exposure and manifestation of asbestos-relat-
ed disease, identification and intervention are 
difficult. Home contamination may pose a se-
rious public health problem; however, the ex-
tent to which these health effects occur is not 
fully known because there are no information 
systems to track them [NIOSH 1995].
2.6 Clinical Issues
A thorough review of how asbestos-related dis-
eases are diagnosed is beyond the scope of this 
document, and authoritative guidance on the 
diagnosis and attribution of asbestos-caused 
diseases has been published elsewhere [Anon-
ymous 1997; British Thoracic Society Stan-
dards of Care Committee 2001; Henderson et 
al. 2004; ATS 2004].
The diagnosis of asbestos-caused malignancies 
(e.g., lung cancer and malignant mesothelioma) 
is almost always based on characteristic histol-
ogy (or abnormal cytology in some cases). De-
spite research on other possible etiologies, genet-
ic susceptibilities, and hypothesized cofactors 
such as simian virus 40, it is generally accepted 
that most cases of malignant mesothelioma are 
caused by exposure to asbestos or other min-
eral (e.g., erionite) fibers [Robinson and Lake 
2005; Carbone and Bedrossian 2006]. Of par-
ticular concern to patients diagnosed with ma-
lignant mesothelioma, as well as to individuals 
who remain at risk due to past exposures, the 
disease currently is essentially incurable [British 
Thoracic Society Standards of Care Committee 
2001]. Diagnosis may be relatively straightfor-
ward but can be difficult because of a challeng-
ing differential diagnosis [Lee et al. 2002]. Ad-
vances have been made to improve diagnostic 
testing for malignant mesothelioma with use of 
immunochemical markers and other more so-
phisticated histopathological analyses, and ad-
ditional research is aimed at improving treat-
ment of the disease [Robinson and Lake 2005]. 
Notable recent research efforts have been direct-
ed toward the development of biomarkers for 
mesothelioma that can be assessed by noninva-
sive means. A long-term goal of the biomarker 
research is to enable screening of high-risk in-
dividuals with sufficiently sensitive and specif-
ic noninvasive biomarkers to identify disease 
at an early stage, when therapeutic interven-
tion might have a greater potential to slow the 
progression of the disease or be curative. Oth-
er goals are to use noninvasive biomarkers for 
monitoring the disease in patients treated for 
mesothelioma and for diagnosing the disease. 
Noninvasive biomarkers, including osteopontin 
and soluble mesothelin-related peptide, have 
been and continue to be evaluated, but none are 
considered ready for routine clinical application 
[Cullen 2005; Scherpereel and Lee 2007].
Nonmalignant asbestos-related diseases are di-
agnosed by considering three major necessary 
criteria: (1) evidence of structural change con-
sistent with asbestos-caused effect (e.g., ab-
normality on chest image and/or tissue his-
tology); (2)  evidence of exposure to asbestos 
(e.g., history of occupational or environmen-
tal exposure with appropriate latency, and/
or higher than normal numbers of asbes-
tos bodies identified in lung tissue, sputum, 
or bronchoalveolar lavage; and/or other con-
current marker of asbestos exposure, such as 
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pleural plaques as evidence of exposure when 
diagnosing asbestosis); and (3) exclusion of al-
ternative diagnoses [ATS 2004]. The specific-
ity of an asbestosis diagnosis increases as the 
number of consistent clinical abnormalities in-
creases [ATS 2004]. In practice, only a small 
proportion of cases are diagnosed on the ba-
sis of tissue histopathology, as lung biopsy is an 
invasive procedure with inherent risks for the 
patient. Thus, following reasonable efforts to 
exclude other possible diagnoses, the diagnosis 
of asbestosis usually rests on chest imaging ab-
normalities that are consistent with asbestosis 
in an individual judged to have sufficient expo-
sure and latency since first exposure.
Chest radiography remains the most com-
monly used imaging method for screening ex-
posed individuals for asbestosis and for eval-
uating symptomatic patients. Nevertheless, as 
with any screening tool, the predictive value of 
a positive chest radiograph alone depends upon 
the underlying prevalence of asbestosis in the 
screened population [Ross 2003]. A widely ac-
cepted system for classifying radiographic ab-
normalities of the pneumoconioses was initial-
ly intended primarily for epidemiological use 
but has long been widely used for other purpos-
es (e.g., to determine eligibility for compensa-
tion and for medicolegal purposes) [ILO 2002]. 
A NIOSH-administered “B Reader” Program 
trains and tests physicians for proficiency in 
the application of this system [NIOSH 2007c]. 
Some problems with the use of chest radiogra-
phy for pneumoconioses have long been rec-
ognized [Wagner et al. 1993] and recent abus-
es have garnered substantial attention [Miller 
2007]. In response, NIOSH recently published 
guidance for B Readers [NIOSH 2007d] and for 
the use of B Readers and ILO classifications in 
various settings [NIOSH 2007e].
In developed countries, conventional film ra-
diography is rapidly giving way to digital ra-
diography, and work is currently under way to 
develop digital standards and validate their use 
in classifying digital chest radiographs under 
the ILO system [Franzblau et al. 2009; NIOSH 
2008a]. Progress on developing technical stan-
dards for digital radiography done for pneu-
moconiosis and ILO classification is under 
way [NIOSH 2008a]. In a validation study in-
volving 107 subjects with a range of chest pa-
renchymal and pleural abnormalities typical of 
dust-induced diseases, Franzblau et al. [2009] 
compared ILO classifications based on digital 
radiographic images and corresponding con-
ventional chest X-ray films. The investigators 
found no difference in classification of small 
parenchymal opacities. Minor differences were 
observed in the classification of large paren-
chymal opacities, though more substantial dif-
ferences were observed in the classification of 
pleural abnormalities typical of asbestos expo-
sure [Franzblau et al. 2009]. 
Computerized tomography, especially high-
resolution computed tomography (HRCT), 
has proven more sensitive and more specif-
ic than chest radiography for the diagnosis of 
asbestosis and is frequently used to help rule 
out other conditions [DeVuyst and Gevenois 
2002]. Standardized systems for classifying 
pneumoconiotic abnormalities have been pro-
posed for computed tomography but have not 
yet been widely adopted [Kraus et al. 1996; 
Huuskonen et al. 2001]. 
In addition to documenting structural tis-
sue changes consistent with asbestos-caused 
disease, usually assessed radiographically 
as discussed above, the diagnosis of asbes-
tosis relies on documentation of exposure 
[ATS 2004]. In clinical practice, exposure 
is most often ascertained by the diagnosing 
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physician from an occupational and environ-
mental history, assessed with respect to in-
tensity and duration. Such a history enables 
a judgment about whether the observed clin-
ical abnormalities can be reasonably attrib-
uted to past asbestos exposure, recognizing 
that severity of lung fibrosis is related to dose 
and latency [ATS 2004]. The presence of 
otherwise unexplained characteristic pleu-
ral plaques, especially if calcified, can also be 
used as evidence of past asbestos exposure 
[ATS 2004]. As explained by the ATS [2004], 
“the specificity of the diagnosis of asbesto-
sis increases with the number of consistent 
findings on chest film, the number of clin-
ical features present (e.g., symptoms, signs, 
and pulmonary function changes), and the 
significance and strength of the history of 
exposure.” In a small minority of cases, par-
ticularly when the exposure history is uncer-
tain or vague or when additional clinical as-
sessment is required to resolve a challenging 
differential diagnosis, past asbestos exposure 
is documented through mineralogical analy-
sis of sputum, bronchoalveolar lavage fluid, 
or lung tissue. Light microscopy can be used 
to detect and count asbestos bodies (i.e., as-
bestos fibers that have become coated with 
iron-containing hemosiderin during resi-
dence in the body, more generically referred 
to as ferruginous bodies) in clinical sam-
ples. Electron microscopy (EM) can be used 
to detect and count uncoated asbestos fibers 
in clinical samples. Methods for such clinical 
mineralogical analyses often vary, and valid 
background levels are difficult to establish. 
The absence of asbestos bodies cannot be 
used to rule out past exposure with certain-
ty, particularly chrysotile exposure, because 
chrysotile fibers are known to be less per-
sistent in the lungs than amphibole asbestos 
fibers and are less likely to produce asbestos 
bodies [De Vuyst et al. 1998; ATS 2004].
2.7 The NIOSH 
Recommendation for 
Occupational Exposure  
to Asbestos 
NIOSH has determined that exposure to as-
bestos fibers causes cancer and asbestosis in 
humans and recommends that exposures be 
reduced to the lowest feasible concentration. 
NIOSH has designated asbestos to be a “Poten-
tial Occupational Carcinogen”§. Currently, the 
designation “Potential Occupational Carcino-
gen” is based on the classification system ad-
opted by OSHA in the 1980s and is the only 
designation NIOSH uses for occupational car-
cinogens. After initially setting an REL at 2 as-
bestos fibers per cubic meter of air (f / cm3) in 
1972, NIOSH later reduced its REL to 0.1   f / c m 3, 
measured as an 8-hour time-weighted average 
(TWA)¶ [NIOSH 1976]. The REL was set at a 
§NIOSH’s use of the term “Potential Occupational Car-
cinogen” dates to the OSHA classification outlined in 
29 CFR 1990.103, and, unlike other agencies, is the 
only classification for carcinogens that NIOSH uses. 
See Section 6.1 for the definition of “Potential Occu-
pational Carcinogen.” The National Toxicology Pro-
gram [NTP 2005], of which NIOSH is a member, has 
determined that asbestos and all commercial forms of 
asbestos are known to be human carcinogens based on 
sufficient evidence of carcinogenicity in humans.  The 
International Agency for Research on Cancer (IARC) 
concluded that there was sufficient evidence for the car-
cinogenicity of asbestos in humans [IARC 1987b].
¶The averaging time for the REL was later changed to 100 
minutes in accordance with NIOSH Analytical Meth-
od #7400 [NIOSH 1994a]. This change in sampling 
time was first mentioned in comments and testimony 
presented by NIOSH to OSHA [NIOSH 1990a,b] and 
was reaffirmed in comments to MSHA in 2002, with 
the explanation that the 100-minute averaging time 
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level intended to (1) protect against the non-
carcinogenic effects of asbestos; (2)  materi-
ally reduce the risk of asbestos-induced can-
cer (only a ban can ensure protection against 
carcinogenic effects of asbestos); and (3)  be 
measured by techniques that are valid, repro-
ducible, and available to industry and official 
agencies [NIOSH 1976]. This REL was set at 
the limit of quantification (LOQ) for the phase 
contrast microscopy (PCM) analytical method 
for a 400-L sample, but risk estimates indicated 
that exposure at 0.1 f/cm3 throughout a work-
ing lifetime would be associated with a residu-
al risk for lung cancer. A risk-free level of ex-
posure to airborne asbestos fibers has not been 
established [NIOSH 1976, 1984].
2.7.1 The NIOSH REL as Revised  
in 1990
In 1990, NIOSH [1990b] revised its REL, retain-
ing the 0.1 f/cm3 limit but explicitly encompass-
ing EMPs from the nonasbestiform analogs of 
the asbestos minerals:
NIOSH has attempted to incorporate the 
appropriate mineralogic nomenclature in 
its recommended standard for asbestos and 
recommends the following to be adopted 
for regulating exposures to asbestos:
The current NIOSH asbestos recommend-
ed exposure limit is 100,000 fibers greater 
than 5 micrometers in length per cubic me-
ter of air, as determined in a sample collect-
ed over any 100-minute period at a flow rate 
of 4 L/min using NIOSH Method 7400, or 
equivalent. In those cases when mixed fi-
ber types occur in the same environment, 
would help “to identify and control sporadic exposures 
to asbestos and contribute to the overall reduction of 
exposure throughout the workshift” [NIOSH 2002].
then Method 7400 can be supplemented 
with electron microscopy, using electron dif-
fraction and microchemical analyses to im-
prove specificity of the fiber determination. 
NIOSH Method 7402 … provides a qualita-
tive technique for assisting in the asbestos fi-
ber determinations. Using these NIOSH mi-
croscopic methods, or equivalent, airborne 
asbestos fibers are defined, by reference, as 
those particles having (1) an aspect ratio of 
3 to 1 or greater; and (2)  the mineralogic 
charz elemental composition) of the asbes-
tos minerals and their nonasbestiform an-
alogs. The asbestos minerals are defined as 
chrysotile, crocidolite, amosite (cumming-
tonite-grunerite), antho phyllite, tremolite, 
and actinolite. In addition, airborne cleav-
age fragments from the nonasbestiform hab-
its of the serpentine minerals antigorite and 
lizardite, and the amphibole minerals con-
tained in the series cumming tonite-gruner ite, 
tremolite-ferroactinolite, and glauco phane-
rie beck ite shall also be counted as fibers pro-
vided they meet the criteria for a fiber when 
viewed microscopically.
The NIOSH REL for asbestos has been de-
scribed in NIOSH publications and in formal 
comments and testimony submitted to the De-
partment of Labor. The recommendation was 
based on the Institute’s understanding in 1990 
of potential hazards, the ability of the analyt-
ical methods to distinguish and count fibers, 
and the prevailing mineral definitions used to 
describe covered minerals.
2.7.1.1  Rationale for Encompassing 
Nonasbestiform Analogs of 
Asbestos Varieties Within the REL
NIOSH’s rationale for recommending that non-
asbestiform analogs of the asbestos minerals 
be encompassed within the policy definition 
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of airborne asbestos fibers was first articulated 
in comments and testimony to OSHA [NIOSH 
1990a,b]. According to the 1990 testimony, 
NIOSH based its recommendation on three 
elements:
 • The first element comprised results of 
epidemiological studies of worker popula- 
tions exposed to EMPs from nonasbesti- 
form mineral analogs of the asbestos va-
rieties (e.g., cleavage fragments). The 1990 
testimony characterized the existing ev-
idence as equivocal for excess lung can-
cer risk attributable to exposure to such 
nonasbestiform EMPs.
 • The second element comprised results of 
animal carcinogenicity studies involving 
experimental intrapleural or intraperitoneal 
administration of various mineral particles. 
The 1990 testimony characterized the re-
sults of the studies as providing strong ev-
idence that carcinogenic potential depends 
on a mineral particle’s length and width and 
reasonable evidence that neither chemical 
composition nor mineralogical origin is a 
critical factor in determining a mineral par-
ticle’s carcinogenic potential.
 • The third element comprised the lack of 
routine analytical methods to accurately 
and consistently distinguish between as-
bestos fibers and nonasbestiform EMPs 
in samples of airborne fibers. The 1990 
testimony argued that asbestiform and 
nonasbestiform minerals can occur in 
the same area and that determining the 
location and identification of tremolite 
asbestos, actinolite asbestos, and antho-
phyllite asbestos within deposits of their 
nonasbestiform mineral analogs can be 
difficult, resulting in mixed exposures 
for some mining operations and down-
stream users of their mined commodities.
Given the inconclusive epidemiological evidence 
for lung cancer risk associated with exposure to 
cleavage fragments (first bullet, above), NIOSH 
took a precautionary approach and relied upon 
the other two elements to recommend that the 
0.1 f/cm3 REL for airborne asbestos fibers also 
encompass EMPs from the nonasbestiform an-
alogs of the asbestos minerals. In fact, the 1990 
NIOSH testimony included an explicit asser-
tion that the potential risk of lung cancer from 
exposure to EMPs (of the nonasbestiform asbes-
tos analog minerals) warranted limiting such ex-
posures. However, even if such EMPs were not 
hazardous, the inability of analytical methods to 
accurately distinguish countable particles as ei-
ther asbestos fibers or cleavage fragments (of 
the nonasbestiform analog minerals) presents a 
problem in the context of potentially mixed ex-
posures (i.e., asbestos fibers together with EMPs 
from the nonasbestiform analogs). NIOSH’s 1990 
recommendation provided a prudent approach 
to mixed dust environments with potential expo-
sure to asbestos; limiting the concentration of all 
countable particles that could be asbestos fibers 
to below the REL would ensure that the asbestos 
fiber component of that exposure would not ex-
ceed the REL.
Some scientists and others have questioned 
NIOSH’s rationale for including EMPs from 
nonasbestiform amphibole minerals in its 
definition of “airborne asbestos fibers.” Miner-
alogists argue that these EMPs do not have the 
morphological characteristics required to meet 
the mineralogical definition of “fibers”; acicular 
and prismatic amphibole crystals and cleav-
age fragments generated from the massive hab-
its of the nonasbestiform analogs of the asbestos 
minerals are not true mineralogical fibers. Oth-
ers have opined that the scientific literature does 
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not demonstrate any clear health risks associated 
with exposure to the nonasbestiform EMPs cov-
ered by the NIOSH “airborne asbestos fiber” def-
inition.
Whether or not to include EMPs from non-
asbesti form analogs of the asbestos minerals 
in federal regulatory asbestos policies has been 
the subject of long-standing debate. The expo-
sure-related toxicity and health effects associat-
ed with the various morphologies (e.g., acicular, 
prismatic) of the nonasbestiform analogs of 
the asbestos minerals continue to be a central 
point in the debate. In 1986, OSHA revised its 
asbestos standard and included nonasbestiform 
anthophyllite, tremolite, and actinolite (ATA) 
as covered minerals within the scope of the re-
vised standard [OSHA 1986]. OSHA’s decision 
to include nonasbestiform ATA proved contro-
versial. In a 1990 proposal to reverse this revi-
sion, OSHA [1990] noted that there were “a 
number of studies which raise serious questions 
about the potential health hazard from occu-
pational exposure to nonasbestiform tremolite, 
anthophyllite and actinolite,” but that the “current 
evidence is not sufficiently adequate for OSHA to 
conclude that these mineral types pose a health 
risk similar in magnitude or type to asbestos.”
In the preamble to the final rule removing 
nonasbestiform ATA from its asbestos stan-
dard, OSHA [1992] stated that:
…various uncertainties in the data** and 
a body of data showing no carcinogenic ef-
fect, do not allow the Agency to perform 
qualitative or quantitative risk assessments 
concerning occupational exposures. Fur-
ther, the subpopulations of nonasbestiform 
**OSHA was referring to the scientific data on which 
NIOSH based its own carcinogenic health effect rec-
ommendation to OSHA.
ATA which, based on mechanistic and tox-
icological data, may be associated with a 
carcinogenic effect, do not appear to pres-
ent an occupational risk. Their presence in 
the workplace is not apparent from the re-
cord evidence.
In its 2005 proposed rule for asbestos, MSHA 
stated that substantive changes to its asbestos 
definition were beyond the scope of the pro-
posed rule and chose to retain its definition of 
asbestos, which “does not include nonfibrous 
or nonasbestiform minerals” [MSHA 2005]. 
These decisions are reflected in MSHA’s final 
rule published in 2008 [MSHA 2008]. In for-
mal comments during the rulemaking pro-
cess, NIOSH agreed with MSHA’s decision not 
to modify its asbestos definition in the current 
rulemaking, stating that “NIOSH is present-
ly re-evaluating its definition of asbestos and 
nonasbestiform minerals, and will work with 
other agencies to assure consistency to the ex-
tent possible” [NIOSH 2005]. In the interim, 
the following subsections provide more detail 
on the three elements comprising NIOSH’s ra-
tionale for recommending in 1990 that nonas-
bestiform analogs of the asbestos minerals be 
encompassed by the REL.
2.7.1.1.1 Epidemiological Studies
The first element of NIOSH’s rationale for rec-
ommending in 1990 that nonasbestiform ana-
logs of the asbestos minerals be encompassed 
by the REL related to evidence from epidemi-
ological studies.
A number of epidemiological studies have been 
conducted to evaluate the health risk to work-
ers reported to be exposed to EMPs. Epidemi-
ological studies have been conducted in the 
Governeur talc district of upstate New York in 
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which the deposits have been reported to con-
tain both amphibole cleavage fragments and 
transitional mineral fibers [Beard et al. 2001]. 
Differing interpretation of the analysis of these 
particles has caused considerable disagreement 
over the asbestos content of these talc depos-
its [Van Gosen et al. 2004]. Because of the dis-
agreement over the classification of these min-
eral particles, the epidemiological studies of 
talc miners and millers in upstate New York 
are reviewed here. Additional epidemiological 
studies of worker populations with exposures 
to EMPs are also reviewed, including studies 
conducted at the Homestake gold mine in South 
Dakota and the taconite mining region of north-
eastern Minnesota. The findings from these in-
vestigations are reviewed in detail below.
Studies of New York Talc Miners and Millers
Workers exposed to talc†† have long been rec-
ognized to have an increased risk of develop-
ing pulmonary fibrosis, often referred to as talc 
pneumoconiosis [Siegel et al. 1943; Kleinfeld et 
al. 1955]. Talc-exposed workers have also been 
reported to have an increased prevalence of 
pleural abnormalities, including pleural thick-
ening and pleural plaques [Siegel et al. 1943; 
Gamble et al. 1982].
Several more recent epidemiological studies and 
reviews have been conducted of workers em-
ployed in talc mines and mills in upstate New 
York [Brown et al. 1979, 1990; Kleinfeld et al. 
1967, 1974; Lamm and Starr 1988; Lamm et al. 
1988; Stille and Tabershaw 1982; Gamble 1993; 
Honda et al. 2002; Gamble and Gibbs 2008]. 
††The characteristics of talc deposits vary with location 
[Van Gosen et al. 2004]. Unless otherwise specified, 
the talc referred to in this section is restricted to the 
deposits in New York State which contain talc and 
other minerals.
Excessive rates of mesothelioma have been re-
ported for Jefferson County, which is immedi-
ately adjacent to the Balmat, Fowler, and Ed-
wards talc-mining areas of St. Lawrence County 
in New York [Vianna et al. 1981; Enterline and 
Henderson 1987; Hull et al. 2002]. In a study 
of all histologically confirmed mesothelioma 
cases reported to New York State’s tumor reg-
istry from 1973 to 1978, Vianna et al. [1981] 
reported six cases from Jefferson County, re-
sulting in a mesothelioma rate for that coun-
ty more than twice that of New York State (ex-
cluding New York City). In a national study 
of pleural cancer mortality (ICD-9 163) from 
1966 through 1981, Enterline and Henderson 
[1987] reported 4 mesothelioma cases in Jef-
ferson County females (0.6 expected) and 7 
cases in Jefferson County males (1.4 expected), 
resulting in county mesothelioma rates that were 
the second and sixth highest county-specific 
rates in the nation for females and males, re-
spectively (both p < 0.01). More recently, Hull 
et al. [2002] updated the Enterline and Hen-
derson pleural cancer mortality analysis for 
Jefferson County, reporting 5 new male cases 
(2 expected) and 3 new female cases (0.5 ex-
pected) through 1997 and describing Jeffer-
son County mesothelioma death rates as “5–10 
times the background rate.” A potential limi-
tation of the Enterline and Henderson [1987] 
and Hull et al. [2002] analyses is that they re-
lied on ICD code 163 (“malignant neoplasms 
of the pleura, mediastinum, and unspecified 
sites”) as a surrogate identification for malig-
nant mesothelioma. That code lacked specifici-
ty and sensitivity for mesothelioma; in a study of 
Massachusetts deaths, many non-mesothelioma 
malignancies involving the pleura were assigned 
code 163 and most mesotheliomas were not as-
signed code 163 [Davis et al. 1992]. The more re-
cent ICD-10 system, which has been used since 
1999 to code death certificate data in the United 
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States, includes a discrete code for malignant 
mesothelioma. Based on that new ICD-10 code, 
the age-adjusted death rates (per million pop-
ulation) for 1999–2004 were 12.9 (based on 5 
mesothelioma deaths) for Jefferson County and 
10.9 (based on 5 mesothelioma deaths) for St. 
Lawrence County. These are similar to the over-
all U.S. mesothelioma death rates for this same 
period (based on a total of 15,379 mesothelioma 
deaths) of 11.5 per million [NIOSH 2007b]. 
An excess of lung cancer has also been report-
ed following several epidemiological studies 
of New York talc mines and mills [Kleinfeld et 
al. 1967, 1974; Brown et al. 1990; Lamm and 
Starr 1988; Stille and Tabershaw 1982; Lamm 
et al. 1988; Honda et al. 2002]. The most ex-
tensive research has been conducted on work-
ers at the talc mine and mills owned by RT 
Vanderbilt Company, Inc. (RTV), located in St. 
Lawrence County. A significant excess of mor-
tality from nonmalignant respiratory disease 
(NMRD) has been consistently noted in these 
studies. These studies have also generally dem-
onstrated an approximately twofold to three-
fold increase in lung cancer mortality among 
these workers [Brown et al. 1990; Honda et al. 
2002; Lamm et al. 1988]. The lung cancer ex-
cess has been reported to be particularly high 
among workers with more than 20 years since 
their first exposure (latency), which is a pat-
tern consistent with an occupational etiology 
[Brown et al. 1979, 1990]. Authors of several 
studies have questioned whether the excess of 
lung cancer observed in these studies is due to 
employment at the RTV mines and mills or to 
other factors [Honda et al. 2002; Lamm et al. 
1988; Stille and Tabershaw 1982]. Attributing 
these findings to employment in the RTV mine 
is difficult because there were numerous mines 
operating in upstate New York, and the min-
eralogical composition of the ores varied sub-
stantially [Petersen et al. 1993]. A high smoking 
rate among the workers at the RTV mine and 
mills has been suggested as one possible ex-
planation for the excess lung cancer mortality 
[Kelse 2005; Gamble 1993]. However, it is gen-
erally considered implausible that confound-
ing by smoking in occupational cohort studies 
could explain such a large (i.e., about twofold 
to threefold) increase in lung cancer mortality 
[Steenland et al. 1984; Axelson and Steenland 
1988; Axelson 1989].
The most persuasive argument against a caus-
al interpretation of these findings is that the 
lung cancer excess in this study population did 
not increase with duration and measures of ex-
posure to dust [Lamm et al. 1988; Stille and 
Tabershaw 1982; Honda et al. 2002]. Also, the 
excess of lung cancer in this cohort has been 
reported to be limited to workers with short 
employment (<1 year) [Lamm et al. 1988] and 
to workers who have been employed in oth-
er industries where exposure to carcinogens 
may have occurred prior to their working in 
the RTV mine and mills [Lamm et al. 1988; 
Stille and Tabershaw 1982]. The latter obser-
vation could be explained by there simply be-
ing too few workers and inadequate follow-up 
of workers who have worked only at RTV to 
provide the statistical power necessary to dem-
onstrate an increased lung cancer risk. For ex-
ample, in one of the studies only 10% of the de-
cedents were reported to have not worked in 
other industries prior to their employment at 
RTV [Stille and Tabershaw 1982].
In the most recent study of RTV miners and 
Millers, Honda et al. [2002] examined lung can-
cer mortality in relation to quantitative estimates 
of exposure to respirable talc dust [Oestenstad et 
al. 2002]. As in previous studies, mortality from 
lung cancer was found to be significantly elevat-
ed (standardized mortality ratio [SMR] = 2.3; 
95% confidence interval [95% CI] = 1.6–3.3), 
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with the most pronounced excess of lung can-
cer mortality found in short-term workers (<5 
years). An exposure-response relationship was 
observed in the study between cumulative ex-
posure to respirable dust and NMRD and pul-
monary fibrosis.
One explanation that has been offered for the 
lack of exposure-response in these studies is 
that the observed excess of lung cancer was a 
result of exposures from employment prior 
to starting work at RTV. It has been suggest-
ed that many of these workers may have had 
prior employment in neighboring talc mines 
in upstate New York with similar exposures 
to talc [NIOSH 1980]. Not considering expo-
sures at these other mines could have substan-
tially impacted results of exposure-response 
analyses. Exposures to dust may also have been 
substantially higher in the neighboring mines 
than in the RTV mine [Kelse 2005]. Because 
RTV workers may have had exposures to dust 
in other mines, their exposures may have been 
underestimated, which could explain the ob-
served lack of an exposure-response relation-
ship in the epidemiological studies of RTV 
workers. There is also evidence to suggest that 
RTV workers may have been exposed to lung 
carcinogens from prior work in non-talc indus-
tries [Lamm et al. 1988].
Gamble [1993] conducted a nested case-con-
trol study of lung cancer in the RTV cohort 
to further explore whether factors unrelated 
to exposures at RTV, such as smoking and ex-
posures from prior employment, might be re-
sponsible for the observed excess of lung can-
cer among RTV workers. Cases and controls 
were identified from among 710 workers who 
were employed between 1947 and 1958, and 
vital status was ascertained through 1983. All 
individuals whose underlying cause of death 
was lung cancer were included as cases (n = 22). 
Three controls (n = 66) for each case were se-
lected from members of the cohort who had 
not died of NMRD or accidents, and they were 
matched to cases on the basis of dates of birth 
and hire. Controls were also required to have 
survived for as long as their matched case. In-
formation on smoking and work histories was 
obtained by interviewing the case (if alive) or 
relatives. An attempt was made to verify infor-
mation on previous employment by checking 
personnel records and by contacting previous 
employers. A panel of epidemiologists and in-
dustrial hygienists classified previous non-talc 
employment with regard to the probability of 
occupational exposure to a lung cancer risk.
As in previous investigations of the RTV co-
hort, Gamble [1993] found that the risk of lung 
cancer decreased with increasing duration of 
employment at RTV. This was true among both 
smokers and nonsmokers, and also when indi-
viduals with inadequate time since first expo-
sure (<20 years) and short duration of employ-
ment were excluded. Lung cancer risk was also 
found to decrease with increasing probability 
of exposure to lung carcinogens from non-talc 
employment. A positive exposure-response re-
lationship was evident when non-RTV talc ex-
posures were included in the analysis, although 
this relationship was not statistically significant.
This study by Gamble [1993] does not provide 
support for the hypothesis that prior employ-
ment in non-talc industries was responsible 
for the excess of lung cancer observed among 
RTV workers. The author interpreted his find-
ings as providing support for the argument 
that the excess of lung cancer was due to con-
founding by smoking, on the basis of the fact 
that smoking was strongly associated with lung 
cancer risk and on the observation that the 
exposure-response relationship with talc was 
more strongly negative (inverse) in analyses 
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restricted to smokers than among all study 
subjects. However, it is no surprise that an as-
sociation was observed between smoking and 
lung cancer, and the fact that the negative (in-
verse) exposure-response trend was stronger 
among smokers does not explain why the co-
hort as a whole experienced much higher lung 
cancer rates than expected.
Only two cases of pleural mesothelioma have 
been reported in the cohort studies of RTV 
miners and millers [Honda et al. 2002], and 
those authors reported that it was unclear 
whether these cases are attributable to exposure 
to talc at the RTV mine and mills. One of the 
individuals had worked for only a short time in 
a job with minimal talc exposure, had previous-
ly worked for many years in the construction of 
a talc mine, and had subsequently worked on 
repairing oil heating systems. The other case 
developed only 15 years after first exposure to 
RTV talc, although mesothelioma has more 
typically been observed to develop after much 
longer times from first exposure. NIOSH has 
recently received unpublished reports of ad-
ditional cases of pleural mesothelioma among 
workers at RTV or its predecessor, Interna-
tional Talc [Abrams 2010; Maimon 2010], and 
a report of at least one worker using products 
from the mine who may also have died from 
mesothelioma [Satterley 2010]. NIOSH has also 
received unpublished observations concerning 
findings from chest radiographs RTV has ob-
tained on its workers semiannually since 1985. 
Although pleural plaques were more frequently 
observed, the program has identified only one 
worker with irregular parenchymal opacities 
consistent with asbestosis-like disease, results 
that a consulting pulmonologist “did not find 
… to be consistent with that of a workforce ex-
posed to asbestos” [Kelse et al. 2008]. 
Van Gosen [2007] has reported that fibrous 
varieties of talc, tremolite, and anthophyllite 
occur in the tremolite-talc deposits of the 
Governeur talc mining district of upstate New 
York. It has been debated whether the fibrous 
amphiboles in those talc ores meet the crite-
ria of asbestos, with the debate centered on the 
complex and unusual transitional fibers com-
posed partly of talc and partly of anthophyllite. 
NIOSH [1980] and others [Van Gosen 2006; 
Webber 2004] have reported that dust from the 
RTV mine, which is in the Governeur talc min-
ing district, contains asbestos. In an industri-
al hygiene assessment conducted at RTV mines 
by NIOSH [1980], X-ray diffraction and pe-
trographic microscopic analyses of talc prod-
uct samples found them to contain 4.5%–15% 
anthophyllite (some of which was categorized 
as asbestos). In contrast, Kelse [2005] report-
ed the percentage by weight of talc from the 
RTV mine in upstate New York as 1%–5% 
nonasbestiform anthophyllite. In airborne sam-
ples collected by NIOSH at the mine and mill 
and analyzed by TEM, 65% of the EMPs that 
were longer than 5 µm were anthophyllite and 
7% were tremolite, and much of the tremolite 
was from a nonfibrous habit [NIOSH 1980]. 
Kelse [2005] reported that up to 1.8% was from 
an asbestiform habit, though the asbestiform 
component was reported not to be asbestos. 
Serpentine and amphibole minerals typical-
ly develop through the alteration of other min-
erals. Consequently, they may exist as partially 
altered minerals having variations in elemen-
tal compositions. Minerals undergoing this al-
teration are often called “transitional minerals.” 
Thus the elemental composition of individual 
mineral particles can vary within a mineral de-
posit containing transitional minerals, which 
could account for differences in the reported 
composition of talc from the RTV mine.
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A limitation of the epidemiological studies of 
RTV talc workers is the lack of an exposure-re-
sponse analysis based on direct measurements 
of airborne EMP concentrations. Most of the 
studies used tenure as a surrogate for exposure, 
and the exposure metric used in the Honda et 
al. [2002] study was respirable dust, which may 
not be correlated with exposure to EMPs. Re-
lationships between health outcomes and ex-
posure to an agent of interest can be attenuated 
when a nonspecific exposure indicator is used 
as a surrogate for exposure to the agent of inter-
est [Blair et al. 2007; Friesen et al. 2007]. Thus, 
when the exposure index used to assess the ef-
fect of EMPs is based on a surrogate measure, 
such as respirable dust, rather than on specif-
ic measurement of EMP concentrations, the 
lack of an exposure-response relationship be-
tween the exposure index and the health out-
come might not accurately reflect the true risk, 
particularly where the composition of a mixed 
dust exposure varies by work area.
Finally, a cohort study of Vermont talc miners 
and millers has some relevance for interpreting 
the findings from the studies of New York talc 
workers [Selevan et al. 1979]. Airborne dust 
samples and talc bulk samples from all locations 
in the mines and mill studied were analyzed 
by X-ray diffraction or analytical EM, which 
showed the talcs to be similar in composition; 
no asbestos was detected in any of the samples. 
To determine potential differences between the 
talcs mined and milled by a company no lon-
ger in operation, seven samples of talcs were 
obtained and also analyzed by X-ray diffrac-
tion or analytical EM. These samples were re-
ported to be free of asbestos contamination and 
the mineral composition was within the range 
of samples from then-producing operations. 
The one remaining company, no longer oper-
ating at that time, had been located in the same 
geographic area as two of the then-producing 
companies. The talc in one of the closed mines 
was reported to have had “cobblestones” of ser-
pentine rock that were highly tremolitic. In the 
mining of this talc, these cobblestones were re-
ported to have been avoided and/or discard-
ed. Therefore, miners may have been exposed 
to tremolite, but it is unlikely that the mill-
ers from this company were exposed [Selevan 
1979]. Van Gosen [2004] described the talc de-
posits in this area as “associated spatially with 
serpentinite masses that in some areas host 
well-developed chrysotile asbestos [Bain 1942; 
Cady et al. 1963]. The alteration zone local-
ly contains actinolite, tremolite, anthophyllite, 
and (or) cummingtonite, as described by Cady 
et al. [1963]. Zodac [1940] described ‘radiating 
masses of fibrous actinolite, which often have 
to be handled carefully as the needlelike crys-
tals may penetrate fingers, are common on the 
dumps’ in a talc quarry near Chester, Vermont. 
The amphiboles present were not identified as 
asbestiform.
A statistically significant excess of NMRD 
mortality was observed among the millers 
(SMR = 4.1; 95% CI = 1.6–8.4), but not among 
the miners (SMR = 1.6; 95% CI = 0.20–9.6), in 
this study [Selevan 1979]. In contrast, respira-
tory cancer mortality was found to be signifi-
cantly elevated among the miners (SMR = 4.3; 
95% CI = 1.4–10), but not among the millers 
(SMR = 1.0; 95% CI = 0.12–4.0). The authors 
suggested that their respiratory cancer findings 
might be due to non-talc exposures, such as ra-
don progeny, because exposures to talc dust 
were higher among millers than miners. The 
pattern of excess respiratory cancer observed 
in this study is similar to that reported in stud-
ies of RTV miners and millers. It has been not-
ed [Lamm and Starr 1988] that this provides 
evidence against the hypothesis that the lung 
cancer excess among RTV miners is caused 
26 NIOSH CIB 62 • Asbestos
by exposure to the EMPs in RTV talc, because 
these were not identified in Vermont talc.
In summary, excesses of pulmonary fibrosis 
and pleural plaques are generally recognized 
to have occurred among workers exposed to 
talc. Pleural cancer mortality rates have been 
reported to be significantly elevated in Jeffer-
son County, adjacent to St. Lawrence County, 
where the New York talc industry has been lo-
cated. However, recent death certificate data 
for 1999–2004 do not suggest a particular-
ly high rate of mesothelioma in St. Lawrence 
County or Jefferson County. Also, aspects of 
the few cases of mesothelioma that have been 
carefully evaluated in the published studies of 
New York talc miners make it unclear whether 
the cases are attributable to employment in the 
talc industry. Lung cancer mortality has been 
consistently reported to be elevated in studies 
of New York talc miners. However, attribution 
of this excess to exposures to dust containing 
talc and other minerals has been questioned, 
because the lung cancer excess was generally 
found to be most pronounced in short-term 
workers and did not increase with cumula-
tive exposure to talc dust. It is highly unlikely 
that chance or confounding from smoking or 
prior mining exposures fully accounts for the 
lung cancer excess observed in these studies. 
These findings may be at least partly explained 
by employment in other industries, including 
other mines in upstate New York.
Studies of Homestake Gold Miners
Three groups of investigators have conduct-
ed retrospective cohort studies of miners at 
the Homestake gold mine in South Dako-
ta, with somewhat different and overlapping 
cohort definitions. Gillam et al. [1976] stud-
ied 440 white males who were employed as of 
1960 and who had worked underground for 
at least 5 years in the mine. McDonald et al. 
[1978] conducted a retrospective cohort study 
of 1,321 men who had retired and worked 
for at least 21 years in the mine as of 1973 
and were followed for vital status until 1974. 
Brown et al. [1986] conducted a retrospective 
cohort study of 3,328 miners who had worked 
for at least 1 year between 1940 and 1965, with 
follow-up of vital status to 1977. Follow-up of 
this same cohort was subsequently updated to 
1990 by Steenland and Brown [1995]. Expo-
sures of potential concern at this mine in-
clude crystalline silica, radon progeny, arse-
nic, and nonasbestiform EMPs. The longer 
(>5  µm) nonasbestiform EMPs have been re-
ported to be primarily cummingtonite-grunerite 
(69%), but tremolite-actinolite (15%) and other 
nonasbestiform amphibole varieties (16%) were 
also detected [Zumwalde et al. 1981]. Most of 
the EMPs observed by TEM (70%–80%) were 
shorter than 5 µm; for the entire population of 
EMPs, the geometric mean length was 3.2 µm 
and the geometric mean diameter was 0.4 µm.
There is very little evidence of an excess of 
mesothelioma in the studies of Homestake 
gold miners. One case of mesothelioma with 
“low” dust exposure was noted in the study 
by McDonald et al. [1978]. Slight excesses of 
cancer of the peritoneum (4 cases; SMR = 2.8; 
95% CI = 0.76–7.2) and other respiratory can-
cer (3 cases; SMR = 2.5; 95% CI = 0.52–7.4) 
were described in the most recently report-
ed study [Steenland and Brown 1995]. These 
categories might be expected to include cas-
es of mesothelioma; however, mesothelioma 
was not mentioned on the death certificates 
for these cases.
Significant excesses in mortality from tuber-
culosis and pneumoconiosis (mainly silicosis) 
were observed in all of the studies. An excess of 
respiratory cancer (10 cases: SMR = 3.7; 95% 
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CI = 1.8–6.7) was noted in the earliest study, by 
Gillam et al. [1976]. Respiratory cancer mor-
tality was not found to be elevated (34 cases; 
SMR = 1.0; 95% CI = 0.71–1.4), and there was 
only weak evidence that it increased with lev-
el of exposure, in the study by McDonald et al. 
[1978]. A slight excess of lung cancer (115 cas-
es; SMR = 1.1; 95% CI = 0.94–1.4) was noted 
in the most recent study, in comparison with 
U.S. mortality rates [Steenland and Brown 
1995]. This lung cancer excess was more pro-
nounced when county rates were used as the 
referent (SMR = 1.3; 95% CI = 1.0–1.5), and 
even more so when South Dakota state rates 
were used (SMR = 1.6; 95% CI = 1.3–1.9). The 
excess was also increased (versus U.S. rates; 
SMR = 1.3; 95% CI = 1.0–1.6) when the anal-
ysis was restricted to individuals with at least 
30 years of time since first exposure (latency). 
Lung cancer mortality was not found to in-
crease with estimated cumulative exposure to 
dust in this study, though a clear exposure- 
response trend was observed for pneumoco-
niosis. The limited available data on smok-
ing habits indicated that miners in this cohort 
smoked slightly more than the U.S. general 
population in a 1960 survey.
Taken together, the studies of Homestake gold 
miners provide, at best, weak evidence of an ex-
cess risk of lung cancer. Although small excesses 
of lung cancer have been reported in the most re-
cent studies of the Homestake gold miners, the in-
creased mortality has not been found to increase 
with measures of cumulative dust exposure. The 
uncertainty of the relationship between contem-
poraneous dust and EMP exposures hinders the 
usefulness of historical dust measurement data 
in estimating EMP exposures [Zumwalde et al. 
1981]. Thus the lack of cancer noted in these 
studies is largely uninformative with respect to 
the hypothesis that nonasbestiform EMPs are 
associated with increased risk of respiratory dis-
eases in this population.
Studies of Taconite Miners
There has been a long history of concern about a 
potential association between exposures associ-
ated with the taconite iron ore industry in north-
eastern Minnesota and the potential cancer risk. 
This concern started in 1973, when amphibole 
fibers were found in the Duluth water supply 
and were traced to tailings that had been dis-
posed of in Lake Superior by the Reserve Mining 
Company. Extensive sampling and analysis of ar-
eas of the Peter Mitchell taconite iron ore mines 
were recently conducted by Ross et al. [2007], 
who reported finding “no asbestos fibers of any 
type” in the mines. However, they did find and 
describe fibrous ferroactinolite, fibrous ferrian 
sepiolite, fibrous grunerite-ferroactinolite, and 
fibrous actinolite in ore samples, some of which 
was very thin (<0.01 μm) with a very high aspect 
ratio. They estimated fibrous amphibole material 
to represent “a tiny fraction of one percent of the 
total rock mass of this taconite deposit” [Ross et 
al. 2007].
Several epidemiological studies have exam-
ined mortality of miners working in the taco-
nite mines and mills of Minnesota. Higgins et al. 
[1983] published the earliest study, which exam-
ined the mortality of approximately 5,700 work-
ers employed at the Reserve Mining Company 
between 1952 and 1976 and followed up to 1976. 
Overall mortality (SMR = 0.87) and mortality 
from respiratory cancer (15 cases; SMR = 0.84) 
were both less than expected. Respiratory cancer 
mortality was not found to be increased among 
workers with at least 15 years since first expo-
sure (latency) and did not increase with estimat-
ed cumulative exposure to dust. The maximum 
follow-up of this cohort was 24 years, which is 
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probably too short to be able to detect increased 
mortality from lung cancer or mesothelioma.
Cooper et al. [1988, 1992] have reported on the 
mortality experience of 3,431 miners and mill-
ers who were employed in the Erie or Minntac 
mines and mills for at least 3 months between 
1947 and 1958. Follow-up of the cohort, ini-
tially to 1983 [Cooper et al. 1988], was extend-
ed to 1988 in their more recent update [Coo-
per et al. 1992]. Comparisons were made with 
white male mortality rates for Minnesota and 
for the U.S. population. Mortality from respi-
ratory cancer was found to be slightly less than 
expected in this study (106 cases, based on 
Minnesota rates: SMR = 0.92; 95% CI = 0.75–
1.1). Respiratory cancer mortality was close to 
the expected value (46 cases, on the basis of 
Minnesota rates: SMR = 0.99; 95% CI = 0.72–
1.3) among workers with more than 20 years 
since first exposure (latency).
A statistically significant excess of mesothelioma 
has been reported in northeastern Minneso-
ta, the area in which the taconite mining and 
milling industry is located [MDH 2007]. In 
its most recent report, the Minnesota Depart-
ment of Health (MDH) reported that a to-
tal of 159 cases occurred in this region during 
the period of 1988 to 2006. The mesothelioma 
rate for males was approximately twice the ex-
pected rate, based on the rest of the state (146 
cases: rate ratio [RR] = 2.1; 95% CI = 1.8–2.5), 
whereas the rate for females was less than ex-
pected (RR = 0.72; 95% CI = 0.38–1.2). The 
fact that the excess of mesothelioma was ob-
served only among males strongly suggests an 
occupational etiology. In addition to the taco-
nite industry, a plant producing asbestos ceil-
ing tiles (Conwed Corporation) was located 
in the northeastern Minnesota region. From 
1958 to 1965 amosite was used at Conwed, and 
from 1966 to 1974 chrysotile was used [Mandel 
2008]. The MDH has initiated epidemiologi-
cal studies of mesothelioma incidence among 
workers at the Conwed Corporation and at the 
iron mines in northeastern Minnesota. The re-
cords from a cohort of approximately 72,000 
iron miners and from 5,700 Conwed work-
ers have been linked with a mesothelioma data 
registry. Between 1988 and 2007, a total of 58 
mesothelioma cases among the miners and 25 
cases among the Conwed workers were iden-
tified. Because only 3 of the 58 mesothelioma 
cases identified in the miner cohort had also 
been employed at Conwed, it is unlikely that 
the mesothelioma excess in miners could be ex-
plained by asbestos exposures during employ-
ment at the Conwed ceiling tile facility [MDH 
2007].
Brunner et al. [2008] have recently reported 
findings from an MDH study of mesothelioma 
cases occurring among iron miners between 
1988 and 1996. The job histories of the cas-
es were reviewed for evidence of exposure to 
commercial asbestos. Mining jobs were identi-
fied from company personnel files. Nonmining 
employment information was obtained from 
worker application files, worker compensation 
records, and obituaries. Potential asbestos ex-
posures for jobs held in the mining industry 
were identified by interviewing 350 workers, 
representing 122 occupations and 7 different 
mining companies. To estimate the probabili-
ty and intensity of potential exposure to com-
mercial asbestos in each of the jobs, an expert 
panel rated the potential for asbestos exposure 
on the basis of these interviews, available job 
descriptions from the relevant time period, 
and their knowledge of the mining environ-
ment. The job histories for 15 of 17 iron min-
ers known to have developed mesothelioma 
were considered sufficient for the study. Elev-
en of these 15 were reported to have had prob-
able exposure, 3 were reported to have possible 
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exposure to commercial asbestos, and 1 did not 
have an identifiable source of exposure to com-
mercial asbestos. The asbestos exposures were 
from nonmining jobs (4 cases), mining jobs (4 
cases), or both (6 cases). The findings from this 
study suggest that the excess of mesothelioma 
observed among taconite miners might be ex-
plained by exposure to commercial asbestos 
rather than from the nonasbestiform amphi-
bole EMPs generated during iron ore process-
ing. However, this was a case series and it was 
not possible to determine whether commer-
cial asbestos exposure was different in the cas-
es than in the cohort as a whole or in a control 
group. This study also did not include the 41 
additional mesothelioma cases that have been 
reported by the MDH since 1996 [MDH 2007].
The age-adjusted rates of deaths due to malig-
nant mesothelioma during the period 2000–
2004 for the two counties considered to be 
in the iron range (Itasca and St. Louis Coun-
ties) are reported as 30.4 and 31.3 per mil-
lion, respectively, which are 2.6 and 2.7 times 
the U.S. average [NIOSH 2009a]. Two coun-
ties (Carlton and Koochiching Counties) ad-
jacent to the iron range counties have malig-
nant mesothelioma rates of 55.3 and 77.5 per 
million, which are 4.8 and 6.7 times the U.S. 
average. The age-adjusted asbestosis rates dur-
ing 1995–2004 were reported for only two of 
these counties: St. Louis County (7.9 per mil-
lion, which is 1.3 times the U.S. average) and 
Carlton County (54.0 per million, or 8.9 times 
the U.S. average) [NIOSH 2009b].
In summary, the results from cohort mortality 
studies of taconite miners and millers in Minne-
sota have not provided evidence of an increased 
risk of respiratory cancer or mesothelioma. 
This appears to be somewhat in conflict with 
reports from the MDH that mesothelioma in-
cidence is significantly elevated among males 
(but not females) in northeastern Minnesota 
and that a large number of these cases involved 
workers in the Minnesota taconite industry. 
There is some evidence that these cases could, 
at least in part, be related to exposures to com-
mercial asbestos that occurred in or outside of 
the taconite mining industry, but further re-
search on this question is needed. The MDH is 
currently working with researchers at the Uni-
versity of Minnesota School of Public Health 
on a mesothelioma case-control study, a respi-
ratory morbidity study, and a mortality study 
of the iron miners of northeastern Minnesota 
[MDH 2007].
Summary of Epidemiological Studies of 
Cohorts Exposed to Nonasbestiform EMPs
The results from studies of populations ex-
posed to nonasbestiform EMPs do not provide 
clear answers regarding the toxicity of these 
EMPs. A number of features limit their use-
fulness. First, the populations in these stud-
ies were exposed to a complex mixture of par-
ticles. Although an excess of pneumoconiosis 
has been observed in the studies of Homestake 
gold miners and New York talc workers, the 
extent to which these findings are attributable 
to their exposures to nonasbestiform EMPs 
cannot be determined. A potential limitation 
of the New York talc studies is that, if the EMPs 
do include fibers from asbestiform minerals, as 
reported in the literature [NIOSH 1980; Van 
Gosen 2006; Webber 2004], it is difficult to de-
termine whether the observed health effects 
can be attributed to them, given the heteroge-
neous mineral composition of exposures.
Another major limitation of these studies is that 
they lack adequate information on past expo-
sure to EMPs. An excess of respiratory cancer 
was observed in the studies of New York talc 
workers, and a small excess was observed in the 
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most recent study of Homestake gold miners. 
In both studies, the excess of respiratory can-
cer was not found to increase with cumulative 
exposure to dust. Relationships between health 
outcomes and exposure to an agent of interest 
can be attenuated when a nonspecific expo-
sure indicator is used as a surrogate for expo-
sure to that agent [Blair et al. 2007; Friesen et 
al. 2007]. Thus, when the exposure index used 
to assess the effect of EMPs is based on a sur-
rogate measure, such as respirable dust, rather 
than on specific measurement of EMP concen-
trations, the lack of an exposure-response rela-
tionship between the exposure index and the 
health outcome might not accurately reflect 
the true risk, particularly where the composi-
tion of a mixed exposure varies by work area. 
Interpretation of findings from the New York 
talc studies has been further complicated by 
the employment of the workers elsewhere, in-
cluding employment at other talc mines in the 
area. Lack of positive findings from exposure-
response analyses in the New York talc studies 
of RTV miners and millers could also have re-
sulted from exposure misclassification—possible 
under-ascertainment of exposure to talc and 
other mineral particles caused by not consid-
ering exposures at neighboring talc mines or 
previous employment in the same mine under 
different ownership.
The reliability of death certificate information 
is another major limitation, particularly for the 
diagnosis of mesothelioma. Mesothelioma did 
not have a discrete ICD code until the 10th re-
vision of the ICD, used for U.S. death certifi-
cate data only since 1999. This likely explains 
the discordance between the apparent recent 
lack of excess mesothelioma deaths in an up-
state New York county adjacent to the county 
in which talc mines and mills have been locat-
ed and the excess “mesothelioma” death rates 
previously reported in that county. This may 
explain the apparent contradiction between 
the lack of an excess of mesothelioma in the co-
hort studies of taconite miners, and the excess 
of mesothelioma that has been reported in the 
more recent studies based on a mesothelioma 
registry in northeastern Minnesota. 
Finally, the lack of information on cigarette 
smoking habits of the studied workers is a ma-
jor issue in interpreting the findings for respira-
tory cancer in these studies. Concern about cig-
arette smoking in occupational cohort studies 
is generally based on the assumption that blue 
collar workers smoke more than the general 
population. However, the extent of this bias is 
generally not expected to be able to account for 
more than a 50% increase in lung cancer risk 
and is unlikely to explain the twofold to three-
fold risk reported in the New York talc stud-
ies. Confounding by smoking could conceiv-
ably explain the small excess of lung cancer that 
has been reported in the most recent study of 
Homestake gold miners [Steenland and Brown 
1995]. However, smoking may have introduced 
a negative bias in some of these studies. Ciga-
rette smoking has been reported to have been 
banned in the Homestake gold mines [Brown 
et al. 1986] and in the underground taconite 
mines [Lawler et al. 1985]. Preventing workers 
from smoking at work could have negatively bi-
ased the lung cancer findings in these studies.
Because of the study limitations described 
above, the findings from these studies should 
best be viewed as providing inconclusive as 
opposed to negative evidence regarding the 
health effects associated with exposures to 
nonasbestiform EMPs. To be more informative, 
additional studies of these populations would 
need improved characterizations of exposure to 
EMPs, smoking status, and exposures associat-
ed with other employment. Additional studies 
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of these populations should be pursued if these 
improvements are deemed feasible.
2.7.1.1.2 Animal Studies
The second element of NIOSH’s rationale for 
recommending in 1990 that nonasbestiform 
analogs of the asbestos minerals be encom-
passed by the REL is related to evidence from 
animal studies. Citing several original studies 
and reviews [Stanton et al. 1977, 1981; Wagner 
et al. 1982; Muhle et al. 1987; Pott et al. 1974, 
1987; Lippmann 1988], NIOSH [1990a] con-
cluded that they provided evidence that fiber 
dimension (and not fiber composition) was the 
major determinant of carcinogenicity for min-
eral fibers, stating that
Literature reviews by Lippmann [1988] 
and Pott et al. [1987] enhance the hypoth-
esis that any mineral particle can induce 
cancer and mesothelioma if it is sufficient-
ly durable to be retained in the lung and if 
it has the appropriate aspect ratio and di-
mensions. Similarly, Wagner [1986] con-
cluded that all mineral particles of a spe-
cific diameter and length size range may 
be associated with development of diffuse 
pleural and peritoneal mesotheliomas.
That general conclusion notwithstanding, a study 
by Smith et al. [1979] that was not cited by 
NIOSH in 1990 addressed the specific question 
of carcinogenicity of EMPs from nonasbestiform 
amphiboles. Pleural tumor induction by intra-
pleural (IP) injection challenge in hamsters was 
compared for various challenge materials, in-
cluding two asbestiform tremolites and two 
nonasbestiform (prismatic) tremolitic talcs. In 
contrast to the two asbestiform tremolites, which 
induced tumors in 22% and 42% of challenged 
hamsters at the higher dose, no tumors result-
ed following challenge with either of the two 
nonasbestiform tremolites [Smith et al. 1979]. In 
its rule-making, OSHA noted several limitations 
of the study, including the small number of an-
imals studied, the early death of many animals, 
and the lack of systematic characterization of fi-
ber size and aspect ratio [OSHA 1992]. One of 
the nonasbestiform tremolitic talcs was later an-
alyzed and determined to have tremolitic chem-
ical composition and 13% “fibers,” as defined by 
a 3:1 aspect ratio [Wylie et al. 1993].
Since 1990, another carcinogenicity study of 
nonasbestiform amphibole minerals has been 
published. An IP injection study in rats used six 
samples of tremolite, including three asbestiform 
samples that induced mesothelioma in 100%, 
97%, and 97% of challenged animals [Davis et 
al. 1991]. Two nonasbestiform tremolite sam-
ples resulted in mesotheliomas in 12% and 5% 
of the animals, and the response rate of 12% was 
above the expected background rate. Another 
sample that was predominantly nonasbestiform 
but reported to contain a small amount of 
asbestiform tremolite resulted in mesothelioma 
in 67% of animals. Of note, the nonasbestiform 
material associated with the 12% mesothelioma 
incidence and this latter material contained an 
approximately equal number of EMPs longer 
than 8 μm and thinner than 0.5 μm.
Studies of in vitro assays of various biolog-
ical responses, some published before and 
some after 1990, have also found relative tox-
icities of asbestiform and non asbestiform 
minerals that generally parallel the differenc-
es observed in the in vivo IP injection stud-
ies of tumorigenicity [Wagner et al. 1982; 
Woodworth et al. 1983; Hansen and Mossman 
1987; Marsh and Mossman 1988; Sesko and 
Mossman 1989; Janssen et al. 1994; Mossman 
and Sesko 1990] A recent review of the litera-
ture concluded that low-aspect-ratio cleavage 
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fragments of amphiboles are less potent than 
asbestos fibers [Mossman 2008].
In summary, there is more literature now than in 
1990 pertaining to differential animal carcinoge-
nicity and toxicity of EMPs from nonasbestiform 
amphiboles (e.g., acicular crystals, prismatic 
crys tals, and cleavage fragments). The number of 
studies is limited and each study has limitations, 
but they suggest that nonasbestiform amphiboles 
might pose different risks than asbestos. More 
detailed discussion of these studies, including 
discussion of important limitations of the studies, 
can be found in Section 2.8.4 of this  document.
2.7.1.1.3 Analytical Limitations
The third element that served as a  basis for 
NIOSH’s 1990 recommendation that non asbesti-
form analogs of the asbestos minerals be encom-
passed by the REL was the inability to accurate-
ly and consistently distinguish asbestos fibers and 
nonasbestiform EMPs in samples of airborne 
particulate. The 1990 NIOSH testimony argued 
that asbestiform and nonasbestiform minerals 
can occur in the same geological area and that 
mixed exposures to airborne asbestos fibers and 
EMPs from the nonasbestiform analog minerals 
can occur at mining operations. The potential for 
mixed exposures can also occur downstream if 
the mined commodity contains both asbestiform 
and nonasbestiform minerals.
The 1990 NIOSH testimony further pointed 
out the lack of routine analytical methods for 
air samples that can accurately and consistent-
ly determine whether an individual EMP that 
meets the dimensional criteria of a countable 
particle is an asbestos fiber or a nonasbestiform 
EMP (e.g., acicular crystals, prismatic crystals, 
cleavage fragments).
Two analytical components of the NIOSH REL 
for airborne asbestos fibers are applied to air 
samples: the microscopic methods and the 
counting rules. The microscopic methods in-
clude the following:
 • Phase contrast microscopy (PCM)—An-
alytical Method 7400 “A rules”—Asbes-
tos and Other Fibers by PCM [NIOSH 
1994a] is used to count all particles that 
are longer than 5 µm and have a length-
to-width ratio equal to or greater than 3:1. 
 • Transmission electron microscopy (TEM)—
Analytical Method 7402—Asbestos by 
TEM [NIOSH 1994b] is used as a sup-
plement to the PCM method when there 
is uncertainty about the identification of 
elongate particles (EPs) that are count-
ed. When TEM analysis is used for par-
ticle identification, only those EPs that 
are identified as “asbestos” and meet 
the dimensional criteria used by PCM 
(>0.25 µm width and >5 µm length) are 
counted as asbestos fibers. PCM counts 
can be adjusted to yield corrected asbes-
tos fiber counts by multiplying them by 
the proportion of fibers determined by 
TEM to be asbestos.
There are several limitations of the use of PCM 
and TEM for asbestos analysis. PCM is stat-
ed to be limited to observing EPs with widths 
>0.25 µm and is not equipped for particle iden-
tification. TEM, although capable of resolving 
EPs with widths as small as 0.001 µm, frequent-
ly cannot differentiate nonasbestiform from 
asbestiform EMPs when the elemental compo-
sition is the same or when present in a hetero-
geneous mix of unknown particles. A poten-
tial limitation of TEM is that partial lengths of 
long fibers may not be observed because they 
intersect grid bars or lie partially outside the 
small field of view. However, this is likely to 
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affect only a small number of observed parti-
cles, because very few particles are greater than 
15 µm length, as evidenced in air samples from 
textile processing [Dement et al. 2009] and min-
ing and milling operations [Gibbs and Hwang 
1980]. A more important limitation of TEM is 
that, because only a small portion of the filter 
sample is being analyzed, airborne fiber concen-
trations might not be determined with certain-
ty. Another limitation of both methods is that 
high concentrations of background dust collect-
ed on samples may interfere with fiber count-
ing by PCM and particle identification by TEM.
Thus, the current PCM and TEM methods 
used for routine exposure assessment lack the 
capability to accurately count, size, and iden-
tify all EMPs collected on airborne samples. 
Further discussion of the analytical limitations 
and possible improvements are discussed in 
Section 2.8.
2.7.2 Clarification of the Current 
NIOSH REL
As described in the preceding sections, uncer-
tainty remains concerning the adverse health 
effects that may be caused by nonasbestiform 
EMPs encompassed by NIOSH since 1990 in 
the REL for asbestos. Also as described in a pre-
ceding section, current analytical methods still 
cannot reliably differentiate between asbestos 
fibers and other EMPs in mixed-dust environ-
ments. NIOSH recognizes that its descriptions of 
the REL since 1990 have created confusion and 
caused many to infer that the additional covered 
minerals were included by NIOSH in its defini-
tion of “asbestos.” NIOSH wishes to make clear 
that such nonasbestiform minerals are not “as-
bestos” or “asbestos minerals.” NIOSH also 
wishes to minimize any potential future confu-
sion by no longer referring to particles from the 
nonasbestiform analogs of the asbestos minerals 
as “asbestos fibers.” However, as the following 
clarified REL makes clear, particles that meet the 
specified dimensional criteria remain countable 
under the REL for the reasons stated above, even 
if they are derived from the nonasbestiform ana-
logs of the asbestos minerals.
With use of terms defined in this Roadmap, the 
NIOSH REL is now clarified as follows:
NIOSH has determined that exposure to asbes-
tos fibers causes cancer and asbestosis in hu-
mans and recommends that exposures be re-
duced to the lowest feasible concentration. 
NIOSH has designated asbestos to be a “Po-
tential Occupational Carcinogen”‡‡ and recom-
mends that exposures be reduced to the lowest 
feasible concentration. The NIOSH REL for air-
borne asbestos fibers and related elongate min-
eral particles (EMPs) is 0.1 countable EMP from 
one or more covered minerals per cubic centi-
meter, averaged over 100 minutes, where
 • a countable elongate mineral particle (EMP) 
is any fiber or fragment of a mineral longer 
than 5  µm with a minimum aspect ratio 
of 3:1 when viewed microscopically with 
use of NIOSH Analytical Method 7400 (‘A’ 
rules) or its equivalent; and
‡‡NIOSH’s use of the term “Potential Occupational Car-
cinogen” dates to the OSHA classification outlined in 
29 CFR 1990.103, and, unlike other agencies, is the 
only classification for carcinogens that NIOSH uses. 
See Section 6.1 for the definition of “Potential Occu-
pational Carcinogen.” The National Toxicology Pro-
gram [NTP 2005], of which NIOSH is a member, has 
determined that asbestos and all commercial forms of 
asbestos are known to be human carcinogens based 
on sufficient evidence of carcinogenicity in humans. 
The International Agency for Research on Cancer 
(IARC) concluded that there was sufficient evidence 
for the carcinogenicity of asbestos in humans [IARC 
1987b].
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 • a covered mineral is any mineral having 
the crystal structure and elemental com-
position of one of the asbestos  variet-
ies (chrysotile, riebeckite asbestos [croci-
dolite], cummingtonite-grunerite as bes tos 
[amosite], anthophyllite asbestos, trem olite 
asbestos, and actinolite asbestos) or one of 
their nonasbestiform analogs (the serp en-
tine minerals antigorite and lizardite, and 
the amphibole minerals contained in the 
cummingtonite-grunerite mineral series, 
the tremolite-ferroactinolite mineral se-
ries, and the glaucophane-riebeckite min-
eral series).
This clarification of the NIOSH REL for air-
borne asbestos fibers and related EMPs re-
sults in no change in counts made, as defined 
by NIOSH Method 7400 (‘A’ rules). However, 
it clarifies definitionally that EMPs included in 
the count are not necessarily asbestos fibers.
The NIOSH REL comprises two components. 
One component states the agency’s intent about 
what minerals should be covered by the REL; 
the other component describes the sampling 
and analytical methods to be used for collect-
ing, characterizing, and quantifying exposure 
to airborne particles from the covered miner-
als. Each of these components of the NIOSH 
REL is discussed in detail in later subsections 
of this Roadmap.
The NIOSH REL remains subject to change 
based on research findings that shed light 
on the toxicity of nonasbestiform amphibole 
EMPs covered by the REL and on the toxic-
ity of other EMPs outside the range of those 
minerals currently covered by the REL. In ad-
dition, because of changes by the IMA in 1978 
[Meeker et al. 2003] in how minerals (e.g., am-
phiboles) are identified and classified (opti-
cal microscopy to chemistry-based), a more 
extensive clarification of specific minerals cov-
ered by the NIOSH REL may be warranted. 
That more extensive clarification of covered 
minerals is beyond the scope of this Roadmap 
but will be addressed through additional efforts 
by NIOSH to encompass contemporary miner-
alogical terminology within the REL.
2.8 EMPs Other than  
Cleavage Fragments
2.8.1 Chrysotile
Chrysotile fibers consist of aggregates of long, 
thin, flexible fibrils that resemble scrolls or 
cylinders, and the dimensions of individual 
chrysotile fibers depend on the extent to which 
the material has been manipulated. Multi-fibril 
chrysotile fibers commonly split along the fiber 
length and undergo partial dissolution within 
the lungs [NRC 1984]. Such longitudinal split-
ting in the lung represents one way that air sam-
ple counts may underestimate the cumulative 
dose of fibers in the lung. 
Epidemiological studies of chrysotile in Que-
bec mines [McDonald and McDonald 1997] 
and South Carolina textile mills [Dement et al. 
1994; Hein et al. 2007] have produced very dif-
ferent estimates of the risk of cancer associat-
ed with exposure to chrysotile fibers. With the 
differences in fiber concentrations accounted 
for, the exposure in the textile mills appears to 
be associated with much higher risk than ex-
posure in the mines. Several explanations for 
the difference in lung cancer risks observed in 
these two different workplaces have been pro-
posed. One suggested explanation is that the 
textile workers were exposed to mineral oil. 
However, this explanation does not satisfacto-
rily explain the differences [Stayner et al. 1996]. 
Considering that the textile mill workers were 
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exposed to fibers considerably longer and thin-
ner than those found in mines [Peto et al. 1982; 
Dement and Wallingford 1990], a more likely 
explanation is that the difference in risk may 
be due, at least in part, to dimensional differ-
ences in the particles to which workers were 
exposed. It has also been proposed that expo-
sures in the textile mills were almost exclusive-
ly to chrysotile asbestos, whereas exposures in 
the mines were to a mixture of chrysotile asbes-
tos fibers and EMPs of related nonasbestiform 
minerals (i.e., antigorite and lizardite) [Wylie 
and Bailey 1992]. Stayner et al. [1997] also 
point out, in comparing a number of epidemi-
ological studies, that the variation in relative 
risk for lung cancer is often greater within an 
industry (e.g., mining or textile) than between 
varieties of asbestos.
Some have argued that pure chrysotile may not 
be carcinogenic and that increased respirato-
ry cancer among chrysotile workers can be ex-
plained by the presence of tremolite asbestos 
as a contaminant of chrysotile [McDonald and 
McDonald 1997]. This is referred to as the am-
phibole hypothesis. However, several studies of 
workers using chrysotile with very little contam-
ination by tremolite have demonstrated strong 
relationships between exposure to chrysotile 
and lung cancer. A study of chrysotile asbestos 
workers in China [Yano et al. 2001] found an 
age- and smoking-adjusted relative risk of 8.1 
for lung cancer among highly exposed work-
ers, compared to workers with low exposure to 
asbestos. The identified contamination of the 
chrysotile by tremolite was less than 0.001%. In 
the South Carolina textile mill study, a strong re-
lationship between lung cancer and chrysotile 
exposure has been demonstrated [Dement et 
al. 1994; Hein et al. 2007]. The plant also pro-
cessed less than 2000 lbs of crocidolite yarn per 
year from the early 1950s until 1972. This small 
amount of crocidolite was processed at one lo-
cation, wet or lubricated with oil or graphite, 
to unite woven tape and braided packing [Mc-
Donald et al. 1983]. Since crocidolite was never 
carded, spun, or twisted, the predominant expo-
sure at the plant was to chrysotile asbestos. A re-
cent reanalysis by transmission electron micros-
copy (TEM) of archived fiber samples collected 
from the study facility in 1965 and 1968 identi-
fied only two amphibole fibers among 18,840 fi-
ber structures (0.01%) in archived airborne dust 
samples from that textile mill study; the remain-
der were identified as chrysotile [Stayner et al. 
2007]. Additionally, in fiber burden studies of 
malignant mesothelioma in humans, chrysotile 
fibers were often present in mesothelioma tissue, 
even in the absence of detectable amphibole fi-
bers [Suzuki and Yuen 2001], though this alone 
does not constitute conclusive evidence of a role 
for chrysotile in the etiology of mesothelioma. 
In addition to analyses of air samples from epi-
demiologic studies, UICC chrysotile B was an-
alyzed, with special attention given to identify-
ing tremolite contamination. Analysis of more 
than 20,000 fibers identified only particles with 
the characteristics of chrysotile, not tremolite 
[Frank et al. 1998]. Additionally, Kohyama et 
al. [1990] reported no amphibole asbestos was 
found in UICC chrysotile B at the detection lev-
el of 0.1%. This material has been used in an in-
halation experiment that produced lung cancers 
and mesotheliomas [Wagner et al. 1974] and 
another study reporting mesotheliomas after 
intrapleural inoculation [Wagner et al. 1973].
A possible difference in risk for carcinogenicity 
between chrysotile and amphibole asbestos ex-
posures has been investigated in animal mod-
el studies. In a one-year rat inhalation study, 
chrysotile samples were extremely fibrogenic 
and carcinogenic. Pulmonary carcinomas de-
veloped in approximately 25% of animals, 
36 NIOSH CIB 62 • Asbestos
and advanced interstitial fibrosis developed in 
lung tissue in 10% of all older animals, where-
as intrapleural injection studies produced 
mesotheliomas in over 90% of animals [Da-
vis et al. 1986]. It was noted that very little 
chrysotile remained in the lungs of the animals 
that survived longest following dust inhala-
tion. From this it was suggested that chrysotile 
is very potent in rodents but, except where ex-
posure levels are very high and of long dura-
tion, may be less hazardous to man because 
chrysotile fibers are removed from lung tis-
sue more rapidly than are amphibole fibers. In 
a further analysis of the data, using regenerat-
ed dusts, Berman et al. [1995] found that al-
though chrysotile and amphiboles do not differ 
in potency for lung tumor induction, mineral-
ogy is a determinant of the relative potency of 
inhaled dusts for mesothelioma induction, and 
chrysotile is less potent than amphiboles.
Hodgson and Darnton [2000] reviewed the lit-
erature and estimated that, at exposure levels 
seen in occupational cohorts, the exposure-
specific risk of mesothelioma from the three 
principal commercial asbestos types is broad-
ly in the ratio 1:100:500 for chrysotile, amosite, 
and crocidolite, respectively, and the risk differ-
ential for lung cancer between chrysotile fibers 
and the two varieties of amphibole asbestos 
fibers is between 1:10 and 1:50. In 2009, Loo-
mis et al. [2009] reported the results of a mor-
tality study of chrysotile textile workers which 
found increased risks of both mesothelioma 
and lung cancer. The increase in mesothelioma 
and pleural cancer in this cohort was consis-
tent with the average of 0.3% mesothelioma 
deaths in the cohorts that previously had been 
reported by Stayner et al. [1996] based on 
12 studies of workers exposed to chrysotile 
in mining and processing plants, but higher 
than the estimates reported by Hodgson and 
Darnton [2000]. Based on the findings of Loo-
mis et al. [2009], Hodgson and Darnton [2010] 
reanalyzed their data. They found that cumu-
lative risk of mesothelioma for chrysotile-ex-
posed asbestos workers in processing plants 
was approximately an order of magnitude 
greater than the risk they had previously re-
ported for mines and processing plants com-
bined, and commented that this risk is still at 
least an order of magnitude lower than that as-
sociated with exposure to amphibole asbestos 
[Hodgson and Darnton 2010]. 
A recent analysis of potency factors of vari-
ous minerals estimated that the relative poten-
cy of chrysotile for producing mesothelioma 
ranged between zero and 1/200th that of am-
phibole asbestos and that amphibole asbes-
tos and chrysotile were not equally potent in 
producing lung cancer [Berman and Crump 
2008b]. However, the Asbestos Committee of 
EPA’s Science Advisory Board expressed sub-
stantial concern that the scientific basis for a 
similar modeling approach being considered 
by EPA for risk assessment was weak and inad-
equate, and specifically cited the lack of avail-
able data to estimate TEM-specific levels of ex-
posure for epidemiological studies used in the 
analysis [EPA 2008a]. Subsequently, EPA chose 
not to pursue this approach [EPA 2008b].
2.8.2 Asbestiform Amphibole 
Minerals
Asbestiform amphibole fibers consist of ag-
gregates of long, thin, flexible fibrils that sep-
arate along grain boundaries between the fi-
brils. Because the fibril diameter of crocidolite 
is less than that of anthophyllite asbestos but 
the flexibility is greater, there is an indication 
that flexibility is a function of fibril diame-
ter. As with chrysotile, the dimensions of in-
dividual amphibole asbestos fibers depend on 
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the extent to which the material has been ma-
nipulated. There are conflicting reports on the 
splitting of amphibole fibers in vivo. Following 
intrapleural inoculation in rats, ferroactinolite 
and amosite have been reported to split lon-
gitudinally in the lung, resulting in increased 
numbers of thinner fibers with increased as-
pect ratio [Coffin et al. 1982, 1992; Cook et al. 
1982], and crocidolite has also been observed 
to split longitudinally [Coffin et al. 1992]. In 
other studies, crocidolite splitting was not ob-
served, even after several years [Bellman et al. 
1987]. Longitudinal splitting of fiber bundles 
after entering the lung represents one way that 
air sample counts may underestimate the cu-
mulative dose of fibers in the lung.
There is little scientific debate that the asbestiform 
varieties of the five commercially important am-
phibole asbestos minerals are carcinogenic and 
should be covered by regulations to protect 
workers. However, concerns have been raised 
that the current OSHA and MSHA asbestos reg-
ulations and even the current NIOSH REL for 
airborne asbestos fibers, which explicitly cover 
the asbestiform varieties of the six commercially 
important asbestos minerals, should be expand-
ed to provide worker protection from exposure 
to EMPs from asbestiform minerals.
This concern is exemplified by exposures to 
winchite and richterite fibers at a vermiculite 
mine near Libby, Montana, where exposures to 
the these fibers have resulted in high rates of 
lung fibrosis and cancer among exposed work-
ers, similar to the occurrence of asbestos-related 
diseases among asbestos-exposed workers in 
other industries [Amandus and Wheeler 1987; 
Amandus et al. 1987a,b; McDonald et al. 2004; 
Sullivan 2007; Rohs et al. 2008]. Workers at the 
mine and residents of Libby were exposed to 
EMPs identified (on the basis of the 1997 IMA 
amphibole nomenclature) as the asbestiform 
amphiboles winchite and richterite, as well as 
tremolite asbestos [Meeker et al. 2003].
The recently updated NIOSH cohort study of 
Libby workers found elevated SMRs for asbes-
tosis (SMR 165.8; 95% CI 103.9–251.1), lung 
cancer (SMR 1.7; 95% CI 1.4–2.1), cancer of 
the pleura (SMR 23.3; 95% CI 6.3–59.5), and 
mesothelioma [Sullivan 2007]. An exposure- 
response relationship with duration of employ-
ment and total fiber-years cumulative exposure 
was demonstrated for both asbestosis and lung 
cancer. Significant excess mortality from non-
malignant respiratory disease was observed 
even among workers with cumulative expo-
sure <4.5 fibers/cc-years (i.e., a worker’s cumu-
lative lifetime exposure, if exposed to asbestos 
fibers at the current OSHA standard of 0.1 f/cm3 
over a 45-year working life). IARC stated min-
eral substances (e.g., vermiculite) that contain 
asbestos should also be regarded as “carcino-
genic to humans” (Group 1) [IARC 2009]. Ver-
miculite from the Libby mine was used to pro-
duce loose-fill attic insulation, which remains in 
millions of homes around the United States, and 
homeowners and/or construction renovation 
workers (e.g., plumbers, cable installers, elec-
tricians, telephone repair personnel, and insu-
lators) are potentially exposed when this loose-
fill attic insulation is disturbed.
Because winchite and richterite are not explic-
itly listed among the six commercial asbestos 
minerals, it is sometimes assumed that they 
are not included in the regulatory definition 
for asbestos. However, some of what is now re-
ferred to as asbestiform winchite and richterite 
in the 1997 IMA nomenclature would have 
been accurately referred to as tremolite asbes-
tos according to the analytical criteria (opti-
cal methods of identification) specified in the 
1978 IMA nomenclature [Meeker et al. 2003]. 
Furthermore, an even greater portion of this 
38 NIOSH CIB 62 • Asbestos
richterite and winchite would have been iden-
tified as tremolite asbestos according to the 
optical methods of identification used prior to 
1978. In fact, over the years, amphibole miner-
als from the Libby mine that are now referred 
to as winchite and richterite were identified by 
mineralogists using then-current terminolo-
gy as soda tremolite [Larsen 1942], soda-rich 
tremolite [Boettcher 1966], and tremolite as-
bestos and richterite asbestos [Langer et al. 
1991; Nolan et al. 1991]; NIOSH identified ex-
posures to workers as tremolite in reports of 
the Libby mine epidemiological studies in the 
1980s [Amandus and Wheeler 1987; Amandus 
et al. 1987a,b].
Similar to the situation in Libby, a study of a 
cluster of malignant mesothelioma cases in east-
ern Sicily has implicated an etiological role for 
an asbestiform amphibole in the fluoro-edenite 
series, initially identified as a mineral in the 
tremolite-actinolite series [Comba et al. 2003].
In the face of past and future nomenclature 
changes in the mineralogical sciences, work-
ers need to be protected against exposures to 
pathogenic asbestiform minerals. The health 
and regulatory communities will need to care-
fully define the minerals covered by their pol-
icies and monitor the nomenclature chang-
es to minimize the impact of these changes on 
worker protections.
2.8.3 Other Minerals of  
Potential Concern 
By analogy to asbestiform amphiboles, there 
is reason to be concerned about potential for 
health risks associated with inhalational expo-
sure to EMPs not covered by asbestos policies.
Erionite is perhaps the most worrisome known 
example [HHS 2005b]. An epidemic of malignant 
mesothelioma affecting several villages in Cen-
tral Turkey has been studied for several decades 
[Baris et al. 1981]. Homes and other buildings in 
those villages were traditionally constructed of 
blocks of local volcanic stone containing erionite, 
a fibrous zeolite mineral. A recently published 
prospective mortality study has document-
ed that mesothelioma accounts for over 40% of 
deaths among those residing in the affected vil-
lages [Baris and Grandjean 2006]. This localized 
epidemic of malignant mesothelioma produced 
an opportunity for a pedigree study that found 
a strong genetic influence on erionite-caused 
mesothelioma [Dogan et al. 2006]. As with ex-
posure to asbestos, there is evidence that expo-
sure to erionite causes other malignant tumors 
[Baris et al. 1996] and pleural plaques [Karakoca 
et al. 1997] in addition to mesothelioma. Like-
wise, as with amphiboles, the mineralogy of zeo-
lites, including erionite, appears to be compli-
cated and subject to misclassification [Dogan 
and Dogan 2008]. Although no clear epidemic 
of erionite-caused disease has been documented 
elsewhere, the mineral occurs in the intermoun-
tain west of the United States and a recent publi-
cation purports to be the first to report a case of 
erionite-associated malignant mesothelioma in 
North America [Kliment et al. 2009]. 
The International Agency for Research on Can-
cer (IARC) has considered evidence relevant to 
carcinogenicity for several EMPs [IARC 1977, 
1987a, 1997]. In addition to the traditional 
commercial asbestos, IARC has made assess-
ments that the evidence is sufficient to deter-
mine that both erionite and talc containing 
asbestiform fibers are human carcinogens (i.e., 
Group 1) [IARC 2009]; the evidence for carci-
nogenicity of nonasbestiform talc was judged 
to be insufficient to determine human carcino-
genicity (i.e., Group 3) [IARC 1987a]. A Group 
3 determination means that “the available 
studies are of insufficient quality, consistency 
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or statistical power to permit a conclusion re-
garding the presence or absence of a causal as-
sociation, or no data on cancer in humans are 
available” [IARC 1997]. On the basis of studies 
in rats, palygorskite (attapulgite) fibers longer 
than 5 mm were determined to be possibly car-
cinogenic to humans (Group 2B) [IARC 1997]. 
In experimental animals the evidence was limit-
ed for the carcinogenicity of long sepiolite fibers 
(>5  µm) and inadequate to assess carcinoge-
nicity of nonerionite fibrous zeolites (includ-
ing clinoptilolite, mordenite, and phillipsite) 
and wollastonite (Group 3) [IARC 1997]. These 
Group 3 determinations highlight the need for 
additional research on nonasbestiform EMPs.
2.9 Determinants of Particle 
Toxicity and Health Effects
Current recommendations for assessing occu-
pational and environmental exposures to as-
bestos fibers rely primarily on dimensional 
and mineralogical characteristics. Dimension, 
which influences the deposition of EMPs in the 
lung, lung clearance mechanisms, and retention 
time in the lung, is an important determinant 
of toxicity. However, other particle character-
istics, such as durability in lung fluids, chemi-
cal composition, and surface activity, may also 
play important roles in causing respiratory dis-
eases. Research to elucidate what roles these 
EMP characteristics play in causing biologi-
cal responses may help to provide better evi-
dence-based recommendations for asbestos fi-
bers and other EMPs.
2.9.1 Deposition
Deposition of airborne particles in the respi-
ratory system is defined as the loss of parti-
cles from the inspired air during respiration. 
Clearance pertains to the removal of deposited 
particles by diverse processes over time, where-
as retention is the temporal persistence of parti-
cles within the respiratory system [Morrow 1985]. 
The deposition of inhaled particles in the respi-
ratory tract is a function of their physical charac-
teristics (dimension and density), the anatomical 
and physiological parameters of the airways, and 
the rate and depth of respiration [Yu et al. 1986]. 
Although particle chemical composition does 
not play a role in deposition, respiratory clearance 
of all particle types is dependent on both physi-
cal and chemical characteristics of the particle. 
In addition, surface charge and hydrophilicity, as 
well as adsorbed materials (e.g., coatings on syn-
thetic fibers) and other physical and chemical fac-
tors, determine whether small particles and fibers 
will agglomerate into larger, nonrespirable mass-
es [ILSI 2005].
Depending on their physical characteristics, in-
haled particles are differentially deposited in one 
of the following three respiratory system com-
partments: the extrathoracic region, consisting 
of the anterior and posterior nose, mouth, phar-
ynx, and larynx; the bronchial region, consisting 
of the trachea, bronchi, and bronchioles down 
to and including the terminal bronchioles; and 
the alveolar-interstitial region, consisting of the 
respiratory bronchioles, alveolar ducts, and al-
veolar sacs.
Important parameters for the deposition of 
airborne particles are their aerodynamic and 
thermodynamic properties. Below a particle 
size of 0.5 µm aerodynamic equivalent diam-
eter (AED), thermodynamic properties pre-
vail. The AED of EPs is mostly determined by 
their geometric diameter and density. Deposi-
tion of EPs in an airway is strongly related to 
the orientation of the particles with respect 
to the direction of the air flow and is affected 
by the interrelationship of four major depo-
sition mechanisms: impaction, interception, 
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sedimentation, and diffusion [Asgharian and 
Yu 1988]. In a study to assess EP deposition in 
the tracheobronchial region, Zhou et al. [2007] 
evaluated the deposition efficiencies of carbon 
fibers (3.66  µm diameter), using two human 
airway replicas that consisted of the oral cavity, 
pharynx, larynx, trachea, and three to four gen-
erations of bronchi. Carbon fiber deposition 
was found to increase with the Stokes number, 
indicating that inertial impaction is the domi-
nant mechanism. Also, fiber deposition in the 
tracheobronchial region was lower than that of 
spherical particles at a given Stokes number, 
indicating a greater likelihood for small-width 
EPs to move past the upper respiratory tract 
and reach the lower airways where diffusion-
al deposition predominates [Yu et al.1986]. 
These results were confirmed by results of lat-
er studies evaluating the deposition of asbes-
tos, using a similar tracheobronchial cast mod-
el [Sussman et al. 1991a, b]. The probability of 
deposition of a particle in a specific location in 
the airways is not the same as the probability 
of penetration to that region, and for particles 
in a certain range of AEDs, the difference be-
tween penetration and deposition may be sub-
stantial [ICRP 1994].
2.9.2 Clearance and Retention 
A variety of mechanisms are associated with the 
removal of deposited particles from the respi-
ratory tract [Warheit 1989]. Physical clearance 
of insoluble particles deposited in the lung is 
an important physiological defense mechanism 
that usually serves to moderate any risk that 
might otherwise be associated with exposure to 
particles. Inhaled particles that deposit on respi-
ratory tract surfaces may be physically cleared 
by the tracheobronchial mucociliary escala-
tor or nasal mucus flow to the throat, and then 
they may be either expectorated or swallowed. 
Clearance depends upon the physicochemical 
properties of the inhaled particles, the sites of 
deposition, and respiratory anatomy and phys-
iology. For example, inhaled insoluble parti-
cles with larger AEDs tend to deposit on the 
nasopharyngeal mucus and are generally cleared 
by sneezing or nose blowing or by flow into the 
oropharynx, where they are swallowed. Insolu-
ble particles with smaller AEDs tend to depos-
it lower in the respiratory tract, with associated 
longer retention times. Those deposited in the 
alveolar region are subject to longer retention 
times than those deposited on the bronchial re-
gion [Lippmann and Esch 1988].
The most important process for removal of in-
soluble particles from the airways is mucociliary 
clearance, which involves a layer of mucus pro-
pelled by the action of ciliated airway cells 
that line the trachea, bronchi, and terminal 
bronchioles [Warheit 1989]. The mucociliary 
transport system is sensitive to a variety of 
agents, including cigarette smoke and ozone 
[Vastag et al. 1985]. These toxicants affect the 
speed of mucus flow and consequent particle 
clearance by altering ciliary action and/or mod-
ifying the properties and/or amount of mucus. 
Chronic exposure to cigarette smoke has been 
shown to cause a prolonged impairment of par-
ticulate clearance from the bronchial region. 
This impaired clearance is associated with in-
creased retention of asbestos fibers in the bron-
chi, where they stimulate inflammatory pro-
cesses in the bronchial epithelium [Churg and 
Stevens 1995; Churg et al. 1992].
Because the alveolar region of the lung does 
not possess mucociliary clearance capabili-
ty, particles (generally <2  µm AED) deposit-
ed in this region are cleared at a much slower 
rate than particles deposited in the bronchi-
al region. Particles that are soluble may dis-
solve and be absorbed into the pulmonary 
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capillaries, whereas insoluble particles may 
physically translocate from the alveolar air-
space [Lippmann et al. 1980; Lippmann and 
Schlesinger 1984; Schlesinger 1985]. Most in-
soluble EPs that deposit in the alveolar regions 
are phagocytized (i.e., engulfed) by alveolar 
macrophages. Macrophages contain lysosomes 
packed with digestive enzymes, such as acid 
hydrolases, at acidic pH levels. Lysosomal con-
tents are capable of digesting many—though not 
all—types of phagocytized particles. Alveolar 
macrophages that have phagocytized particles 
tend to migrate to the bronchoalveolar junc-
tions, where they enter onto the mucociliary 
escalator for subsequent removal from the 
lung [Green 1973]. It has been postulated by 
some investigators that dissolution of parti-
cles within macrophages is a more important 
determinant of long-term clearance kinetics 
for many mineral dusts than is mucociliary 
transport and the migratory potential of lung 
macrophages [Brain et al. 1994]. However, 
certain circumstances can disrupt the normal 
phagosomal function of alveolar macrophages. 
One such circumstance involves the toxic 
death of macrophages initiated by highly re-
active particle surfaces (e.g., crystalline silica 
particles). Another such circumstance involves 
overwhelming the capacity of macrophages 
by an extreme burden of deposited particles, 
sometimes referred to as “overload,” even by 
particles that would be considered “inert” at 
lower doses. A third type of circumstance, typ-
ified by asbestos fibers, involves EPs that, even 
though having a small enough AED (defined 
primarily by particle width) to permit depo-
sition in the alveolar region, cannot be read-
ily phagocytized because particle length ex-
ceeds macrophage capacity. When alveolar 
macrophages attempt to phagocytize such EPs, 
they cannot completely engulf them (some-
times referred to as “frustrated phagocytosis”), 
and lysosomal contents are released into the al-
veolar space. Frustrated phagocytosis can initi-
ate a process in which reactive oxygen species 
(ROS) are generated, stimulating the induction 
of tumor necrosis factor-alpha (TNF-α). TNF-α 
is considered an inflammatory and fibrogenic 
cytokine that plays an important role in the patho-
genesis of pulmonary fibrosis [Blake et al. 1998].
All three types of disruption of normal mac-
rophage function contribute to decreased par-
ticle clearance rates and can result in inflam-
mation of the alveolar spaces. In addition, 
particles that are not phagocytized in the al-
veoli can translocate to the lung interstitium, 
where they may be phagocytized by intersti-
tial macrophages or transported through the 
lymphatic system to pulmonary lymph nodes 
[Lippmann et al. 1980; Lippmann and Schlesinger 
1984; Schlesinger 1985; Oberdorster et al. 1988]. 
Tran and Buchanan [2000] have reported find-
ings suggesting that sequestration of particles 
in the interstitial compartment is more promi-
nent in exposed humans than is the observed 
retention of particles due to overload in animal 
studies. The importance of interstitialization in 
humans is consistent with the kinetic differ-
ences observed in lung clearance rates in hu-
mans and rats. The first-order rate coefficient 
for alveolar clearance is approximately 1 or-
der of magnitude faster in rats than in humans 
[Snipes 1996], which may allow for greater 
interstitialization of particles in humans at all 
levels of lung dust burden. These findings in-
dicate that adjustment of kinetic differences 
in particle clearance and retention is required 
when using rodent data to predict lung disease 
risks in humans and that current human lung 
models underestimate working lifetime lung 
dust burdens in certain occupational popula-
tions [Kuempel et al. 2001].
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Evidence from in vivo studies in rodents and in 
vitro studies indicates that EPs (vitreous glass 
and EMPs) with a length equal to or greater 
than the diameter of rodent lung macrophages 
(about 15 µm) are most closely linked to bio-
logical effects observed in rodent lungs [Blake 
et al. 1998]. Alveolar macrophages appear to 
be capable of phagocytizing and removing EPs 
shorter than approximately 15  µm, either by 
transport to the mucociliary system or to local 
lymph channels. With increasing length above 
approximately 15 µm, alveolar macrophages ap-
pear to be increasingly ineffective at physical re-
moval, resulting in differential removal rates for 
EPs of different lengths. Although EP lengths 
greater than 15 µm appear to be associated with 
toxicity in experimental studies with rodents, a 
“critical” length for toxicity in humans is prob-
ably greater than 15  µm [Zeidler-Erdely et al. 
2006]. For long EPs that cannot be easily cleared 
by macrophages, biopersistence in the lung is 
influenced by the ease with which the EPs break 
into shorter lengths.
2.9.3 Biopersistence and Other 
Potentially Important Particle 
Characteristics
It has been hypothesized that the differenc-
es in crystalline structure between amphibole 
asbestos fibers and amphibole cleavage frag-
ments account for apparent differences in tox-
icological response to these particles. Cleavage 
fragments that meet the dimensional crite-
ria for countable particles under federal reg-
ulatory policies for asbestos fibers are gen-
erally shorter and wider than asbestos fibers 
[Siegrist and Wylie 1980; Wylie 1988]. This 
dimensional difference between populations 
of asbestos fibers and populations of cleav-
age fragments might contribute to generally 
shorter biopersistence in the lung for cleavage 
fragments than for asbestos fibers. Asbestos fi-
bers also tend to separate longitudinally once 
deposited in the lung, thus increasing the total 
number of retained fibers without an accom-
panying reduction in lengths of the retained 
fibers [NRC 1984]. In contrast, cleavage frag-
ments tend to break transversely because of 
dissolution of their weaker crystalline struc-
ture, resulting in shorter particles that can be 
more easily cleared through phagocytosis and 
mucociliary clearance [Zoltai 1981]. The im-
pact of these structural differences on solubil-
ity in lung fluids warrants study, because sub-
stantial differences in solubility in lung fluids 
between asbestos fibers and other EMPs (in-
cluding amphibole cleavage fragments) could 
translate into differences in toxicity.
2.9.3.1 Biopersistence
Dissolution of EPs in the lung is a poorly un-
derstood process that is dependent on particle 
characteristics, biological processes, and con-
comitant exposure to other particulates. The 
ability of an EP to be retained and remain intact 
in the lung is considered an important factor in 
the process of an adverse biological response. 
EPs of sufficient length that remain intact and 
are retained in the lung are thought to pose the 
greatest risk for respiratory disease. The ability 
of an EP to reside long-term in the lung is gener-
ally referred to as biopersistence. Biopersistence 
of EPs in the lung is a function of site and rate 
of deposition, rates of clearance by alveolar 
macrophages and mucociliary transport, solu-
bility in lung fluids, breakage rate and breakage 
pattern (longitudinal or transverse), and rates 
of translocation across biological membranes. 
The rates of some of these processes can affect 
the rates of other processes. For example, a high 
rate of deposition in the alveolar region could 
potentially overwhelm macrophage clearance 
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mechanisms and increase the rate of transloca-
tion to the lung interstitium.
The persistence of an EP in the lung is influenced 
by changes that may occur in its dimension, sur-
face area, chemical composition, and surface 
chemistry. Differences in any of these charac-
teristics can potentially result in differences in 
clearance and retention and affect toxic poten-
tial. For example, EPs too long to be effectively 
phagocytized by alveolar macrophages will tend 
to remain in the alveolar compartment and be 
subjected to other clearance mechanisms, in-
cluding dissolution, breakage, and translocation 
to interstitial sites and subsequently to pleural 
and other sites.
The durability of EPs residing in the lung is an 
important characteristic influencing biopersis-
tence. An EP’s durability is generally measured 
by its ability to resist dissolution and mechani-
cal disintegration after being subjected to lung 
extracellular fluid (approximate pH of 7) and 
lysosomal fluids (approximate pH of 5). EPs 
that are more soluble will be less biopersistent, 
and thicker EPs may take longer to dissolve 
than thinner EPs, all else being equal. For ex-
ample, long, thin EPs that are not very dura-
ble could dissolve and/or fragment into short-
er EPs, increasing their probability of being 
cleared from the lung and thus potentially de-
creasing lung retention time and risk for fibrot-
ic or neoplastic effects. Some EPs, such as cer-
tain types of glass fibers, are fairly soluble in 
lung fluid and are cleared from the lung in a 
matter of days or months. Other EPs, such as 
amphibole asbestos, can remain in the lung for 
decades. It has been suggested that some types 
of EPs may alter the mobility of macrophages 
and the translocation of EPs to the pleura or 
lymph nodes [Davis 1994]. No relationship has 
been established between biopersistence of EPs 
in the lung and the risk of induction of genetic 
and epigenetic changes that may lead to can-
cer [Barrett 1994]. Although some evidence 
indicates that durability may be a determinant 
of toxicity for various synthetic vitreous fibers 
(SVFs), EMPs need to be evaluated to deter-
mine whether they conform to this paradigm 
[ILSI 2005].
Measurement of the biopersistence of various 
EMPs has been suggested as a means for estimat-
ing their relative potential hazard. Short-term 
inhalation and intratracheal instillation studies 
have been used to determine the biopersistence 
of various SVFs and asbestos fibers. Animal in-
halation studies are preferred over animal tra-
cheal instillation studies to assess biopersistence 
because they more closely mimic typical hu-
man exposure. The European Commission has 
adopted specific testing criteria that permit the 
results from either short-term biopersistence 
studies or chronic animal studies to be used as a 
basis for determining carcinogenicity [Europe-
an Commission 1997]. 
Several animal inhalation studies have indicat-
ed that oncogenic potential of long SVFs can 
be determined by their biopersistence [Mast 
et al. 2000; Bernstein et al. 2001; Moolgavkar 
et al. 2001]. It has been suggested that a cer-
tain minimum persistence of long EPs is nec-
essary before even minute changes appear in 
the lungs of exposed animals [Bernstein et al. 
2001]. Furthermore, Moolgavkar et al. [2001] 
have suggested that EP-induced cancer risk, 
in addition to being a linear function of expo-
sure concentration, is also a linear function of 
the weighted half-life of EPs observed in inha-
lation studies with rats. Also, dosimetry mod-
els for rodents and humans indicate that, on a 
normalized basis, EP clearance rates are lower 
in humans than in rats [Maxim and McConnell 
2001] and that EPs frequently sequester in the 
interstitial compartment of humans [Snipes 
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1996; Tran and Buchanan 2000]. Thus, results 
from chronic inhalation studies with rodents 
exposed to EPs may underestimate risks for 
humans, and adjustment for kinetic differences 
in particle clearance and retention in rats is re-
quired to predict lung disease risks in humans 
[Kuempel et al. 2001]. 
Studies using in vitro assays have been con-
ducted with various SVFs and silicate minerals 
to determine the dissolution rate in simulated 
lung and lysosomal fluids [Hume and Rimstidt 
1992; Werner et al. 1995; Hesterberg and Hart 
2000; Jurinski and Rimstidt 2001]. In vitro dis-
solution studies can provide a rapid and more 
controlled alternative to classic long-term tox-
icity testing in animals and could provide use-
ful information when performed as companion 
experiments with in vivo studies if conditions 
of exposure and test agent can be made simi-
lar. The design of in vitro assays is intended to 
mimic the biological conditions that exist in the 
lung once the EP comes into contact with lung 
tissue or macrophages. Although uncertainties 
exist about the specific physiological processes 
that occur in the lung, results from in vitro as-
says can provide some insight into the chemi-
cal reactions that influence EP dissolution. For 
example, it appears that EP (e.g., glass fiber) 
dissolution occurs more readily when the EP 
is in contact with a fluid that is undersaturated 
with respect to the EP’s composition. The con-
dition of undersaturation must be maintained 
at the EP’s surface for dissolution to continue. 
If an EP is surrounded by a saturated or super-
saturated solution (compared to the EP com-
position), then no further dissolution occurs.
The results from many in vitro experiments 
demonstrate different patterns of dissolution 
for most of the tested EP types (i.e., glass, asbes-
tos) under various test conditions. This effect 
was most notable in those experiments where 
different pH conditions were used. Fluid pH 
appears to influence the creation of complexes 
from the leached elements of the EP, which in 
turn alters the rate of solubility. Chrysotile fibers 
tend to dissolve readily in acids because of the 
preferential leaching of magnesium (Mg) from 
the fiber. The leaching of Mg from tremolite and 
anthophyllite and of sodium from crocidolite 
also occurs more readily in acid conditions. 
The rate of EP dissolution has also been ob-
served to be affected by differing internal and 
surface structures. EPs with porous or rough 
surfaces have larger surface areas than smooth 
EPs with the same gross dimensions. These 
larger surface areas interact more readily with 
the surrounding medium because of the great-
er number of sites where solute molecules can 
be absorbed. EMPs with cleavage plane sur-
faces will contain varying degrees of defects; 
the higher the number of surface defects, the 
greater the potential instability of the particle. 
Dissolution of these types of EMPs is typical-
ly initiated where surface vacancies or impuri-
ties are present [Searl 1994]. Chrysotile asbes-
tos is an example of a sheet silicate made up 
of numerous fibrils composed of tightly bound 
rolled layers of Mg hydroxide. These Mg hy-
droxide layers are readily leached by acid so-
lutions within human tissues [Spurny 1983], 
causing disintegration of the fibril’s crystal-
line structure. In contrast, the amphibole as-
bestos minerals are chain silicates with a crys-
talline structure comprising alkali and alkali 
earth metals that are tightly bound, making 
the fibers less susceptible to dissolution. In 
contrast to the crystalline structure of the as-
bestos fibers, some high-temperature glass fi-
bers are more stable than chrysotile fibers be-
cause they are composed of silicate chains, 
sheets, and frameworks [Searl 1994]. The ab-
sence of cleavage planes or structural defects 
in glass fibers limits the degree to which fluids 
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can penetrate their interior to promote disso-
lution. Chrysotile fibers were found to be less 
durable in rat lungs than some high-tempera-
ture SVFs [Bellmann et al. 1987; Muhle et al. 
1987] but more durable in physiological so-
lutions than some refractory ceramic fibers 
(RCFs) [Scholze and Conradt 1987].
EP surface characteristics (e.g., structural de-
fects, porosity) and composition affect not 
only the rate of dissolution but also the manner 
in which dissolution occurs. In some instanc-
es, surface dissolution will cause alterations in 
internal structure sufficient to cause mechan-
ical breakage. In some studies, slagwools and 
rockwools exposed to water developed irreg-
ular surfaces, creating stress fractures that 
caused transverse breakage [Bellmann et al. 
1987]. Similar occurrences of glass fiber break-
age have been observed when there was leach-
ing of alkaline elements [Searl 1994].
Results from in vitro and short-term in vivo 
studies conducted with various EMPs and 
SVFs provide some confirmation that persis-
tence of EPs in the lung is influenced by par-
ticle durability [Bernstein et al. 1996]. However, 
other evidence suggests that, because of the rela-
tively short biodurability of chrysotile fibers, any 
damage to the lung tissue caused by chrysotile fi-
bers must be initiated soon after exposure [Hume 
and Rimstidt 1992], suggesting that biopersistence 
of EPs in the lung may be only one of many factors 
that contribute to biological response. A better un-
derstanding of the factors that determine the bio-
logical fate of EMPs deposited in the lung is criti-
cal to understanding the mechanisms underlying 
differences in toxic potential of various EMPs of 
different dimensions and compositions. Because 
biopersistence of EMPs is thought to play an im-
portant role in the development of disease, it may 
eventually prove to be an important characteristic 
to incorporate into occupational safety and health 
policies concerning exposures to EMPs.
2.9.3.2 Other Potentially Important 
Particle Characteristics
Surface composition and surface-associated ac-
tivities have been suggested as factors affect-
ing the potential for disease induction by EMPs 
(e.g., asbestos) [Bonneau et al. 1986; Kane 1991; 
Jaurand 1991; Fubini 1993]. For nonelongate re-
spirable mineral particles (e.g., crystalline silica), 
surface composition and surface interactions can 
directly and profoundly affect in vitro toxicities 
and in vivo pathogenicity; they can also direct-
ly cause membranolytic, cytotoxic, mutagenic, or 
clastogenic damage to cells and have been shown 
to induce fibrogenic activities in animals and hu-
mans. Investigation is warranted to confirm that 
these effects of surface composition and surface 
interactions also apply to EMPs. One strategy 
is to determine the effects of well-characterized 
surface modification of different types of EMPs 
on cell-free interactions with biological materials, 
in vitro cellular cytotoxicities or genotoxicities, 
and pathology in animal models.
Surface properties of mineral fibers and oth-
er EMPs may have direct impact on cytotoxic 
or genotoxic mechanisms responsible for 
fibrogenic or carcinogenic activity. Chemical 
surface modification of asbestos fibers has been 
shown to affect their cytotoxicity [Light and 
Wei 1977a,b; Jaurand et al. 1983; Vallyathan 
et al. 1985]. Although asbestos fibers clearly 
can be carcinogenic, they are not consistently 
positive in genotoxicity assays; their principal 
damage is chromosomal rather than gene mu-
tation or DNA damage [Jaurand 1991]. One 
study linked cytotoxicity with in vitro mam-
malian cell transformation [Hesterberg and 
Barrett 1984]; thus, surface factors affecting 
cytotoxicity might affect potential for inducing 
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some genotoxic activities. However, modify-
ing the surface of a well-characterized sam-
ple of chrysotile fibers by depleting surface Mg 
while retaining fiber length did not result in a 
significant quantitative difference for in vitro 
micronucleus induction between the native 
and surface-modified materials, both of which 
were positive in the assay [Keane et al. 1999].
The surface of mineral fibers and other EMPs 
also might be an indirect but critical factor in 
the manifestation of pathogenic activity. EMP 
surfaces may be principal determinants of EMP 
durability under conditions of in vivo dissolu-
tion in biological fluids. As such, they would 
be a controlling factor in biopersistence, criti-
cal to the suggested mechanisms of continuing 
irritation or inflammatory response in causing 
fibrosis or neoplastic transformation.
2.9.4 Animal and In Vitro  
Toxicity Studies
Over the last half-century, in vivo animal 
model studies have explored induction of lung 
cancer, mesothelioma, and pulmonary fibrosis 
by asbestos fibers and other EMPs following 
intrapleural, intraperitoneal, or inhalation chal-
lenge. Numerous cell-free, in vitro cellular, and 
in vivo short-term animal model studies have 
been pursued, attempting to (1) examine tissue 
and cellular responses to EMPs and impact of 
EMP conditioning on these responses; (2) iden-
tify and evaluate interactions and mechanisms 
involved in pathogenesis; and (3) seek morpho-
logical or physicochemical EMP properties con-
trolling those mechanisms. These short-term 
studies provide an evolving basis for design or 
interpretation of higher- tier chronic exposure 
studies of selected EMPs.
Some of the short-term studies have addressed 
the following: 
 • the general question of extrapolating hu-
man health effects from in vivo animal 
model studies; 
 • the physiological relevance of in vitro cel-
lular studies of EMP toxicities;
 • the association of EMP dimensions with 
pathology demonstrated in animal mod-
el studies;
 • the potential mechanisms and associated 
EMP properties responsible for initiating 
cell damage;
 • the extensive information now available on a 
“central dogma” of subsequent intracellular 
biochemical pathway stimulation leading to 
toxicity or intercellular signaling in disease 
promotion; and
 • the use of these mechanistic paradigms to 
explain specific questions of 
 ȣ differences between the activities of as-
besti form and nonasbestiform EMPs, 
including seemingly anomalous differ-
ences between some in vitro and in vivo 
EMP activities;
 ȣ differences between the activities of 
erionite fibers and amphibole asbes-
tos fibers; and 
 ȣ the possibility of EMP-viral co-carcino-
genesis.
Several reviews and recommendations for ani-
mal model and cellular studies on these issues 
have been developed by expert workshops and 
committees. Early studies on the carcinoge-
nicity of asbestos and erionite fibers were re-
viewed by IARC [1977, 1987a,b], and SVFs 
were reviewed more recently [IARC 2002]. 
Short-term in vivo and in vitro studies to eluci-
date mechanisms of fiber-induced genotoxicity 
and genetic mechanisms affecting fiber-induced 
lung fibrosis have been extensively reviewed. 
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A review for the EPA by an international work-
ing group assembled in 2003 provides an up-
date on short-term assay systems for fiber tox-
icity and carcinogenic potential [ILSI 2005], 
and two additional reviews discuss the fiber 
genotoxicity literature up to the current decade 
[Jaurand 1997; Schins 2002].
2.9.4.1 Model Systems Used to Study  
EMP Toxicity
The paucity of information on human health 
effects of some new synthetic EPs has led to re-
newed considerations of the value and limita-
tions of animal model studies, as well as the in-
terpretability of intrapleural, intraperitoneal, or 
inhalation challenge methods of animal mod-
el tests to make predictions of human health 
effects [IARC 2002]. One analysis conclud-
ed that rat inhalation is not sufficiently sen-
sitive for prediction of human carcinogenici-
ty by EMPs other than asbestos fibers [Muhle 
and Pott 2000]. Another review concluded that 
there are significant interspecies differenc-
es between the mouse, hamster, rat, and hu-
man, with the available evidence suggesting 
that the rat is preferable as a model for the hu-
man, noting that rats develop fibrosis at com-
parable lung burdens, in fibers per gram of dry 
lung, to those that are associated with fibro-
sis in humans. The review suggested that, on a 
weight-of-evidence basis, there is no reason to 
conclude that humans are more sensitive to fi-
bers than rats with respect to the development 
of lung cancer [Maxim and McConnell 2001]. 
However, others suggest that, because inhaled 
particles frequently sequester in the interstitial 
compartment of humans, alveolar clearance is 
approximately one order of magnitude slow-
er in humans than in rats [Snipes 1996; Tran 
and Buchanan 2000]. Those comparisons im-
ply that results of inhalation studies with rats 
exposed to particles underestimate the risk for 
humans and that adjustment for kinetic differ-
ences in particle clearance and retention in rats 
is required to predict lung disease risks in hu-
mans [Kuempel et al. 2001].
How the results of in vitro tests that use cells or 
organ cultures apply to humans has been ques-
tioned because of differences in cell types and 
species-specific responses. It is difficult to iso-
late and maintain epithelial or mesothelial cells 
for use as models. Interpretation of in vitro test 
results may be limited because in vitro models 
may not consider all processes, such as clear-
ance or surface conditioning, which occur in 
vivo. A major deficiency of in vitro systems is 
that biopersistence is not easily addressed. In 
addition to the usual exposure metric of mass, 
experimental designs should also include ex-
posure metrics of EMP number and surface 
area [Mossman 2008; Wylie et al. 1997].
As frequently performed, in vitro assays of min-
eral particle-induced damage, measured by cell 
death or cytosolic or lysosomal enzyme release, 
do not adequately model or predict the results 
of in vivo challenge or epidemiological findings. 
For example, respirable aluminosilicate clay 
dust is as cytotoxic as quartz dust in such in vitro 
assays, whereas quartz, but not clay, is strongly 
fibrogenic in vivo [Vallyathan et al. 1988].
2.9.4.2 Studies on Effects of  
Fiber Dimension
Early animal inhalation studies showed that 
chrysotile fibers induced fibrosis, hyperplasia 
of lung epithelial cells, and carcinomas in mice 
[Nordman and Sorge 1941] and tumors in rats 
[Gross et al. 1967]. Another study revealed 
lung carcinomas and mesotheliomas in rats af-
ter inhalation exposure to asbestos fiber sam-
ples of amosite, anthophyllite, crocidolite, and 
chrysotile [Wagner et al. 1974]. The effects of 
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fiber length, width, and aspect ratio on carci-
nogenicity were addressed in a seminal study 
using a pleural surface implantation meth-
od of challenge in the rat [Stanton et al. 1977, 
1981]. Tests were performed on 72 durable 
EPs: 13 crocidolites; 22 glasses; 8 aluminum ox-
ide sapphire whiskers; 7 talcs; 7 dawsonites; 4 
wollastonites; 2 asbestos tremolites; 1 amosite; 
2 attapulgites; 2 halloysites; 1 silicon carbide 
whisker; and 3 titanates. The incidence of ma-
lignant mesenchymal neoplasms a year after 
implantation correlated best with EPs that were 
longer than 8 µm and no wider than 0.25 µm, 
with relatively high correlations with EPs lon-
ger than 4 µm and no wider than 1.5 µm. This 
suggested that carcinogenicity of durable EPs 
depends on dimension and durability, rather 
than physicochemical properties. This is some-
times referred to as the Stanton hypothesis and 
has been the subject of continuing research. 
Reanalysis of the dimensions of seven of the 
crocidolite samples used in the 1981 study 
found that tumor probability was significant-
ly correlated with the number of index parti-
cles (defined as particles longer than 8 µm and 
no wider than 0.25 µm), but the coefficient was 
low enough to suggest that factors other than 
size and shape play a role in carcinogenic ef-
fects of durable EPs [Wylie et al. 1987]. Further 
analysis confirmed the number of such index 
particles as the primary dimensional predictor 
of tumor incidence, but the correlation was in-
creased when the data were analyzed by sepa-
rate mineral types [Oehlert 1991]. These anal-
yses suggested that mineral type is important, 
which is counter to the Stanton hypothesis.
Lippmann [1988] reviewed data from animal 
models exposed by instillation or inhalation of 
EMPs of defined size distributions, along with 
data on human lung fiber burden and associ-
ated effects, and concluded that (1) asbestosis 
is most closely associated with the surface area 
of retained EMPs; (2)  mesothelioma is most 
closely associated with numbers of EMPs lon-
ger than about 5  µm and thinner than about 
0.1 µm; and (3) lung cancer is most closely as-
sociated with EMPs longer than about 10 µm 
and thicker than about 0.15  µm. Lippmann 
[1988] also stated that the risk of lung cancer is 
associated with a substantial number of fibers 
longer than 10 µm with widths between 0.3 µm 
and 0.8  µm. A more recent review of the re-
sponse to asbestos fibers of various lengths in 
animal models, along with data from studies of 
human materials, concluded that asbestos fi-
bers of all lengths induce pathological respons-
es; it suggested caution when attempting to ex-
clude any subpopulation of inhaled asbestos 
fibers, on the basis of length, from being con-
sidered contributors to the development of as-
bestos-related diseases [Dodson et al. 2003].
2.9.4.3 Initiation of Toxic Interactions
A first question in seeking a full understanding 
of EMP properties and mechanisms responsi-
ble for fibrosis, lung cancer, or mesothelioma 
risks is the identity of initiating toxic interac-
tions and the morphological, physical, and/or 
chemical properties of EMPs controlling them. 
Among proposed initiating mechanisms are 
these: (1) EMP surfaces generate ROS (even in 
vitro in the absence of cells), which are the pri-
mary toxicants to cells; (2)  EMP surfaces are 
directly membranolytic or otherwise direct-
ly cytotoxic or genotoxic to components of the 
cell, as are some nonelongate mineral particles, 
and that damage can cause necrosis, apoptosis, 
mutation, or transformation directly or by re-
sponsive cellular production of secondary re-
active intermediates; and (3) EMP morpholo-
gy itself can result in frustrated phagocytosis 
with an anomalous stimulation or release of 
ROS or other toxic reactive species.
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2.9.4.3.1 Reactive Oxygen Species
Asbestos fibers can generate ROS or reactive 
nitrogen species in in vitro systems through 
direct aqueous-phase surface chemical reac-
tions, as well as by stimulating secondary re-
lease of reactive species from cells. Electron 
spin resonance with use of spin-trapping tech-
niques showed that crocidolite, chrysotile, and 
amosite asbestos fibers were all able to catalyze 
the generation of toxic hydroxyl radicals in a 
cell-free system containing hydrogen peroxide, 
a normal byproduct of tissue metabolism, and 
that the iron chelator desferroxamine inhibited 
the reaction, indicating a major role for iron in 
the catalytic process [Weitzman and Graceffa 
1984]. ROS generated by some EMP surfaces 
in cell-free media may provide toxicants to ini-
tiate cell structural or functional damage, in-
cluding chromosomal or DNA genetic damage 
or aneuploidy from spindle apparatus damage. 
They also may activate cellular signaling path-
ways that promote cell proliferation or trans-
formation. Research has investigated the possi-
ble roles of iron in this reactivity and the roles 
of released versus surface-borne iron.
Asbestos fibers can cause lipid peroxidation 
in mammalian cells and artificial membranes 
that can be prevented by removal of catalyt-
ic iron. Reduction of crocidolite cytotoxicity 
by certain antioxidants (including superoxide 
dismutase [SOD], a depletor of superoxide an-
ion [SO]; catalase, a scavenger of hydrogen per-
oxide [H2O2]; dimethylthiourea [DMTU], a 
scavenger of the hydroxyl radical [•OH]; and 
desferroxamine, an iron chelator) suggested 
that iron is involved in the generation of ROS 
through a modified Haber-Weiss Fenton-type 
reaction resulting in the production of hydroxyl 
radical (e.g., from SO and H2O2 generated dur-
ing phagocytosis) [Goodglick and Kane 1986; 
Shatos et al. 1987]. Such scavenging or chelation 
prevented DNA strand breakage in cells in vitro 
by crocidolite fibers [Mossman and Marsh 1989].
In a cell-free study of five natural and two syn-
thetic fibers, erionite, JM code 100 glass fibers, 
and glass wool were the most effective initia-
tors of hydroxyl radical formation, followed 
by crocidolite, amosite, and chrysotile fibers. 
Hydroxyl radical formation activity showed 
positive correlations with tumor rates in rats 
challenged by intrapleural injection and with 
human mesothelioma mortality rates, but 
not with tumor rates in rats challenged by 
intraperitoneal injection [Maples and John-
son 1992]. SO-produced ROS then might in-
duce DNA oxidative damage, measured as el-
evated 8-hydroxydeoxyguanosine (8-OHdG). 
In cell-free systems, the crocidolite-induced 
increase of 8-OHdG in isolated DNA was en-
hanced by addition of H2O2 and diminished by 
addition of desferroxamine [Faux et al. 1994]. 
However, de-ironized crocidolite fibers incu-
bated in a cell-free system induced twice the 
8-OHdG oxidative damage to DNA as untreat-
ed crocidolite fibers. In parallel rat exposures, 
the combination of de-ironized crocidolite fi-
bers plus Fe2O3 resulted in mesothelioma in all 
animals, whereas mesothelioma developed in 
only half the animals injected with crocidolite 
fibers alone and none of the animals injected 
with Fe2O3 alone [Adachi et al. 1994]. Other re-
search suggested that unreleased fiber-surface- 
bound iron is important to the reactivity; 
long fibers of amosite and crocidolite both 
caused significant dose-dependent free radi-
cal damage to cell-free phage DNA, suppress-
ible by the hydroxyl radical scavenger mannitol 
and by desferroxamine, but short RCFs and 
man-made vitreous fibers (MMVFs) did not, 
while releasing large quantities of Fe(III) iron 
[Gilmour et al. 1995]. Crocidolite fibers in-
duced mutations in peritoneal tissue in vivo in 
rats, most prominently guanine-to- thymine 
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(G-to-T) trans-versions known to be in-
duced by 8-OHdG; this was interpreted as 
strong evidence for the involvement of ROS 
or reactive nitrogen species in crocidolite- 
induced mutagenesis in vivo, consistent with 
in vitro and cell-free studies [Unfried et al. 
2002]. In contrast to glass fiber, crocidolite fi-
ber intratracheal instillation in rats increased 
8-OHdG levels in DNA at one day and in its 
repair enzyme activity at seven days. This in 
vivo activity is consistent with asbestos- and 
MMVF-induced increases of 8-OHdG oxida-
tive damage in vitro [Yamaguchi et al. 1999].
2.9.4.3.2 Membrane Interactions
Many mineral particles, elongate or not, can di-
rectly cause membranolysis or other cytotoxic 
responses without necessarily invoking extra-
cellular generation of ROS. Mechanisms of cell 
damage by EMPs, independent of ROS forma-
tion, have been proposed to involve direct in-
teractions of particle surface functional groups 
(e.g., silicon or aluminum or magnesium) with 
lipoproteins or glycoproteins of the cell mem-
brane. It has been suggested that silica particle 
cytotoxicity to macrophages is due to distortion 
and disruption of secondary lysosomal mem-
branes by phagocytosed particles whose surface 
silanol groups hydrogen-bond to membrane 
lipid phosphates, but that chrysotile-induced 
cellular release of hydrolytic enzymes is due to 
surface magnesium interacting ionically with 
sialic acid residues of membrane glycoproteins, 
inducing cation leakage and osmotic lysis [Alli-
son and Ferluga 1977]. Chrysotile fibers cause 
lysis of red blood cells. EM indicates that cell 
membranes become wrapped around the fi-
bers and that cell distortion and membrane 
deformation correlate with an increase in the 
intracellular ratio of sodium to potassium ions. 
Cell pretreatment with neuraminidase pre-
vents fiber-cell binding, suggesting mediation 
by cell membrane glycoproteins [Brody and Hill 
1983]. However, chrysotile and crocidolite fi-
bers both induced increased membrane rigidi-
ty in model unilamellar vesicles made of satu-
rated dipalmitoyl phosphatidylcholine (DPPC), 
suggesting that lipid peroxidation is not in-
volved in membrane rigidity induced by asbes-
tos [Gendek and Brody 1990]. Silicate slate dust 
and chrysotile fibers both induced hemolysis 
in vitro and peroxidation of polyunsaturat-
ed membrane lipids. However, poly(2-vinyl-
pyridine N-oxide) (PVPNO) and DPPC sur-
face prophylactic agents suppressed lysis but 
not peroxidation, whereas SOD and catalase 
did the reverse; and lysis was much faster than 
peroxidation. This suggested that membrane ly-
sis and peroxidation are independent process-
es [Singh and Rahman 1987]. However, either 
mechanism may be involved in membrane dam-
age by EMPs; and seemingly disparate findings 
suggest uncharacterized details of EMP proper-
ties or of cellular or mineral conditioning under 
test conditions may be  important.
In in vitro studies, quartz dust and chrysotile 
fibers induced loss of viability and release of lactate 
dehydrogenase (LDH) from alveolar macrophages. 
DPPC reduced these activities of the quartz but 
not of the asbestos [Schimmelpfeng et al. 1992]. 
DPPC is adsorbed from aqueous dispersion 
in approximately equal amounts on a surface 
area basis, about 5 mg phospholipid per square 
meter, by asbestos fibers [Jaurand et al. 1980] 
and by nonfibrous silicate particles [Wallace 
et al. 1992]; this is close to the value predicted 
by mathematical modeling of an adsorbed bi-
layer [Nagle 1993]. In the case of silica or clay 
membranolytic dusts, this adsorption fully sup-
presses their activity until toxicity is manifested 
as the prophylactic surfactant is digested from 
the particle surface by lysosomal phospholipase 
enzyme; mineral-specific rates of the process 
suggest a basis for differing fibrogenic potentials 
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of different types of mineral particles [Wallace 
et al. 1992].
Samples of intermediate-length and short-
length NIEHS chrysotile were compared, with 
and without DPPC lung surfactant pretreat-
ment, for micronucleus induction in Chinese 
hamster lung V79 cells in vitro. Increase in 
micronuclei frequency and multinuclear cell 
frequency were induced by all samples, with 
the greatest micronucleus induction by un-
treated intermediate-length chrysotile fibers 
and with greater activity for untreated versus 
treated short chrysotile fibers. Cell viability 
was greater for treated fibers [Lu et al. 1994]. 
NIEHS intermediate-length chrysotile was 
mildly acid-treated to deplete surface-borne 
magnesium while only slightly affecting fiber 
length. Challenge of Chinese hamster lung fi-
broblast cells in vitro for micronucleus induc-
tion found no significant difference between 
the treated and untreated samples, support-
ing a model of chemically nonspecific chro-
mosomal and spindle damage effects [Keane et 
al. 1999]. Chrysotile fiber induction of mucin 
secretion in a tracheal cell culture was inhib-
ited by using lectins to block specific carbo-
hydrate residues on the cell surface; leached 
chrysotile was inactive, suggesting that the sur-
face cationic magnesium of chrysotile was re-
sponsible for interaction with cell surface 
glycolipids and glycoproteins [Mossman et al. 
1983]. However, complete removal of accessible 
sialic acid residues from erythrocytes did not 
inhibit hemolysis by chrysotile fibers, suggest-
ing that chrysotile fibers can induce lysis by in-
teraction with some other component of the cell 
[Pelé and Calvert 1983].
2.9.4.3.3 Morphology-mediated Effects
A third possible mechanism for damage by EMP 
principally involves morphology. The possibility 
of frustrated phagocytosis is suggested by the 
Stanton hypothesis of an overriding significance 
of particle dimension for disease induction by 
durable EPs. A general concept is that EMPs 
longer than a phagocytic cell’s linear dimen-
sions cannot be completely incorporated in a 
phagosome. Recruitment of membrane from the 
Golgi apparatus or endoplasmic reticulum may 
provide extensive addition to the plasma mem-
brane for a cell’s attempted invagination to ac-
commodate a long EMP in a phagosomal mem-
brane [Aderem 2002]. However, because of the 
length of the EMP relative to the dimensions of 
the cell, the final phagosomal structure is topo-
logically an annulus extending fully through the 
cell, rather than an enclosed vacuole fully with-
in the cell. Following uptake of nonelongate par-
ticles, there is a maturation of the phagosomal 
membrane; the initial phagosomal membrane is 
that of the cell’s external plasmalemma, which 
cannot kill or digest phagocytosed material. Af-
ter sealing of the fully invaginated phagosomal 
vesicle in the interior of the cell, there is a rap-
id and extensive change in the membrane com-
position [Scott et al. 2003]. This involves, in 
part, an association with lysosomal vesicles 
and exposure of particles within the secondary 
phagosome or phagolysosome to lytic enzymes 
and adjusted pH conditions. It is speculated 
that failure of the phagosome to close, as occurs 
in frustrated phagocytosis, induces dysfunc-
tion of the system. Conventional phagocytosis 
of nonelongate particles can lead to a respira-
tory or oxidative burst of membrane-localized 
NADPH oxidase of SO radicals, which may be 
converted to H2O2, hydroxyl radicals, and oth-
er toxic reactive products of oxygen. If these are 
released extracellularly in connection with frus-
trated phagocytosis, they are potentially harm-
ful to the tissue [Bergstrand 1990].
Failure of normal phagocytosis to be com-
pleted may affect the duration or intensity 
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of the phagocytic response. It may also affect 
the generation or release of reactive species 
or membranolytic digestive enzymes into the 
still-exterior annulus. Another possible effect 
is to alter the maturation of the annular frus-
trated phagocytic membrane from the nor-
mal structural and functional evolution of a 
closed phagolysosomal vesicle fully interior to 
the cell. Even in the response to such a frustrat-
ed phagocytosis, there might be some mineral 
specificity beyond morphology alone for EMP-
induced release of reactive species. Amosite fi-
bers, MMVF, silicon carbide fibers, and RCF-1 
fibers all stimulated modest release of SO that 
was not dose-dependent in isolated rat alveo-
lar macrophages. However, when IgG, a normal 
component of lung lining fluid, was adsorbed 
onto the fiber surfaces, SO release was strong-
ly enhanced for all but the silicon carbide fibers. 
SO release correlated with fibers’ IgG- adsorptive 
capacity, except for the amosite, which required 
only poorly adsorbed IgG for strong activi-
ty, suggesting some mineral specificity beyond 
morphology alone for the EMP-induced cellu-
lar respiratory burst [Hill et al. 1996].
2.9.4.3.4 Cellular Responses to Initiation  
of Toxicity
Subsequent to initiating damage by direct or in-
duced ROS generation—by direct membranolysis 
generated by interactions of mineral surface 
sites with membrane lipids or glycoproteins, 
or by not-fully-defined toxic response to mor-
phology-based frustrated phagocytosis—a stan-
dard model for consequent complex cellular re-
sponse has evolved and has been the subject of 
extensive and detailed analyses [Mossman et 
al. 1997]. EMP-generated primary toxic stimu-
li to the cell are subject to signal transduction by 
mitogen-activated protein kinase (MAPK), be-
ginning an intracellular multiple kinase signal 
cascade, which then induces transcription factors 
in the nucleus such as activator protein (AP)-1 or 
nuclear factor kappa beta (NF-κB), which in turn 
regulate the transcription of mRNA from genes 
for TNF-α or other cytokines involved in cell pro-
liferation or inflammation.
Fibers of the six asbestos minerals generate 
MAPK in lung epithelium in vitro and in vivo, 
increasing AP-1 transcription activation, cell 
proliferation, death, differentiation, or inflam-
mation. This is synergistic with cigarette smoke 
[Mossman et al. 2006]. Macrophage release of 
oxidants or mitogenic factors through such a 
pathway could then cause cell proliferation or 
DNA damage [Driscoll et al. 1998]. In contrast 
to MMVF-10 and RCF-4, amosite and two other 
carcinogenic fibers (silicon carbide and RCF-1) 
produced significant dose-dependent transloca-
tion of NF-κB to the nucleus in A549 lung epi-
thelial cells. It was hypothesized that carcinogen-
ic fibers have greater free radical activity, which 
produces greater oxidative stress and results in 
greater translocation of NF-κB to the nucleus 
for the transcription of pro-inflammatory genes 
(e.g., cytokines) [Brown et al. 1999]. Crocidolite 
induced AP-1 in vitro in JB6 cells and induced 
AP-1 transactivation in pulmonary and bronchi-
al tissue after intratracheal instillation in trans-
genic mice, apparently mediated by activation of 
MAPK [Ding et al. 1999]. Chrysotile challenge 
to blood monocytes co-cultured with bronchi-
al epithelial cells resulted in elevated levels in ep-
ithelial cells of protein-tyrosine kinase activity, 
NF-κB activity, and mRNA levels for interleukin 
(IL)-1β, IL-6, and TNF-α. Protein-tyrosine ki-
nase activity, NF-κB activity, and mRNA syn-
thesis were inhibited by antioxidants, suggesting 
ROS-dependent NF-κB-mediated transcription 
of inflammatory cytokines in bronchial epitheli-
al cells [Drumm et al. 1999].
Chemokines known to be associated with par-
ticle-induced inflammation were found to be 
53NIOSH CIB 62 • Asbestos
secreted by mesothelial cells after amosite chal-
lenge to cultured rat pleural mesothelial cells, 
and they were found in pleural lavage of rats 
challenged in vivo [Hill et al. 2003].
Fibers from crocidolite (asbestiform riebeckite) 
and EMPs from nonfibrous milled riebeckite 
increased phosphorylation and activity of a 
MAPK cascade in association with induction of 
an inflammatory state of rat pleural mesothelial 
cells and progenitor cells of malignant meso-
thelioma. Amelioration by preincubation with 
vitamin E indicated this to be an oxidative 
stress effect [Swain et al. 2004]. Lung lysate, 
cells from bronchoalveolar lavage, and alve-
olar macrophages and bronchiolar epitheli-
al cells from lung sections from rats exposed 
to crocidolite or chrysotile fibers contained 
nitrotyrosine and phosphorylated extracellular 
signal-regulated kinases (ERKs); nitrotyrosine 
is a marker for peroxynitrile that activates 
ERK signaling pathways, altering protein func-
tion [Iwagaki 2003]. In vitro challenge of hu-
man bronchiolar epithelial cells with crocidolite 
or chrysotile fibers induced tissue factor (TF) 
mRNA expression and induced NF-κB and 
other transcription factors that bind the TF gene 
promoter. TF in vivo is involved in blood coag-
ulation with inflammation and tissue remodel-
ing [Iakhiaev et al. 2004]. Asbestos fibers acti-
vate an ERK pathway in vitro in mesothelial and 
epithelial cells. Crocidolite challenge to mice re-
sults in phosphorylation of ERK in bronchiolar 
and alveolar type II epithelial cells, epithelial cell 
hyperplasia, and fibrotic lesions. Epithelial cell 
signals through the ERK pathway lead to tissue 
remodeling and fibrosis [Cummins et al. 2003].
Crocidolite and erionite fibers, but not non-
fibrous milled riebeckite, upregulated the ex-
pression of epidermal growth factor receptor 
(EGFR) in rat pleural mesothelial cells in vitro. 
Cell proliferation was co-localized subsequent 
to EGFR, suggesting initiation of a cell-sig-
naling cascade to cell proliferation and can-
cer [Faux et al. 2000]. “Long” amosite fibers 
were more active than “short” amosite fibers in 
causing (1) damage to nude DNA; (2) in vitro 
cytotoxicity in a human lung epithelial cell 
line; (3)  free radical reactions; (4)  inhibition 
of glycerol-6-phosphate dehydrogenase and 
pentose phosphate pathways; (5)  decrease in 
intracellular reduced glutathione; (6)  increase 
in thiobarbituric acid reaction substances; and 
(7) leaking of LDH [Riganti et al. 2003].
An important paradox or seeming failure of 
in vitro studies concerns mesothelioma. Al-
though chrysotile and amphibole asbestos fibers 
each clearly induce malignant mesothelioma 
in vivo, they do not transform primary human 
mesothelial cells in vitro, whereas erionite fibers 
do. Asbestos fibers can induce some genotoxic 
changes; crocidolite fibers induced cytogenotoxic 
effects, including increased polynucleated cells 
and formation of 8-OHdG in a phagocytic hu-
man mesothelial cell line, but did not induce 
cytogenotoxic effects in a nonphagocytic hu-
man promyelocytic leukemia cell line [Takeuchi 
et al. 1999]. Tremolite, erionite, RCF-1, and 
chrysotile fiber challenges of human-hamster 
hybrid A(L) cells showed chrysotile fibers to 
be significantly more cytotoxic. Mutagenic-
ity was not seen at the hypoxanthine-guanine 
phosphoribosyltransferase (HPRT) locus for 
any of the fibers. Erionite and tremolite fibers 
induced dose-dependent mutations at the gene 
marker on the only human chromosome in the 
hybrid cell. Erionite was the most mutagenic 
type of fiber. RFC-1 fibers were not mutagenic, 
in seeming contrast to their known induction 
of mesothelioma in hamsters [Okayasu et al. 
1999]. Crocidolite fibers induced significant but 
reversible DNA single-strand breaks in trans-
formed human pleural mesothelial cells, and 
TNF-α induced marginal increases; co-exposure 
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to crocidolite fibers and TNF-α caused greater 
damage than fibers alone. Antioxidant enzymes 
did not reduce the DNA damage, suggesting a 
mechanism of damage other than by free radi-
cals [Ollikainen et al. 1999]. Crocidolite fibers 
were also very cytotoxic to the cells; presumably, 
cell death may prevent the observation of cell 
transformation. In vitro challenge to mesothelial 
cells and to fibroblast cells by crocidolite fibers, 
but not by glass wool, induced dose-dependent 
cytotoxicity and increased DNA synthesis activi-
ty [Cardinali et al. 2006]. Crocidolite fibers were 
found to induce TNF-α secretion and receptors 
in human mesothelial cells, and TNF-α reduced 
cytotoxicity of crocidolite fibers by activating 
NF-κB and thus improving cell survival and per-
mitting expression of cytogenetic activity [Yang 
et al. 2006]. Erionite fibers transformed immor-
talized nontumorigenic human mesothelial cells 
in vitro only when exposed in combination with 
IL-1β or TNF-α [Wang et al. 2004]. Erionite fi-
bers were poorly cytotoxic but induced prolifer-
ation signals and a high growth rate in hamster 
mesothelial cells. Long-term exposure to erionite 
fibers resulted in transformation of human 
mesothelial cells in vitro, but exposure to asbes-
tos fibers did not transform those cells [Bertino 
et al. 2007]. In vitro challenge of mesothelial cells 
to asbestos fibers induced cytotoxicity and apop-
tosis but not transformation. In vitro challenge 
of human mesothelial cells to asbestos fibers in-
duced the ferritin heavy chain of iron-binding 
protein, an anti-apoptotic protein, with decrease 
in H2O2 and other ROS and resistance to apopto-
sis [Aung et al. 2007]. This was seen also in a hu-
man malignant mesothelial cell line.
The question of a co-carcinogenic effect of as-
bestos fibers with a virus has been raised. Most 
malignant mesotheliomas are associated with 
asbestos exposures, but only a fraction of ex-
posed individuals develop mesothelioma, indi-
cating that other factors may play a role. It has 
been suggested that simian virus 40 (SV40) and 
asbestos fibers may be co-carcinogens. SV40 is 
a DNA tumor virus that causes mesothelioma 
in hamsters and has been detected in sever-
al human mesotheliomas. Asbestos fibers ap-
pear to increase SV40-mediated transformation 
of human mesothelial cells in vitro [Carbone 
et al. 2002]. In an in vivo demonstration of 
co-carcinogenicity of SV40 and asbestos fibers, 
mice containing high copy numbers of SV40 
viral oncogene rapidly developed fast-growing 
mesothelioma following asbestos challenge. 
Transgenic copy number was proportional to 
cell survival and in vitro proliferation [Robin-
son et al. 2006].
Various mechanisms protect cells and tissues 
against oxidants, and it is conceivable that ge-
netic and acquired variations in these sys-
tems may account for individual variation in 
the response to oxidative stress [Driscoll et al. 
2002]. Similarly, species differences in antiox-
idant defenses or the capacity of various de-
fenses may underlie differences in response to 
xenobiotics that act, in whole or part, through 
oxidative mechanisms. Oxidative mechanisms 
of response to xenobiotics are especially rel-
evant to the respiratory tract, which is direct-
ly and continually exposed to an external en-
vironment containing oxidant pollutants (e.g., 
ozone, oxides of nitrogen) and particles that 
may generate oxidants as a result of chemi-
cal properties or by stimulating production of 
cell-derived oxidants. In addition, exposure to 
particles or other pollutants may produce ox-
idative stress in the lung by stimulating the re-
cruitment of inflammatory cells. For example, 
the toxicity of asbestos fibers likely involves the 
production of oxidants, such as hydroxyl radi-
cal, SO, and H2O2. Studies have also shown that 
asbestos fibers and other mineral particles may 
act by stimulating cellular production of ROS 
and reactive nitrogen species. In addition to 
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direct oxidant production, exposure to asbes-
tos and SVFs used in high-dose animal stud-
ies stimulates the recruitment and activation of 
macrophages and polymorphonuclear leuko-
cytes that can produce ROS through the activi-
ty of NADPH oxidase on their cell membranes. 
Developing an understanding of the oxidative 
stress/NF-ĸB pathway for EMP-mediated in-
flammation and the interplay among exposure-
induced oxidant production, host antioxidant 
defenses, and interindividual or species vari-
ability in defenses may be very important for 
appropriate risk assessments of inhaled EMPs 
[Donaldson and Tran 2002].
2.9.4.4 Studies Comparing EMPs from 
Amphiboles with Asbestiform 
versus Nonasbestiform Habits
Smith et al. [1979] compared tumor induction 
after IP injection in hamsters of two asbestiform 
tremolites, two nonasbestiform prismatic tre-
mo litic talcs, and one tremolitic talc of uncer-
tain asbestiform status. No tumors were ob-
served following the nonasbestiform tremolite 
challenge, in contrast to the asbestiform tre-
mo lites. However, tumors were observed from 
the tremolitic talc of uncertain amphibole sta-
tus. In rule-making, OSHA [1992] noted the 
small number of animals in the study, the ear-
ly death of many animals, and the lack of sys-
tematic characterization of particle size and as-
pect ratio. Subsequent analyses (by chemical 
composition) performed on the nonasbestiform 
tremolitic talc from the study, which was not as-
sociated with mesothelioma, found 13% of par-
ticles had at least a 3:1 aspect ratio [Wylie et al. 
1993]. A prismatic, nonasbestiform tremolitic 
talc and an asbestiform tremolite from the study 
were analyzed for aspect ratio [Campbell et al. 
1979]. The researchers analyzed 200 particles of 
the asbestiform tremolite sample and found 17% 
had an aspect ratio of 3:1 or greater and 9.5% 
had an aspect ratio greater than 10:1. Analysis of 
200 particles of the prismatic tremolite showed 
that 2.5% (five EMPs) had an aspect ratio of 3:1 
or greater and 0.5% (one EMP) had an aspect ra-
tio greater than 10:1.
Wagner et al. [1982] challenged rats by IP in-
jection of tremolite asbestos, a prismatic non-
asbestiform tremolite, or a tremolitic talc con-
sidered nonasbestiform containing a limited 
number of long fibers. Only the tremolite asbes-
tos produced tumors; mesothelioma was found 
in 14 of 37 animals. The authors speculated that 
tumor rate may have risen further if the testing 
period had not been shortened due to infection-
induced mortality. Per microgram of injected 
dose, the asbestiform sample contained 3.3 × 
104 nonfibrous particles, 15.5 × 104 fibers, and 
56.1 × 103 fibers >8 µm long and <1.5 µm wide. 
Corresponding values for the prismatic amphi-
bole were 20.7 × 104, 4.8 × 104, and 0. Tremolitic 
talc values were 6.9 × 104, 5.1 × 104, and 1.7 × 
103. Infection-reduced survival prevented eval-
uation of a crocidolite-exposed positive control.
Another IP injection study with the rat used six 
samples of tremolite of different morphological 
types [Davis et al. 1991]. For three asbestiform 
samples, mesothelioma occurred in 100%, 97%, 
and 97% of exposed animals, at correspond-
ing doses of 13.4 × 109 fibers with aspect ra-
tio >3:1 per 121 × 106 fibers with length >8 µm 
and diameter <0.25 µm (100% of exposed ani-
mals); 2.1 × 109 per 8 × 106 (97% of exposed an-
imals); and 7.8 × 109 per 48 × 106 (97% of ex-
posed animals). For an Italian tremolite from 
a nonasbestos source and containing relative-
ly few asbestiform fibers (1.0 × 109 per 1 × 
106), mesothelioma was found in two-thirds of 
the animals, with delayed expression. For two 
nonasbestiform tremolites (0.9 × 109 per 0; 0.4 
× 109 per 0), tumors were found in 12% and 
5% of the animals, respectively; of these, and 
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the response rate of 12% was above the expect-
ed background rate. The Italian sample result-
ing in 67% mesothelioma incidence contained 
only one-third the number of EMPs >8  µm 
long, in comparison with the nonasbestiform 
sample associated with 12% mesothelioma, and 
those two samples contained an approximate-
ly equal number of fibers with length >8  µm 
and width <0.5  µm. The preparations of the 
three asbestiform samples and the Italian sam-
ple were essentially identical. However, the two 
nonasbestiform samples associated with low 
mesothelioma incidence required significantly 
different pretreatment: the first required mul-
tiple washings and sedimentation, and the sec-
ond, grinding under water in a micronizing 
mill. It was noted that those two nonasbestiform 
samples and the Italian sample contained minor 
components of long, thin asbestiform tremolite 
fibers. This study suggested that carcinogenic-
ity may not depend simply on the number of 
EMPs, and the researchers called for methods 
of distinguishing “carcinogenic tremolite fi-
bers” from nonfibrous tremolite dusts that con-
tain similar numbers of EMPs of similar aspect 
ratios [Davis et al. 1991]. It has been suggest-
ed that the response observed for the Italian 
tremolite is of a pattern expected for a low dose 
of highly carcinogenic asbestos tremolite [Ad-
dison 2007].
A recent review of past studies of varieties of 
tremolite and the limitations of earlier studies 
(e.g., their use of injection or implantation ver-
sus inhalation) suggested that, on the basis of 
observed differences in the carcinogenicity of 
tremolite asbestos and nonasbestiform prismat-
ic tremolite, differences in carcinogenicity of 
amphibole asbestos fibers and nonasbestiform 
amphibole cleavage fragments are sufficiently 
large to be discernable, even with the study lim-
itations [Addison and McConnell 2008]. The 
authors also concluded the evidence supports 
a view that shorter, thicker cleavage fragments 
of the nonasbestiform amphiboles are less haz-
ardous than the thinner asbestos fibers [Addi-
son and McConnell 2008].
In summary, several types of animal studies have 
been conducted to assess the carcinogenicity and 
fibrogenicity of asbestiform and nonasbestiform 
tremolite fibers and other EMPs. Tremolite as-
bestos was found to be both fibrogenic and carci-
nogenic in rats by inhalation. However, the data 
for other particle forms of tremolite and for oth-
er amphiboles in general are much more limited 
and are based primarily on mesotheliomas pro-
duced by intrapleural administration studies in 
rats. Although these tests can be highly sensitive 
for specific material-tissue interactions, these 
studies bypass the lung entirely and thus pro-
vide no information on the test material’s po-
tential for causing lung tumors. In addition, 
they have often been criticized for employing 
a nonphysiological route of administration. 
Some of the older studies [Smith et al. 1979; 
Wagner et al. 1982] are difficult to interpret 
because of inadequate characterization of the 
tremolite preparation that was used, although 
the studies do show fewer or no tumors from 
prismatic tremolite than from asbestiform 
tremolite when tested similarly. Unfortunately, 
doses used in most animal studies are general-
ly reported in terms of mass (e.g., 10, 25, or 40 
mg/rat). Unless the test preparations are well 
characterized in terms of fiber counts and fi-
ber size distributions, it is difficult to relate the 
mass-based dose in the animals to fiber count 
concentrations used to assess human occupa-
tional exposures. Where semiquantitative fiber 
count and size distribution data are provided, as 
in the study report by Davis et al. [1991], it is evi-
dent that the prismatic tremolite samples contain 
fewer particles >5 µm in length with an aspect 
ratio of >3:1 per 10-mg dose than the asbestiform 
tremolite samples, and the median particle 
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widths are greater for the prismatic tremolite 
samples. Although the prismatic tremolite sam-
ples clearly generated fewer mesotheliomas than 
the asbestiform tremolite samples, it is not appar-
ent whether the tumorigenic potency per EMP is 
lower for the nonasbestiform tremolites.
In a comparison of one asbestiform and two 
nonasbestiform tremolites, cellular in vitro as-
says for LDH release, beta-glucuronidase release, 
cytotoxicity, and giant cell formation showed rel-
ative toxicities that parallel the differences seen in 
an in vivo rat IP injection study of tumorigenicity 
using the same samples [Wagner et al. 1982]. 
In vitro cellular or organ tissue culture stud-
ies showed squamous metaplasia and increased 
DNA synthesis in tracheal explant cultures treat-
ed with long glass fibers or with crocidolite or 
chrysotile fibers, whereas cleavage fragments 
from their nonasbestiform analogues, riebeckite 
and antigorite, were not active [Woodworth 
et al. 1983]. For alveolar macrophages in vitro, 
crocidolite fibers induced the release of ROS 
at an order of magnitude greater than cleav-
age fragments from nonasbestiform riebeckite 
[Hansen and Mossman 1987]. Similar differenc-
es were observed in hamster tracheal cells for
 • induction of ornithine decarboxylase, an 
enzyme associated with mouse skin cell 
proliferation and tumor promotion [Marsh 
and Mossman 1988]; 
 • stimulating survival or proliferation in a 
colony-forming assay using those ham-
ster tracheal epithelial cells [Sesko and 
Mossman 1989]; 
 • activation of proto-oncogenes in tracheal 
epithelial and pleural mesothelial cells in 
vitro [Janssen et al. 1994]; and 
 • cytotoxicity [Mossman and Sesko 1990].
A recent review concludes that a large body of 
work shows that cleavage fragments of amphi-
boles are less potent than asbestos fibers in a 
number of in vitro bioassays [Mossman 2008]. 
Several studies have investigated induction of 
molecular pathways in cells exposed to EMPs. 
The goals of such studies were to elucidate 
mechanisms involved in fiber-induced patho-
genicity and to compare the relative potency of 
asbestiform and nonasbestiform EMPs. How-
ever, seemingly contradictory findings between 
some experiments suggest that improved meth-
ods for preparation of size-selected test parti-
cles and more extensive characterization of 
EMPs are needed. 
Although few animal studies of nonasbestiform 
amphibole dusts have been conducted, this re-
search has revealed generally significant differ-
ences in pathogenicity between nonasbestiform 
and asbestiform amphiboles. There are few find-
ings of biological effects or tumorigenicity in-
duced by samples classified as nonasbestiform, 
and there are rational hypotheses as to the 
cause of those effects. There are general funda-
mental uncertainties concerning EMP proper-
ties and biological mechanisms that determine 
mineral particle toxicities and pathogenicities, 
specifically concerning the similarities or dif-
ferences in disease mechanisms between EMPs 
from asbestiform versus nonasbestiform am-
phiboles. In vitro studies have generally shown 
differences in specific toxic activities between 
some asbestiform and nonasbestiform am-
phibole EMPs, although in vitro systems are 
not yet able to predict relative pathogenic risk 
for mineral fibers and other EMPs. This sug-
gests a focus of research to determine if and 
when nonasbestiform amphibole EMPs are ac-
tive for tumorigenicity or other pathology, if 
there is a threshold for those activities, and if 
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distinguishing conditions or properties that 
determine such pathogenicity can be found.
2.9.5 Thresholds
Discussions of thresholds for adverse health 
effects associated with exposure to asbestos 
fibers and related EMPs have focused on the 
characteristics of dimension, including length, 
width, and the derived aspect ratio, as well as 
concentration. Although other particle char-
acteristics discussed above may impact these 
thresholds or may have thresholds of their own 
that impact the toxicity of EMPs, they are not 
well discussed in the literature. The following 
discussion is focused on thresholds for dimen-
sion and concentration.
The seminal work of Stanton et al. [1981] laid 
the foundation for much of the information on 
dimensional thresholds. Their analyses showed 
that malignant neoplasms in exposed rats were 
best predicted by the number of EMPs longer 
than 8  µm and thinner than 0.25  µm. How-
ever, the number of EMPs in other size cate-
gories, having lengths greater than 4  µm and 
widths up to 1.5 µm, were also highly correlat-
ed with malignant neoplasms. Also, some sam-
ples with relatively larger proportions of short-
er particles, such as the tremolites, produced 
high rates of tumors. Lippmann [1988, 1990] 
reviewed the literature and suggested that lung 
cancer is most closely associated with asbes-
tos fibers longer than 10 µm and thicker than 
0.15 µm, whereas mesothelioma is most close-
ly associated with asbestos fibers longer than 
5 µm and thinner than 0.1 µm. Evidence from 
animal studies and some in vitro studies sug-
gests that short asbestos fibers (e.g., <5  µm 
long) may play a role in fibrosis but are of less-
er concern than longer asbestos fibers for can-
cer development.
Berman et al. [1995] statistically analyzed ag-
gregate data from 13 inhalation studies in 
which rats were exposed to 9 types of asbestos 
(4 chrysotiles, 3 amosites, 1 crocidolite, and 1 
tremolite asbestos) to assess fiber dimension and 
mineralogy as predictors of lung tumor and 
mesothelioma risks. Archived samples from the 
studies were reanalyzed to provide detailed in-
formation on each asbestos structure, including 
mineralogy (chrysotile, amosite, crocidolite, or 
tremolite), size (length and width, each in 5 cat-
egories), type (fiber, bundle, cluster, or matrix), 
and complexity (number of identifiable com-
ponents of a cluster or matrix). Multiple con-
centrations (each for asbestos structures with 
different specified characteristics) were calcu-
lated for the experimental exposures. Although 
no univariate index of exposure adequately de-
scribed lung tumor incidence observed across all 
inhalation studies, certain multivariate indices of 
exposure did adequately describe outcomes. Fi-
bers and bundles longer than 5 µm and thinner 
than 0.4 µm contributed to lung tumor risk; very 
long (>40 µm) and very thick (>5 µm) complex 
clusters and matrices possibly contributed. Al-
though structures <5 µm long did not contrib-
ute to lung tumor risk, potency of thin (<0.4 µm) 
structures increased with increasing length above 
5 µm, and structures >40 µm long were estimat-
ed to be about 500 times more potent than struc-
tures between 5 and 40 µm long. With respect to 
lung tumor risk, no difference was observed be-
tween chrysotile and amphibole asbestos. With 
respect to mesothelioma risk, chrysotile was 
found to be less potent than amphibole asbestos. 
Although the analysis of Berman et al. [1995] 
was limited to studies of asbestos exposure, sim-
ilar statistical approaches may be adaptable to as-
sess study outcomes from exposures to a broader 
range of EMPs, beyond asbestos.
In addressing the issue of a length thresh-
old, the Health Effects Institute [HEI 1991] 
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concluded that asbestos fibers <5 µm long ap-
pear to have much less carcinogenic activity 
than longer fibers and may be relatively inac-
tive. A panel convened by ATSDR [2003] con-
cluded that “given findings from epidemiolog-
ical studies, laboratory animal studies, and in 
vitro genotoxicity studies, combined with the 
lung’s ability to clear short fibers, the panelists 
agreed that there is a strong weight of evidence 
that asbestos and SVFs shorter than 5 µm are 
unlikely to cause cancer in humans.” Also, an 
EPA [2003] peer consultant panel “agreed that 
the available data suggest that the risk for fibers 
<5 µm long is very low and could be zero.” They 
generally agreed that the width cutoff should 
be between 0.5 and 1.5 µm but deserved fur-
ther analysis.
However, Dodson et al. [2003] have argued 
that it is difficult to rule out the involvement 
of short (<5  µm) asbestos fibers in causing 
disease, because exposures to asbestos fibers 
overwhelmingly involve fibers shorter than 
5 µm, and fibers observed in the lung and in 
extrapulmonary locations are also overwhelm-
ingly shorter than 5  µm. For example, in a 
study of malignant mesothelioma cases, Suzuki 
and Yuen [2002] and Suzuki et al. [2005] found 
that the majority of asbestos fibers in lung and 
mesothelial tissues were shorter than 5  µm. 
Another study [Berman and Crump 2008a] 
showed that the best estimate for the potency 
of asbestos fibers between 5 and 10 µm is zero, 
but the hypothesis that these shorter fibers are 
not potent could not be rejected. Likewise, in 
no case could the hypothesis be rejected that fi-
bers shorter than 5 µm are not potent.
NIOSH investigators have recently evaluat-
ed the relationship between the dimensions 
(i.e., length and width) of airborne chrysotile 
fibers and risks for developing lung can-
cer  or asbestosis, by updating the cohort of 
chrysotile-exposed textile workers previous-
ly studied by Dement et al. [1994], Stayner et 
al. [1997], and Hein et al. [2007]. Archived air 
samples collected at this chrysotile textile plant 
were reanalyzed by TEM to generate exposure 
estimates based on bivariate  fiber-size distri-
bution [Dement et al. 2008]. TEM analysis of 
sampled fibers found all size-specific categories 
(35 categories were assigned, based on combi-
nations of fiber width and length) to be highly 
statistically significant predictors of lung can-
cer and asbestosis [Stayner et al. 2007]. The 
smallest fiber size–specific category was thin-
ner than 0.25 µm and <1.5 µm long. The largest 
size-specific category was thicker than 3.0 µm 
and >40 µm long. Both lung cancer and asbes-
tosis were most strongly associated with expo-
sures to thin fibers (<0.25 µm), and longer fi-
bers (>10 µm) were found to be the strongest 
predictors of lung cancer. A limitation of the 
study is that cumulative exposures for the co-
hort were highly correlated across all fiber-size 
categories, which complicates the interpreta-
tion of the study results.
In addition to length and width, an impor-
tant parameter used to define EMPs is the as-
pect ratio. The use of the 3:1 length:width as-
pect ratio as the minimum to define an EMP 
was not established on scientific bases such as 
toxicity or exposure potential. Rather, the deci-
sion was based on the ability of the microsco-
pist to determine the elongate nature of a par-
ticle [Holmes 1965], and the practice has been 
carried through to this day. As bivariate analy-
ses are conducted, the impact of aspect ratio, in 
addition to length and width, on toxicity and 
health outcomes needs to be addressed.
As discussed in Section 2.4.2, the nature of oc-
cupational exposures to asbestos has changed 
over the last several decades. Once dominated 
by chronic exposures in textile mills, friction 
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product manufacturing, and cement pipe fabri-
cation, current occupational exposures to asbes-
tos in the United States are primarily occurring 
during maintenance activities or remediation 
of buildings containing asbestos. These current 
occupational exposure scenarios frequently in-
volve short-term, intermittent exposures. The 
generally lower current exposures give added 
significance to the question of whether or not 
there is an asbestos exposure threshold below 
which workers would incur no risk of adverse 
health outcomes.
Risk assessments of workers occupationally ex-
posed to asbestos were reviewed by investiga-
tors sponsored by the Health Effects Institute 
[1991]. They found that dose-specific risk is 
highly dependent on how the measurement of 
dose (exposure) was determined. A common 
problem with many of the epidemiological 
studies of workers exposed to asbestos is the 
quality of the exposure data. Few studies have 
good historical exposure data, and the avail-
able data are mostly area samples with concen-
trations reported as millions of particles per 
cubic foot of air (mppcf). Although correction 
factors have been used to convert exposures 
measured in mppcf to f/cm3, the conversions 
were often based on more recent exposure 
measurements collected at concentrations low-
er than those prevalent in earlier years. In ad-
dition, a single conversion factor was typically 
used to estimate exposures throughout a facil-
ity, which may not accurately represent differ-
ences in particle sizes and counts at different 
processes in the facility.
More recently, the concept of a concentration 
threshold has been reviewed by Hodgson and 
Darnton [2000]. It is generally accepted that 
lung fibrosis requires relatively heavy expo-
sure to asbestos and that the carcinogenic re-
sponse of the lung may be an extension of the 
same inflammatory processes that produce lung 
fibrosis. Some evidence for a threshold is pro-
vided by an analysis of a chrysotile-exposed co-
hort, which suggests a potential threshold dose 
of about 30   f / mL-yr to produce radiologically 
evident fibrosis [Weill 1994]. Another study of 
necropsy material from textile workers exposed 
to chrysotile shows a distinct step increase in fi-
brosis for exposures in the 20–30 f/mL-yr range 
[Green et al. 1997]. However, a study of textile 
mill workers exposed to chrysotile did not reveal 
evidence of significant concentration thresholds 
for either asbestosis or lung cancer [Stayner et 
al. 1997]. Hodgson and Darnton [2000] pointed 
out that any evidence suggesting a threshold for 
chrysotile would likely not apply to amphibole 
asbestos because radiologically evident fibrosis 
has been documented among workers exposed 
to amphibole asbestos at low levels (<5  f / mL-yr). 
They concluded that if a concentration threshold 
exists for amphiboles, it is very low.
For mesothelioma, Hodgson and Darnton [2000] 
identified cohorts with high rates of mesotheli-
oma at levels of exposure below those at which in-
creased lung cancer has been identified; in some 
studies, the proportion of mesothelioma cases 
with no likely asbestos exposure is much high-
er than expected. Hodgson and Darnton [2000] 
concluded that these studies support a nonzero 
risk, even from brief, low-level exposures.
Animal studies using intraperitoneal and intra-
pleural injection of asbestos fibers cited by Ilgren 
and Browne [1991] suggest a possible threshold 
concentration for mesothelioma. However, it is 
not clear how this would be useful to determine 
a threshold for inhalation exposure in humans.
2.10 Analytical Methods
Available analytical methods can characterize 
the size, morphology, elemental composition, 
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crystal structure, and surface composition of 
bulk materials and individual airborne parti-
cles. There are two separate paradigms for se-
lecting among these methods for their use or 
further development for application to EMPs: 
one is for their support of standardized surveys 
or compliance assessments of workplace expo-
sures to EMPs; another is for their support of 
research to identify physicochemical proper-
ties of EMPs that are critical to predicting tox-
icity or pathogenic potential for lung fibrosis, 
lung cancer, or mesothelioma. The former re-
fers to analytical methods that can be applied 
to samples of airborne particles, whereas the 
latter can be used to characterize airborne par-
ticles and bulk materials.
Cost, time, availability, standardization require-
ments, and other pragmatic factors limit the se-
lection of analytical methods for standard-
ized analysis of field samples for the first set of 
uses. Additionally, those uses require meth-
ods employed historically to establish exposure-
response relationships. Principal among these 
analyses for standardized industrial hygiene use 
is an optical microscopy method, PCM (e.g., 
NIOSH Method 7400 or equivalent) [NIOSH 
1994a]. Under the current NIOSH REL for air-
borne asbestos fibers, particles are counted 
if they are EMPs (i.e., mineral particles with 
an aspect ratio [length:width] of 3:1 or great-
er) of the covered minerals and they are lon-
ger than 5  µm when viewed microscopically 
according to NIOSH Method 7400 or its equiv-
alent. The assumption when using this meth-
od is that all particles meeting the dimension-
al criteria are airborne asbestos fibers, because 
PCM cannot identify the chemistry or crystal-
line structure of a particle. This assumption may 
be appropriate in situations where the majori-
ty of particles are reasonably assumed to be one 
of the minerals covered by the airborne asbes-
tos fiber REL. Electron microscopy can be used 
to determine the actual proportion of the total 
particles that are covered by the airborne asbes-
tos fiber REL, and this proportion can be used 
to adjust the count from PCM (NIOSH Method 
7402) [NIOSH 1994b]. Such counts are known 
as PCM-equivalents, or PCMe. Note that this 
is not the same procedure as counting parti-
cles that would meet the PCM criteria under the 
electron microscope. Methods have been devel-
oped for performing counts under both scan-
ning electron microscopy (SEM) [ISO 2002] 
and TEM [40 CFR§§ 763.A.E (2001)]. Howev-
er, only a few countries (e.g., Germany, Austria, 
Netherlands, and Switzerland) use SEM rou-
tinely for counting.
Characterization of bulk minerals is a process 
known as petrographic analysis. Petrograph-
ic analysis includes a number of techniques, 
including polarized light microscopy (PLM), 
electron microscopy (SEM or TEM), X-ray dif-
fraction (XRD), X-ray fluorescence (XRF), and 
electron microprobe analysis. Other techniques, 
such as infrared and Raman spectroscopy and 
surface area measurements, can also be used. 
Some of these techniques can also be applied to 
individual airborne particles. If it is determined 
that the toxicity of EMPs has a basis in prop-
erties that can be measured by one or more of 
these techniques, then it may be possible to tai-
lor analytical procedures in the future to more 
precisely estimate risk.
Care should be taken in developing or applying 
new analytical methods to the analysis of as-
bestos for standardized and compliance assess-
ments. The use of new or different analytical 
methods to assess exposures must be careful-
ly evaluated and validated to ensure that they 
measure exposures covered by the health pro-
tection standard.
§§Code of Federal Regulations. See CFR in references.
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One consideration in developing new methods 
for assessing workplace exposures is that silicate 
mineral particles thinner than the resolution of 
PCM in NIOSH Method 7400 are in the same 
size range as the deposition minimum observed 
for small particles in human respirable particle 
studies. Current standards for assessing particle 
dose are based on particle penetration into the 
human respiratory system, which may overes-
timate deposition [ISO 1995a]. More recent-
ly, proposals have been developed to account 
for deposition [Vincent 2005]. In addition, af-
ter depositing in the lung, a single asbestos fiber 
bundle can split into a great many individual fi-
brils. Accounting for this behavior may be im-
portant in developing methods that accurately 
represent risk from exposure.
It is also important to recognize that the sampling 
and analytical methods for assessing workplace 
exposures to EMPs have different constraints 
from methods used to assess environmental ex-
posures. NIOSH is focused on developing and 
validating methods for assessing workplace ex-
posures to EMPs and provides assistance in de-
veloping environmental exposure methods, where 
possible and appropriate, through its relation-
ships with other federal agencies.
2.10.1 NIOSH Sampling and 
Analytical Methods for 
Standardized Industrial 
Hygiene Surveys
The analytical components of NIOSH’s REL for 
asbestos exposure take on substantial signifi-
cance because the current REL was set on the 
basis of the limit of quantification (LOQ) of the 
PCM method with use of a 400-L sample, rather 
than solely on estimates of the health risk. Had 
a lower LOQ been possible, a lower REL may 
have been proposed to further reduce the risk 
of occupational cancer among asbestos-exposed 
workers. With advances in sampling pump ca-
pabilities—and if interference from other dust is 
not excessive—a lower limit of quantitation and 
thus a shorter averaging time for the REL may 
be possible.
PCM was designated as the principal analyt-
ical method for applying the REL because it 
was thought to be the most practical and reli-
able available method, particularly for field as-
sessments. The particle counting rules speci-
fied for PCM analysis of air samples result in 
an index of exposure that has been used with 
human health data for risk assessment. PCM-
based counts do not enumerate all EMPs be-
cause very thin particles, such as asbestos fi-
brils, are typically not visible by PCM when 
using NIOSH Method 7400. The ratio of 
countable EPs to the total number of EPs col-
lected on air samples can therefore vary for 
samples collected within the same workplace, 
as well as between different workplaces where 
the same or different asbestos materials are 
handled [Dement and Wallingford 1990]. The 
result of this is that equivalent PCM asbestos 
exposure concentrations determined at differ-
ent workplaces would be considered to pose 
the same health risk, when, in fact, those risks 
may be different because of unknown amounts 
of unobserved fibers on the samples. It is com-
monly stated that particles thinner than about 
0.2–0.25 µm typically cannot be observed with 
PCM because they are below the resolution 
limits of the microscope. However, the results 
for PCM counts may also vary according to the 
index of refraction of the material being exam-
ined. When the index of refraction of the par-
ticle is similar to that of the filter substrate or 
mounting medium, the ability to resolve par-
ticles is less than when the refractive index of 
the particle differs from that of the substrate 
[Kenny and Rood 1987]. When a microscope 
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is calibrated appropriately for NIOSH Meth-
od 7400 and triacetin is used as the mounting 
medium, calculation and experiment have in-
dicated that chrysotile fibers as thin as 0.15 µm 
can be resolved [Rooker et al. 1982], which im-
plies that amphibole fibers thinner than 0.2 µm 
and with higher refractive index may actually 
be visible and potentially counted.
Individual asbestos fibrils range in width from 
<10 nm (0.01 µm) for chrysotile up to 40 nm 
(0.04  µm) or more for amosite. Thus, indi-
vidual asbestos fibrils are not likely to be vis-
ible by PCM. Early studies suggested that as-
bestos particles of 3:1 aspect ratio and longer 
than 5 µm are not usually individual fibrils but 
fibrillar bundles that are much wider than fi-
brils [Hwang and Gibbs 1981; further data cit-
ed in Walton 1982], so that the number of par-
ticles meeting these criteria counted under 
PCM were not generally found to differ greatly 
from the number of particles meeting the same 
criteria counted under the electron microscope 
[Lynch et al. 1970; Hwang and Gibbs 1981; 
Marconi et al. 1984; Dement and Wallingford 
1990]. However, more recent studies suggest 
there is a substantial difference between counts 
of particles seen by PCM and TEM [Dement et 
al. 2009], and the importance of these differ-
ences in developing new methods to be used 
routinely for industrial hygiene surveys will be 
important to reconcile with the particle char-
acteristics important in disease causation. 
Another aspect of NIOSH Method 7400 is that 
two sets of counting rules are specified, de-
pending on the type of fiber analysis. The rules 
for counting particles for asbestos determina-
tion, referred to as the “A” rules, instruct the 
microscopist to count EPs of any width that are 
longer than 5 µm and have an aspect ratio of 
at least 3:1. However, EPs wider than 3 µm are 
not likely to reach the thoracic region of the 
lung when inhaled. The “B” counting rules, 
which are used to evaluate airborne exposure 
to other EPs, specify that only EPs thinner than 
3 µm and longer than 5 µm should be count-
ed [NIOSH 1994a]. The European Union is 
moving toward a standardized PCM method 
for evaluating asbestos exposures with count-
ing rules recommended by the World Health 
Organization (WHO), which specify counting 
only EPs thinner than 3 µm and with a 3:1 or 
larger aspect ratio [WHO 1997; European Par-
liament and Council 2003].
2.10.2 Analytical Methods 
for Research
For research purposes, it may be important for 
a more expansive set of analyses to be consid-
ered. However, EMPs thinner than the limit of 
spatial resolution of the optical microscope are 
thought to be important etiologic agents for 
disease, so other detection and measurement 
methods may be needed for improved inves-
tigations of the relationship between fiber di-
mension and disease outcomes.
TEM has much greater resolving power than 
optical microscopy, on the order of 0.001  µm. 
Additionally, TEM has the ability to semiquan-
titatively determine elemental composition by 
means of EDS. Incident electrons excite elec-
tronic states of atoms of the sample, and the at-
oms decay that excess energy either by emitting 
an X-ray of frequency specific to the element 
(X-ray spectroscopy) or by releasing a second-
ary electron with equivalent kinetic energy 
(an Auger electron). Furthermore, TEM can 
provide some level of electron diffraction (ED) 
analysis of particle mineralogy by producing a 
mineral-specific diffraction pattern based on 
the regular arrangement of the particle’s crys-
tal structure [Egerton 2005].
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The greater spatial resolving power and the 
crystallographic analysis abilities of TEM and 
TEM-ED are used in some cases for standard-
ized workplace industrial hygiene character-
izations. TEM methods (e.g., NIOSH 7402) 
are used to complement PCM in cases where 
there is apparent ambiguity in EMP identifi-
cation [NIOSH 1994b] and, under the Asbes-
tos Hazardous Emergency Response Act of 
1986, the EPA requires that TEM analysis be 
used to ensure the effective removal of asbestos 
from schools [EPA 1987]. Each of these meth-
ods employs specific criteria for defining and 
counting visualized fibers and reporting differ-
ent fiber counts for a given sample. These data 
subsequently can be independently interpret-
ed according to different definitional criteria, 
such as those developed by the International 
Organization for Standardization (ISO), which 
provides methods ISO 10312 and ISO 13794 
[ISO 1995b, 1999].
Improved analytical methods that have become 
widely available should be reevaluated for com-
plementary research applications or for ease of 
applicability to field samples. SEM is now gen-
erally available in research laboratories and 
commercial analytical service laboratories. SEM 
resolution is on the order of ten times that of 
optical microscopy, and newly commercial field 
emission SEM (FESEM) can improve this res-
olution to about 0.01 µm or better, near that of 
TEM. SEM-EDS and SEM- wavelength disper-
sive spectrometers (WDS) can identify the ele-
mental composition of particles. It is not clear 
that SEM- backscatter electron diffraction anal-
ysis can be adapted to crystallographic analy-
ses equivalent to TEM-ED capability. The ease 
of sample collection and preparation for SEM 
analysis in comparison with TEM and some 
of the advantages of SEM in visualizing fields 
of EMPs and EMP morphology suggest that 
SEM methods should be reevaluated for EMP 
analyses, both of field samples and for research 
[Goldstein 2003].
Research on mechanisms of EMP toxicity in-
cludes concerns for surface-associated factors. 
To support this research, elemental surface 
analyses can be performed by scanning Au-
ger spectroscopy on individual particles with 
widths near the upper end of SEM resolution. In 
scanning Auger spectroscopy, the Auger elec-
trons stimulated by an incident electron beam 
are detected; the energy of these secondary 
electrons is low, which permits only secondary 
electrons from near-surface atoms to escape 
and be analyzed, thus analyzing the particle el-
emental composition to a depth of only one or a 
few atomic layers [Egerton 2005]. This method 
has been used in some pertinent research stud-
ies (e.g., assessing effects on toxicity of leaching 
Mg from chrysotile fiber surfaces) [Keane et al. 
1999]. Currently, this form of analysis is time-
consuming and not ideal for the routine analy-
sis of samples collected in field studies.
Surface elemental composition and limited va-
lence state information on surface-borne ele-
ments can be obtained by X-ray photoelectron 
spectroscopy (XPS or ESCA), albeit not for in-
dividual particles. XPS uses X-ray excitation of 
the sample, rather than electron excitation as 
used in SEM-EDS or TEM-EDS. The X-rays 
excite sample atom electrons to higher ener-
gy states, which then can decay by emission of 
photoelectrons. XPS detects these element-spe-
cific photoelectron energies, which are weak 
and therefore emitted only near the sample sur-
face, similar to the case of Auger electron sur-
face spectroscopy. In contrast to scanning Au-
ger spectroscopy, XPS can in some cases provide 
not only elemental but also valence state infor-
mation on atoms near the sample surface. How-
ever, in XPS the exciting X-rays cannot be fine-
ly focused on individual particles, so analysis 
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is made of an area larger than a single particle 
[Watts and Wolstenholme 2003]. Thus, analysis 
of a mixed-composition dust sample would be 
confounded, so XPS is applicable only to some 
selected or prepared homogeneous materials or 
to pure field samples. 
2.10.3 Differential Counting 
and Other Proposed 
Analytical Approaches for 
Differentiating EMPs 
In assessments of asbestos fiber counts in 
mixed exposures, the use of PCM to deter-
mine concentrations of airborne fibers from 
asbestos minerals cannot ensure that EMPs 
from nonasbestiform minerals are excluded. 
No reliable, reproducible methods are available 
for analysis of air samples that would distin-
guish between asbestos fibers and EMPs from 
nonasbestiform analogs of the asbestos miner-
als. The lack of such validated analytical meth-
ods is clearly a major limitation in applying 
federal agencies’ definitions of airborne asbes-
tos fibers. 
A technique referred to as differential count-
ing, suggested as an approach to differenti-
ate between asbestiform and nonasbestiform 
EMPs, is mentioned in a nonmandatory ap-
pendix to the OSHA asbestos standard. That 
appendix points out that the differential count-
ing technique requires “a great deal of experi-
ence” and is “discouraged unless legally neces-
sary.” It relies heavily on subjective judgment 
and does not appear to be commonly used 
except for samples from mines. In this tech-
nique, EMPs that the microscopist judges to be 
nonasbestiform (e.g., having the appearance 
of cleavage fragments) are not counted; any 
EMPs not clearly distinguishable as either as-
bestos or not asbestos in differential counting 
are to be counted as asbestos fibers. One effect 
of using differential counting is to introduce an 
additional source of variability in the particle 
counts, caused by different “reading” tenden-
cies between microscopists. The technique has 
not been formally validated and has not been 
recommended by NIOSH.
For counting airborne asbestos fibers in mines 
and quarries, ASTM has proposed “discrimina-
tory counting” that incorporates the concepts 
of differential counting. The proposed meth-
od uses PCM and TEM in a tiered scheme. Air 
samples are first analyzed by PCM. If the initial 
PCM fiber count exceeds the MSHA permis-
sible exposure limit (PEL), TEM is performed 
to determine an equivalent PCM count of reg-
ulated asbestos fibers only. If the initial PCM 
count is greater than one-half the PEL but less 
than the PEL, discriminatory counting is then 
performed. Discriminatory counts are restrict-
ed to fiber bundles, fibers longer than 10 µm, 
and fibers thinner than 1.0 μm. If the discrim-
inatory count is at least 50% of the initial PCM 
fiber count, TEM is performed to determine an 
equivalent PCM count of regulated asbestos fi-
bers only. These results are then compared to 
regulatory limits [ASTM 2006].
ASTM has begun an interlaboratory study (ILS 
#282) to determine the interlaboratory preci-
sion of “binning” fibers into different classes 
based on morphology [Harper et al. 2007]. The 
first part of the validation process was to evalu-
ate samples of ground massive or coarsely crys-
talline amphiboles and air samples from a taco-
nite mine that have amphibole particulates, of 
which the majority are characterized as cleav-
age fragments. Almost none of the observed 
particles met the Class 1 criteria (i.e., potential-
ly asbestiform on the basis of curved particles 
and/or fibril bundles). Many particles were clas-
sified as Class 2 (i.e., potentially asbestiform on 
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the basis of length >10 μm or width <1 μm), al-
though their morphology suggested they were 
more likely cleavage fragments. With use of al-
ternate criteria for Class 2 (length >10 µm plus 
width <1 µm), the number of Class 2 particles 
was greatly reduced. However, evidence from 
the literature [Dement et al. 1976; Griffis et al. 
1983; Wylie et al. 1985; Siegrist and Wylie 1980; 
Beckett and Jarvis 1979; Myojo 1999] indicates 
that as many as 50% of airborne asbestos fibers 
are <10 µm long. The proportion of asbestos fi-
bers in the length “bin” bracketed by 5 µm and 
10  µm was also quite large (about 30%), and 
the adoption of the alternate Class 2 criteria as 
length >10 µm and width <1 µm would cause 
this proportion of asbestos fibers to be classified 
as nonasbestiform and excluded from counts of 
asbestos fibers [Harper et al. 2008].
Other procedures have been suggested with 
the intent of ensuring that the counts on air 
samples do not include cleavage fragments 
[IMA-NA 2005; NSSGA 2005]. These proce-
dures include reviewing available geological 
information and/or results from analysis of 
bulk materials to establish that asbestos is pres-
ent in the sampled environment, or specifying 
dimensional criteria to establish that airborne 
particulates have population characteristics 
typical of asbestos fibers (e.g., mean particle 
aspect ratios exceeding 20:1).
For research purposes, it is critically important 
that an analytical method that clearly distin-
guishes between asbestiform and nonasbestiform 
EMPs be developed, validated, and used. Wheth-
er any of these suggested procedures would 
ensure adequate health protection for exposed 
workers is unclear, and the practical issues associ-
ated with implementing these supplemental pro-
cedures are also undetermined.
2.11 Summary of Key Issues
For asbestos fibers and other EMPs, an im-
portant question that remains unanswered 
is “What are the important dimensional and 
physicochemical determinants of pathogenic-
ity?” Evidence from epidemiological and an-
imal studies indicates that risks for asbesto-
sis and lung cancer decrease with decreasing 
exposure concentration and that the potency 
of asbestos is reduced as the fiber length de-
creases. However, the results from lung burden 
studies indicate the presence of short asbestos 
fibers at disease sites, and positive correlations 
between lung cancer and exposure to short as-
bestos fibers make it difficult to rule out a role 
for short asbestos fibers in causing disease. 
Other areas of debate remain. For example, 
there is a continuing debate as to whether or 
not amphibole asbestos fibers are more potent 
lung carcinogens than chrysotile fibers. This 
possible greater potency has been postulated to 
result from slower dissolution (in lung, inter-
stitial, and phagolysosomal fluids) of amphi-
bole asbestos fibers compared to chrysotile fi-
bers. Thus, amphibole asbestos fibers may tend 
to persist for longer periods in the lungs and 
other tissues, thereby imparting a greater po-
tential to trigger carcinogenesis. A related issue 
that continues to be debated is the magnitude 
of the difference in potency for mesothelioma 
associated with types of asbestos fiber. 
Understanding the determinants of toxicity of 
asbestos fibers and other EMPs, as well as of 
nonelongate mineral particles such as quartz, 
may help to elucidate some of these issues. The 
human, animal, and in vitro studies performed 
to date have been on asbestos fibers and a limit-
ed number of nonasbestiform EMPs relative to 
the large and highly variable group of minerals 
to which there is potential exposure. Additional 
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data are needed to more fully assess the parti-
cle characteristics that cause adverse health out-
comes and to develop risk assessments.
Information on occupational exposures to non- 
asbestiform EMPs is limited, as is information 
on exposure to asbestos fibers and other EMPs 
in mixed-dust environments, making it difficult 
to assess the range of particle characteristics, 
including dimension, in occupational settings 
with exposures to nonasbestiform EMPs. The 
few studies that have assessed biopersistence or 
durability suggest that nonasbestiform EMPs are 
not as biopersistent as asbestiform fibers of the 
same length, but more information is needed 
to systematically assess the ranges and impor-
tance of biopersistence in determining toxicity. 
Any assessment of risk needs to address the in-
fluence of EMP dimensions, so studies that sys-
tematically compare, to the extent possible, the 
effects of asbestiform and nonasbestiform par-
ticles of similar dimensions and dosimetrics—
such as particle count, disaggregation, and 
surface area—from the same mineral (e.g., 
crocidolite and nonasbestiform riebeckite) are 
needed for a variety of mineral types. Ulti-
mately, management of risk needs to be based 
on an understanding of the estimated quantita-
tive risk from exposures to various EMPs and 
on an understanding of the concentrations and 
particle characteristics of the various EMPs to 
which humans are or could be exposed and the 
exposures in occupational and other settings. 
An important need is to identify and develop 
analytical methods that can be used or mod-
ified to quantify occupational exposures to 
EMPs of toxicological importance and that are 
capable of differentiating EMPs on the basis of 
particle characteristics demonstrated to be im-
portant in causing disease. The current PCM 
method is inadequate for assessing exposures 
to fibers in mixed-dust environments, and 
it lacks the capability to measure all the im-
portant physical and chemical parameters of 
EMPs thought to be associated with toxicity. 
The feasibility of using EM methods will need 
to be addressed if they are to replace the PCM 
method. Until these issues are addressed, im-
provements in PCM methodologies should be 
pursued. In epidemiological and toxicological 
research, EM methods will need to be used to 
carefully characterize the exposure materials. 
Also, the results of toxicological and epidemio-
logical studies may identify additional particle 
characteristics that warrant further evaluation 
to determine whether they can be incorporat-
ed into sampling and analytical methods used 
to assess worker exposures. 
Section 3 of this Roadmap presents a frame-
work for proposed research intended to ad-
dress these scientific issues and inform future 
public health policies and practices. 
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3 Framework for Research
3.1 Strategic Research Goals and Objectives
Strategic goals and objectives for a multi disci-
plinary research program on mineral fibers 
and other EMPs are identified below. Shown in 
brackets following each goal and objective is the 
number of the section of this Roadmap in which 
the goal or objective is subsequently discussed.
I. Develop a broader understanding of the important determinants of toxicity for 
asbestos fibers and other EMPs [3.2].
 • Conduct in vitro studies to ascertain what physical, chemical, surface properties, 
and other particle characteristics influence the toxicity of asbestos fibers and other 
EMPs [3.2.1]; and
 • Conduct animal studies to ascertain what physical and chemical properties, surface 
properties, and other particle characteristics influence the toxicity of asbestos fibers 
and other EMPs [3.2.2].
II. Develop information and knowledge on occupational exposures to asbestos fibers 
and other EMPs and related health outcomes [3.3].
 • Assess available occupational exposure information relating to various types of 
asbestos fibers and other EMPs [3.3.1];
 • Collect and analyze available information on health outcomes associated with 
exposures to various types of asbestos fibers and other EMPs [3.3.2]; 
 • Conduct selective epidemiologic studies of workers exposed to various types of 
asbestos fibers and other EMPs [3.3.3]; and
 • Improve clinical tools and practices for screening, diagnosis, treatment, and 
secondary prevention of diseases caused by asbestos fibers and other EMPs [3.3.4].
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3.2 An Approach to Conducting 
Interdisciplinary Research
Within each of the goals and objectives laid out 
in this framework, a more detailed research 
program will have to be developed. Research to 
support these three goals must be planned and 
conducted by means of an interdisciplinary ap-
proach, incorporating toxicological, epidemio-
logical, exposure assessment, medical, analyti-
cal, and mineralogical methods. The research 
must also be integrated to optimize resources, 
facilitate the simultaneous collection of data, 
and ensure, to the extent feasible, that the re-
search builds toward a resolution of the key is-
sues. An aim of the research is to acquire a level 
of mechanistic understanding that can provide 
the basis for developing biologically-based 
models for extrapolating results of animal inha-
lation and other types of in vivo studies to ex-
posure conditions typically encountered in the 
workplace. The information gained from such 
research can then be used by regulatory agen-
cies and occupational health professionals to 
implement appropriate exposure limits and risk 
management programs for monitoring worker 
exposure and health. Much of this research may 
be accomplished by NIOSH, other federal agen-
cies, or other stakeholders. Any individual re-
search project undertaken should be designed 
to ensure that the results can be interpreted and 
applied within the context of other studies in the 
overall program and lead to outcomes useful for 
decision-making and policy-setting. 
3.3 National Reference 
Repository of Minerals and 
Information System
To support the needed research, a national ref-
erence repository of samples of asbestos and re-
lated minerals will be required, and a database 
of relevant information should be developed. 
Minerals vary in composition and morphology 
by location and origin, and differences within the 
same mineral type can be significant. Currently, 
no national repository exists to retain, docu-
ment, and distribute samples of asbestiform and 
nonasbestiform reference minerals for research 
and testing. These reference samples should be 
well-characterized research-grade materials that 
III. Develop improved sampling and analytical methods for asbestos fibers and other 
EMPs [3.4].
 • Reduce inter-operator and inter-laboratory variability of the current analytical 
methods used for asbestos fibers [3.4.1];
 • Develop analytical methods with improved sensitivity to visualize thinner EMPs to 
ensure a more complete evaluation of airborne exposures [3.4.2];
 • Develop a practical analytical method for air samples to differentiate between 
exposures to asbestiform fibers from the asbestos minerals and exposures to EMPs 
from their nonasbestiform analogs [3.4.3];
 • Develop analytical methods to assess durability of EMPs [3.4.4]; and
 • Develop and validate size-selective sampling methods for EMPs [3.4.5].
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are made available to the research community 
for testing and standardization. This will allow 
minerals with matching properties (e.g., mor-
phology, dimension) to be chosen for study. To 
accomplish this research, exhaustive character-
ization of the samples, including contaminants, 
is necessary. Detailed characterizations of miner-
als should include their ability to affect biologi-
cal activities and properties such as (1) purity, 
(2) particle morphology (range of dimensions 
and sizes), (3) surface area, (4) surface chemis-
try, and (5) surface reactivity. The particle char-
acteristics identified by Hochella [1993] should 
be considered for particle characterization. The 
use of these samples in research would facilitate 
meaningful comparisons and reduce uncertain-
ties in the interpretation of results between and 
among studies.
Care must be taken to ensure that a sufficient 
amount of the studied material is available, not 
only for current studies, but also as reference ma-
terial for possible future studies. The repository 
should accept and store samples from research-
ers conducting EMP studies so that further test-
ing and characterizations can be performed. The 
information developed from all of these efforts 
should be entered into a database, which can 
serve as a tool for selection of minerals for test-
ing and validation of toxicological tests, as well 
as to assist in identification of worker popula-
tions for possible epidemiological studies. 
The development of a comprehensive, publicly 
available information system incorporating all 
studies of the toxicity, exposures, and health 
effects of asbestos and related minerals could 
help enhance the development of the research 
programs, avoid duplication of effort, and en-
hance interpretation of the data generated. The 
system should include all pertinent informa-
tion about methods, doses or exposures, min-
erals, particle characteristics, and other topics. 
3.4 Develop a Broader 
Understanding of the 
Important Determinants of 
Toxicity for Asbestos Fibers 
and Other EMPs
To address this objective, one of the first steps 
will be to identify the range of minerals and min-
eral habits needed to systematically address the 
mineral characteristics that may determine par-
ticle toxicity. Care must be taken to ensure that 
mineralogical issues in a study are adequately ad-
dressed. Information on both crystalline lattice 
structure and composition is needed to define a 
mineral species, because information on either 
alone is insufficient to describe the properties of 
a mineral. For example, nonasbestiform riebeck-
ite and asbestiform riebeckite (crocidolite) share 
the same elemental composition but have differ-
ent expressions of their crystalline lattices. EMPs 
from nonasbestiform riebeckite are not flexible. 
Crocidolite fibers generally have chain-width de-
fects, which explain their flexibility. These chain-
width defects also affect diffusion of cations and 
dissolution properties, both of which can explain 
greater release of iron into surrounding fluid by 
crocidolite than by nonasbestiform riebeckite 
[Guthrie 1997]. 
In addition to elemental content and crystal-
line habit, the particle characteristics identi-
fied by Hochella [1993] should be considered 
for particle characterization. For example, the 
current paradigm for fiber pathogenicity does 
not discriminate between different composi-
tions of biopersistent fibers, except insofar as 
composition determines biopersistence. Two 
biopersistent fiber types, erionite [Wagner et 
al. 1985] and silicon carbide [Davis et al. 1996], 
show a special proclivity to cause mesothelio-
ma, for reasons that are not easily explained by 
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the current paradigm because their biopersis-
tence and distributions of fiber lengths are not 
substantially different from those of the amphi-
boles. The biochemical basis of the enhanced 
pathogenicity of these two fiber types has not 
been elucidated. This suggests that some fiber 
types may possess surface or chemical reactiv-
ity that imparts added pathogenicity over and 
above what would be anticipated for long biop-
ersistent fibers. Because of the many variations 
in elemental composition, crystalline struc-
ture, and other characteristics of these miner-
als, it will be impossible to study all variants. 
Therefore, a strategy will need to be developed 
for selecting minerals for testing. This strategy 
should include consideration of occupationally 
relevant minerals and habits in order to com-
plement available information, availability of 
appropriate and well-characterized specimens 
for testing, and practical relevance of the results 
to be achieved through testing. 
EPA’s Office of Pollution Prevention and Tox-
ics, NIEHS, NIOSH, and OSHA assembled an 
expert panel in the 1990s to consider major is-
sues in the use of animal models for chronic 
inhalation toxicity and carcinogenicity testing 
of thoracic-size elongate particles. Issues con-
sidered included the design of animal tests of 
chronic inhalation exposure to EMPs; prelimi-
nary studies to guide them; parallel mechanis-
tic studies to help interpret study results and 
to extrapolate findings with regard to potential 
health effects in humans; and available screen-
ing tests for identifying and assigning a priority 
for chronic inhalation study. There was general 
agreement that (1) chronic inhalation studies of 
EMPs in the rat are the most appropriate tests 
for predicting inhalation hazard and risk of 
EMPs to humans; (2) no single assay or battery 
of short-term assays could predict the outcome 
of a chronic inhalation bioassay for carcinoge-
nicity; and (3) several short-term in vitro and in 
vivo studies may be useful to assess the relative 
potential of various EMPs to cause lung toxicity 
or carcinogenicity [Vu et al. 1996]. 
Such short-term assays and strategies were con-
sidered by an expert working group assembled 
by the International Life Sciences Institute’s 
Risk Science Institute to arrive at a consensus 
on current assays useful for screening EMPs 
for potential toxicity and carcinogenicity [ILSI 
2005]. Dose, dimension, durability, and pos-
sible surface reactivities were identified as criti-
cal parameters for study, although it was noted 
that no single physicochemical property or 
mechanism can now be used to predict carci-
nogenicity of all EMPs. The strategy for short-
term (i.e., 3 months or less) testing in animal 
models included sample preparation and char-
acterization (composition, crystallinity, habit, 
size distribution); testing for biopersistence in 
vivo with use of a standard protocol such as 
that of the European Union [European Com-
mission 1999]; and a subchronic inhalation or 
instillation challenge of the rat, with evaluation 
of lung weight and fiber burden, bronchoalveo-
lar lavage profile, cell proliferation, fibrosis, and 
histopathology. Additionally, other nonroutine 
analyses for particle surface area and surface re-
activities and short-term in vitro cellular toxico-
logical assays might be evaluated. The use of in 
vitro tests should be tempered by the observa-
tions that standard protocols fail to distinguish 
relative pathogenic potentials of even nonelon-
gate silicates (such as quartz versus clay dusts) 
and that treatment of particle surfaces (such as 
modeling their conditioning upon deposition 
on the lipoprotein-rich aqueous hypophase 
surface of the deep lung) can greatly affect their 
expression of toxicities [ATSDR 2003]. 
EMPs encountered in any particular work envi-
ronment are frequently heterogeneous, which 
limits the ability of epidemiological and other 
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types of health assessment studies to evaluate 
the influence on toxicity of EMP dimensions 
(length and width), chemical composition, biop-
ersistence, and other characteristics. Toxico-
logical testing is needed to address some of the 
fundamental questions about EMP toxicity that 
cannot be determined through epidemiology or 
other types of health assessment studies. Irre-
spective of study type or design, the full char-
acterization of all particulate material in a test 
sample is an essential step in understanding 
the mechanisms of EMP toxicity. The determi-
nation of EMP dimensions is important, and 
they are best expressed as bivariate size distri-
butions (i.e., width and length). Such deter-
minations should be made by using both rela-
tively simple procedures (optical microscopy) 
and highly specialized techniques (e.g., TEM 
or SEM with EDS), because size-specific frac-
tions of EMP exposures have both biological 
and regulatory significance. 
The chemical composition (e.g., intrinsic chem-
ical constituents and surface chemistry) of as-
bestos fibers and other EMPs has been shown 
to have a direct effect on their ability to persist 
in the lung and to interact with surrounding 
tissue to cause DNA damage. For example, fer-
ric and ferrous cations are major components 
of the crystalline structure of amphibole asbes-
tos fibers; iron may also be present as a surface 
impurity on chrysotile asbestos fibers and oth-
er EMPs. The availability of iron at the surface 
of asbestos fibers and other EMPs has been 
shown to be a critical parameter in catalyz-
ing the generation of ROS that may indirectly 
cause genetic damage [Kane 1996]. Also, at-
tempted clearance of long asbestos fibers from 
the lung causes frustrated phagocytosis, which 
stimulates the release of ROS [Mossman and 
Marsh 1989]. Individual adaptive responses 
to oxidant stress and the body’s ability to re-
pair damaged DNA are dependent on multiple 
exogenous and endogenous factors, but few 
experiments have been attempted to evalu-
ate these variables in animal or human model 
systems. Kane [1996] has suggested that the 
mechanisms responsible for the genotoxic ef-
fects of asbestos fibers are due to indirect DNA 
damage mediated by free radicals and  direct 
physical interference with the mitotic appara-
tus by the fibers themselves. Research to ad-
dress the following questions would assist in 
validating these proposed mechanisms: 
 • Are in vitro genotoxicity assays relevant 
to carcinogenesis of asbestos fibers and 
other EMPs?
 • Are in vitro doses relevant for in vivo ex-
posures?
 • Can genotoxic effects of asbestos fibers 
and other EMPs be assessed in vivo?
Macrophages are the initial target cells of EMPs 
and other particulates deposited in the lungs 
or pleural and peritoneal spaces. Phagocyto-
sis of asbestos fibers has been shown to be ac-
companied by the activation of macrophages, 
which results in the generation of ROS as well 
as a variety of chemical mediators and cyto-
kines [Kane 1996]. These mediators amplify 
the local inflammatory reaction. Persistence 
of asbestos fibers in the lung interstitium or 
in the subpleural connective tissue may lead 
to a sustained chronic inflammatory reaction 
accompanied by fibrosis [Oberdorster 1994]. 
The unregulated or persistent release of these 
inflammatory mediators may lead to tissue 
injury, scarring by fibrosis, and proliferation 
of epithelial and mesenchymal cells. This re-
sponse appears to occur independently of fiber 
length. In the lungs and pleural linings, chron-
ic inflammation and fibrosis are common reac-
tions following exposure to asbestos fibers, but 
research is needed to understand the effects of 
fiber dimension, loading, and surface reactivity 
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on the development of disease endpoints such 
as inflammation, fibrosis, and cancer.
It has been suggested that asbestos fibers and 
other EMPs may contribute to carcinogenesis 
by multiple mechanisms and that EMPs may act 
at multiple stages in neoplastic development, 
depending on their physicochemical composi-
tion, surface reactivity, and biopersistence in the 
lung [Barrett 1994]. Animal inhalation studies 
are needed to investigate the biopersistence and 
toxicity of asbestos fibers and other EMPs rep-
resenting a range of chemical compositions and 
morphological characteristics (including crys-
talline habits) and representing a range of dis-
crete lengths and widths. An additional factor 
that should be considered and evaluated is the 
influence of concurrent exposure to other par-
ticles and contaminants on the biopersistence 
and toxicity of EMPs. In a recently reported 
short-term (5-day) animal inhalation study to 
evaluate the biopersistence of chrysotile fibers 
with and without concurrent exposure to joint 
compound particles (1–4 µm MMAD), the 
clearance half-time of all fiber sizes was approx-
imately an order of magnitude less for the group 
exposed to chrysotile and joint-compound par-
ticles [Bernstein et al. 2008]. Histopathological 
examination indicated that the combination of 
chrysotile and fine particles accelerated the re-
cruitment of alveolar macrophages, resulting in 
a 10-fold decrease in the number of fibers re-
maining in the lung. Although no mention was 
made of any pathological changes in the lungs of 
the chrysotile/particulate-exposed group, other 
studies have shown that the recruitment of mac-
rophages then increases the production and re-
cruitment of polymorphonuclear leukocytes, 
which themselves can generate ROS [Driscoll et 
al. 2002; Donaldson and Tran 2002]. 
Much research has been focused on lung can-
cer and mesothelioma. Even if it is determined 
that EMPs from some minerals have low po-
tency for causing cancer, additional studies 
may be needed to investigate their potential for 
causing inflammation, fibrosis, and other non-
malignant respiratory effects. Also, the rela-
tionship between EMP dimension and fibrosis 
should be more fully investigated. The results 
of such research may allow currently used stan-
dard exposure indices to be modified by speci-
fying different dimensional criteria (lengths 
and widths) relevant to each of the disease out-
comes associated with EMP exposures, and by 
determining whether biopersistence should be 
included as an additional criterion. However, 
this research may be dependent on the devel-
opment of new technology that can generate 
mineral fibers and other EMPs of specific di-
mensions in sufficient quantities to conduct 
animal inhalation experiments. Consequently, 
the development of revised exposure indices 
based on EMP dimension may not be possible 
in the short term.
The research strategy described above should 
conform with the general strategies and tactics 
that have been recommended by several expert 
panels for clarifying the risks and causes of as-
bestos exposure–associated diseases and with the 
current effort of the U.S. Federal Government In-
teragency Asbestos Working Group (IAWG), in-
volving participation of the EPA, USGS, NIOSH, 
ATSDR, CPSC, OSHA, MSHA, and NIEHS/
NTP, to identify federal research needs and pos-
sible actions regarding asbestos fibers and other 
durable EMPs of public health concern [Vu et al. 
1996; ILSI 2005; Schins 2002; Greim 2004; Moss-
man et al. 2007].
An ILSI Risk Science Institute Working Group 
supported by EPA published a tiered testing 
strategy for fibrous particles in 2005 [ILSI 2005]. 
Consideration should be given to the following 
slight modification of this published scheme. 
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Noteworthy in the findings of the ILSI Work-
ing Group report is the inadequacy of in vitro 
test models to predict the in vivo toxicity of 
EMPs. Indeed, many man-made mineral fibers 
are positive in cell test systems but do not cause 
fibrosis or cancer in chronic animal models. 
The in vitro test systems lack predictive ability 
because they do not incorporate biopersistence. 
For this reason, in vitro tests, other than assays 
for durability, are not included in the tiered test-
ing strategy given below. 
Step 1. Preparation and characterization 
of test EMPs
This is the initial, required step for any toxico-
logical evaluation. It should include
 • comprehensive chemical and mineralogi-
cal characterization, including crystallin-
ity and EMP habit.
 • size distribution of the EMPs found in the 
workplace (total particulate sample), as 
well as dimensional characteristics of size-
selected fraction(s) to be used for hazard 
evaluation. A limiting step for detailed tox-
icological evaluation is the availability of 
sufficient quantities of size-selected EMPs 
of known chemistry and mineralogy. 
Step 2. Assessment of in vitro durability
Evidence indicates that highly soluble fibrous 
particles do not exhibit fibrotic or carcinogenic 
potential in animal studies. Rate of dissolution in 
simulated body fluids should be measured with 
a dynamic flow-through system, as outlined by 
Potter et al. [2000]. In brief, EMPs are exposed 
by continuous flow to a modified Gamble’s solu-
tion, and fiber diameter is monitored optically 
over time. Biopersistence would be an indica-
tion of concern and would indicate the need for 
further testing of the pathogenic potential of the 
EMP. This step is optional, as one could move 
directly to Step 3. 
Step 3. Short-term in vivo biopersistence test
Biopersistence of fibers longer than 20 µm has 
been found to be an excellent predictor of col-
lagen deposition in chronic inhalation studies 
[Bernstein et al. 2001]. Two alternative meth-
ods are accepted by the European Commission 
[1997]: intratracheal instillation and 5-day 
inhalation by rats. It is recommended that fi-
ber burden be measured at time points up to 
3 months post-exposure. Biopersistence would 
be an indication of concern and would indicate 
the need for further testing of the pathogenic 
potential of the EMP.
Step 4. Subchronic inhalation study
Parameters that should be measured in such 
an inhalation study are noted by EPA [2001]. 
The test should involve inhalation exposure 
for 3 months and should evaluate pulmonary 
responses over 6 months post-exposure. Re-
sponses to be measured should include bio-
persistence, persistent inflammation, cell pro-
liferation (bromodeoxyuradine [BrdU] assay), 
fibrosis, epithelial cell hyperplasia, lung weight, 
and fiber burden. Biopersistence and persistent 
inflammation are notable markers of concern. 
If the subchronic study is positive, a long-term 
inhalation study is necessary to conduct a full-
risk assessment. 
Step 5. Long-term inhalation study
The test would include a 2-year inhalation 
study in rats, with lifelong follow-up.  Fibro-
sis, lung tumors, and mesothelioma should be 
measured according to EPA guidelines [EPA 
2001] for long-term inhalation studies of fi-
bers.  Obtainment of lung burden, dose-related 
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response, and time-course data would enable 
risk assessment. 
Implicit in any new or revised occupational 
health policy for EMPs would be the need to 
conduct appropriate assessments of risk. Risk 
assessments for lung cancer, mesothelioma, 
and asbestosis have been conducted on worker 
populations exposed to various asbestos min-
erals. These risks have been qualitatively con-
firmed in animals, but no adequate quantitative 
 multidose inhalation studies with asbestos have 
been conducted in rodents that would permit 
direct comparisons to lung cancer and meso-
thelioma risks determined from exposed hu-
man populations. Given the availability of risk 
estimates for lung cancer in asbestos-exposed 
humans, chronic studies with rats exposed to 
asbestos (e.g., chrysotile) fibers would provide 
an assessment of the rat as a valid “predictor” 
of human lung cancer risks associated with ex-
posure to asbestos fibers and other EMPs.
3.4.1 Conduct In Vitro Studies to 
Ascertain the Physical and 
Chemical Properties that 
Influence the Toxicity of 
Asbestos Fibers and Other EMPs
Although in vitro studies may not be appropri-
ate for toxicology screening tests of EMPs, they 
can help clarify the mechanisms by which some 
EMPs induce cancer, mesothelioma, or fibrosis, 
as well as the properties of EMPs and condi-
tions of exposure that determine pathogenic-
ity. In vitro studies allow specific biological and 
mechanistic pathways to be isolated and tested 
under controlled conditions that are not feasible 
in animal studies. In vitro studies can yield data 
rapidly and provide important insights and con-
firmations of mechanisms, which can be con-
firmed with specifically designed in vivo studies. 
With the exception of in vitro genotoxicity 
testing of asbestos fibers, little testing informa-
tion is available on the potential genotoxicity 
of EMPs. In contrast to standard genotoxicity 
testing of soluble substances, the results from 
testing EMPs can be influenced by dimen-
sion, surface properties, and biopersistence. The 
mechanisms of asbestos-induced genotoxicity 
are not clear, but direct interaction with the 
genetic material and indirect effects via pro-
duction of ROS have been proposed. A combi-
nation of the micronucleus test and the comet 
assay with continuous treatment (without exog-
enous metabolic activation) has been reported 
to detect genotoxic activity of asbestos fibers 
[Speit 2002]. However, further research is need-
ed to determine whether this approach is ap-
plicable for genotoxicity testing of other EMPs. 
Before conducting such studies, the following 
EMP interactions should be addressed:
 • initial lesions evoking cell damage or re-
sponse (e.g., direct or indirect cytotoxic 
or genotoxic events or induction of toxic 
reactive intermediate materials);
 • subsequent multistage cellular response 
(e.g., intracellular signaling through a ki-
nase cascade to nuclear transcription of 
factors for apoptosis, cell transformation, 
and cell or cell system proliferation or re-
modeling and initiation or promotion of 
neoplasia or fibrosis); and 
 • critical time-course events in those pro-
cesses (e.g., cell-cycle-dependent EMP in-
teractions or EMP durability under differ-
ent phagocytic conditions).
Capabilities for conducting these studies im-
proved during the 2000s, including
 • advancement in analytical methods for 
physico chemical characterization of 
EMP properties (e.g., for resolving small 
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dimensions and nanoscale surface proper-
ties); and 
 • ability to prepare EMP samples that are 
“monochromatic” in size or surface prop-
erties in quantities sufficient for well-con-
trolled in vitro assays.
Identification of the initiating EMP-cell interac-
tions calls for research on the mechanisms of 
 • cell-free generation of toxic ROS by EMPs 
or EMP-induced cellular generation of 
toxic ROS; and
 • direct membranolytic, cytotoxic, or geno-
toxic activities of the EMP surface in contact 
with cellular membranes or genetic material. 
These investigations will require attention to the 
following:
 • effects of EMP surface composition (e.g., 
surface-borne iron species); 
 • effects of normal physiological condition-
ing of respired particles (e.g., in vitro mod-
eling of in vivo initial conditioning of EMP 
surfaces by pulmonary surfactant);
 • nonphysiological conditioning of EMP un-
der in vitro test conditions (e.g., by compo-
nents of nutrient medium);
 • cell type (e.g., phagocytic inflammatory 
cell or phagocytic versus nonphagocytic 
target cell); and 
 • EMP dimensions in relation to cell size (e.g., 
as a factor distinguishing total phagocytosis 
and partial frustrated phagocytosis).
Cell generation of ROS is seen generally in 
phagocytic uptake of elongate or nonelongate 
particles (e.g., as a respiratory burst). In nor-
mal phagocytosis, there is a maturation of the 
phagosomal membrane, with progression to a 
phagolysosomal structure for attempted lyso-
somal digestion. Anomalous behavior of this 
system may occur in frustrated phagocytosis 
of long EMPs. The hypothesis of frustrated 
phagocytosis suggests that EMPs that are too 
long to permit full invagination may stimulate 
cells to generate ROS or anomalously release 
lytic factors into the extracellular annulus rath-
er than into a closed intracellular phagosome. 
EMP surfaces may be tested for direct membra-
nolytic or cytotoxic activities that are dependent 
on surface composition or structure. As a guide, 
membranolytic or cytotoxic activities of non-
elongate particulate silicates are dependent on 
surface properties. Nonelongate particulate sili-
cates also provide an example of failure of in vi-
tro cytotoxicity to relate with pathogenicity (e.g., 
respirable particles of quartz or kaolin clay sig-
nificantly differ in disease risk for fibrosis, but 
are comparably cytotoxic in vitro unless they are 
preconditioned with pulmonary surfactants and 
then subjected to phagolysosomal digestion). In 
vitro studies of direct versus indirect induction 
of genotoxic activities may consider factors af-
fecting the bioavailability of the nuclear genetic 
material (e.g., the state of phagocytic activity of 
the cell or the stages in the cell cycle with col-
lapse of the nuclear membrane in mitosis). 
These again suggest care in the preparation of 
EMPs and the manner of challenge with EMPs 
employed in in vitro experiments.
The two modes of primary damage, a release 
of reactive toxic agents induced by long par-
ticulates or a surface-based membranolytic or 
genotoxic mechanism, may be involved singly 
or jointly in primary cell responses to EMPs. 
These may be investigated by comparing the 
effects of different types of EMPs (e.g., rela-
tive potencies of erionite fibers and amphibole 
asbestos fibers in in vitro cell transformation 
studies are different than their potencies in in 
vivo induction of mesothelioma). 
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In the second phase of cellular response to EMPs, 
the central dogma of intracellular response is 
being intensively researched. The initial extra-
cellular primary damage induces intracellular 
signaling (e.g., by MAPK), which causes a cas-
cade of kinase activities that stimulate selective 
nuclear transcription of mRNAs, leading to 
production of TNF-α or other cytokines for ex-
tracellular signaling of target cells. Those other 
cytokines may induce cell proliferation toward 
cancer or collagen synthesis toward fibrosis. 
Further definition of signaling mechanisms and 
analyses of their induction by different primary 
EMP-cellular interactions may better define the 
ultimate role of EMP properties in the overall 
process. That research, again, may be facilitated 
by using different specific types of EMPs, each 
with relatively homogeneous morphology and 
surface properties. 
Although full investigation of biopersistence 
of EMPs may require long-term animal model 
studies, in vitro systems coupled with advanced 
surface analytical tools (e.g., field emission 
SEM–energy dispersive X-ray spectroscopy or 
scanning Auger spectroscopy) may help guide 
in vivo studies. This could be done by detailing 
specific surface properties of EMPs and their 
modifications under cell-free or in vitro con-
ditions representing the local pH and reactive 
species at the EMP surface under conditions 
of extracellular, intra-phagolysosomal, or frus-
trated annular phagocytic environments. 
3.4.2 Conduct Animal Studies to 
Ascertain the Physical and 
Chemical Properties that 
Influence the Toxicity of 
Asbestos Fibers and Other EMPs
A multispecies testing approach has been rec-
ommended for short-term assays [ILSI 2005] 
and chronic inhalation studies [EPA 2000] 
that would provide solid scientific evidence 
on which to base human risk assessments for a 
variety of EMPs. To date, the most substantial 
base of human health data for estimating lung 
cancer risk is for workers exposed to fibers 
from different varieties of asbestos minerals.
There are similarities between animal species 
and humans in deposition, clearance, and re-
tention of inhaled particles in the lungs. For 
example, peak alveolar deposition fraction is 
greatest for particles at an AED of about 2 µm in 
humans and about 1 µm for rodents. However, 
some interspecies differences have been identi-
fied. Variations in ventilation, airway anatomy, 
and airway cell morphology and distribution ac-
count for quantitative differences in deposition 
pattern and rate of clearance among species. In 
addition, the efficacy of pulmonary macrophage 
function differs among species. All these differ-
ences could affect particle clearance and reten-
tion. It has been suggested that the following 
species differences should be considered in the 
design of experimental animal inhalation stud-
ies of elongate particles [Dai and Yu 1988; War-
heit et al. 1988; Warheit 1989].
 • Due to differences in airway structure, 
airway size, and ventilation parameters, a 
greater fraction with large AED particles 
are deposited in humans than in rodents.
 • Alveolar deposition fraction in humans 
varies with workload. An increase in the 
workload reduces the deposition fraction 
in the alveolar region because more of 
the inhaled particulate is deposited in the 
 extra-thoracic and bronchial regions. 
 • Mouth breathing by humans results in a 
greater upper bronchial deposition and 
enhanced particle penetration to the pe-
ripheral lung.
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 • For rats and hamsters, alveolar deposition 
becomes practically zero when particle 
AED exceeds 3.0 µm and aspect ratio ex-
ceeds 10. In contrast, considerable alveolar 
deposition is found for humans breathing 
at rest, even for EPs with AEDs approach-
ing 5 µm and aspect ratio exceeding 10.
 • Rodents have smaller-diameter airways 
than humans, a characteristic which in-
creases the chance for particle deposition 
via contact with airway surfaces. 
 • Turbulent air flow, which enhances particle 
deposition via impaction, is common in 
human airways but rare in rodent airways.
 • Variations in airway branching patterns 
may account for significant differences 
in deposition between humans and ro-
dents. Human airways are characterized 
by symmetrical branching, wherein each 
bifurcation is located near the centerline 
of the parent airway. This symmetry fa-
vors deposition “hotspots” on carinal 
ridges at the bifurcations due to disrupted 
airstreams and local turbulence. Rodent 
airways are characterized by asymmetric 
branching, which results in a more diffuse 
deposition pattern because the bulk flow 
of inspired air follows the major airways 
with little change in velocity or direction. 
 • Alveolar clearance is slower in humans 
than in rats. Human dosimetry models 
predict that, at nonoverloading exposure 
concentrations, a greater proportion of 
particles deposited in the alveolar region 
will be interstitialized and sequestered in 
humans than in rats.
An important consideration in the conduct and 
interpretation of animal studies is the selection 
of well characterized (with respect to chemi-
cal and physical parameters) and appropriately 
sized EMPs that take into account differences 
in deposition and clearance characteristics 
between rodents and humans. EMPs that are 
capable of being deposited in the bronchoal-
veolar region of humans cannot be completely 
evaluated in animal inhalation studies because 
the maximum thoracic size for particles in ro-
dents is approximately 2 µm AED, which is 
less than the maximum thoracic size of about 
3 µm AED for humans [Timbrell 1982; Su and 
Cheng 2005].
3.4.2.1 Short-Term Animal Studies
There are several advantages to conducting 
short-term animal studies in rats; one is that 
the information gained (e.g., regarding over-
load and maximum tolerated dose [MTD]) 
can be used to more effectively design chronic 
inhalation studies [ILSI 2005]. The objectives 
of these studies would be to
 • Evaluate EMP deposition, translocation, 
and clearance mechanisms;
 • Compare the biopersistence of EMPs re-
tained in the lung with results from in vi-
tro durability assays; 
 • Compare in vivo pulmonary responses to 
in vitro bioactivity for EMPs of different 
dimensions; and 
 • Compare cancer and noncancer toxicities 
for EMPs from asbestiform and nonas-
bestiform amphibole mineral varieties of 
varying shapes, as well as within narrow 
ranges of length and width. 
More fundamental studies should also be per-
formed to
 • Identify biomarkers or tracer/imaging 
methods that could be used to predict or 
monitor active pulmonary inflammation, 
pulmonary fibrosis, and malignant trans-
formation; 
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 • Investigate mechanisms of EMP-induced 
pulmonary disease; and 
 • Determine whether cell proliferation in 
the lungs (terminal bronchioles and alveo-
lar ducts) can be a predictive measure of 
pathogenicity following brief inhalation ex-
posure and use of the BrdU assay [Cullen et 
al. 1997].
Exposure protocols for tracheal inhalation or 
instillation in an animal model for short-term 
in vivo studies using field-collected or labora-
tory-generated EMPs should address possible 
adulteration of EMP morphology (e.g., anom-
alous agglomeration of particles). This might 
be addressed in part by preconditioning EMPs 
in a delivery vehicle containing representative 
components of pulmonary hypophase fluids. 
Exposure protocols using pharyngeal aspira-
tion as a delivery system should be considered, 
given the observations in studies with single-
walled carbon nanotubes that such a delivery 
system closely mimics animal inhalation stud-
ies [Shvedova et al. 2005, 2008].
Studies evaluating the roles of biopersistence 
and dimension in the development of  noncancer 
and cancer endpoints from exposure to EMPs 
are also needed. These studies should attempt to 
elucidate the physicochemical parameters that 
might affect bio-durability of EMPs of specific 
dimensions. Although short-term animal inha-
lation studies would be informative, companion 
in vitro assays should also be conducted to as-
sess their validity for screening EMPs.
3.4.2.2 Long-Term Animal Studies
Chronic animal inhalation studies are required 
to address the impacts of dimension, morphol-
ogy, chemistry, and biopersistence on critical 
disease endpoints of cancer induction and 
nonmalignant respiratory disease. The EPA’s 
proposed testing guidelines should be consid-
ered as the criteria for establishing the testing 
parameters for chronic studies [EPA 2001].
To date, chronic inhalation studies have been 
conducted with different animal species and dif-
ferent types of EPs. However, it remains uncer-
tain which species of animal(s) best predict(s) 
the risk of respiratory disease(s) for workers 
exposed to different EPs. Chronic inhalation 
studies should be initiated to establish exposure/
dose-response relationships for at least two ani-
mal species. The rat has historically been the 
animal of choice for chronic inhalation studies 
with EPs, but the low incidence of lung tumors 
and mesotheliomas in rats exposed to asbestos 
fibers suggests that rats may be less sensitive than 
humans. Therefore, any future consideration for 
conducting long-term animal inhalation studies 
should address the need for using a multispecies 
testing approach to help provide solid scientific 
evidence on which to base human risk assess-
ments for a variety of EMPs of different durabil-
ities and dimensions. For example, some recent 
studies suggest that the hamster may be a more 
sensitive model for mesothelioma than the rat. 
Validation of appropriate animal models could 
reduce the resources needed to perform long-
term experimental studies on other EMP types 
[EPA 2001].
Multidose animal inhalation studies with as-
bestos (probably a carefully selected and well-
characterized chrysotile, because most of the 
estimates of human risk have been established 
from epidemiological studies of chrysotile- 
exposed workers) are needed to provide an im-
proved basis for comparing the potential can-
cer and noncancer risks associated with other 
types of EMPs and various types of synthetic 
EPs. The asbestos fibers administered in these 
animal studies should be comparable in dimen-
sion to those fibers found in the occupational 
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environment. The results from these studies 
with asbestos (e.g., chrysotile) would provide 
a “gold standard” that could be used to validate 
the utility of long-term inhalation studies (in 
rats or other species) for predicting human risks 
of exposure to various types of EMPs.
3.4.3 Evaluate Toxicological 
Mechanisms to Develop  
Early Biomarkers of Human 
Health Effects
The following scheme using acellular and cel-
lular tests can be conducted to develop a mech-
anistic understanding of fiber toxicity and to 
support the development of in vivo biomark-
ers of effect in humans. These studies must use 
well-characterized EMP samples as described 
in the tiered testing strategy presented in Sec-
tion 3.4. The use of size-selected fractions of 
EMPs could provide information needed to 
understand the relationships between dimen-
sion and bioactivity. 
Acellular assays could include measurement of 
the generation of ROS employing electron spin 
resonance (ESR) or oxidant sensitive fluorescent 
dyes. Evaluation of the mobilization of metal ions 
from EMPs could indicate cytotoxic potential. 
The in vitro cellular tests could include the fol-
lowing: 
 • generation of reactive species measured 
by ESR or fluorescent dyes;
 • generation of inflammatory, fibrogenic, 
and proliferative mediators, such as TNF-
alpha, IL-1, and TGF;
 • DNA damage by comet assay;
 • effects on cell growth regulation by mea-
suring cell proliferation;
 • effects on mitosis and aneuploidy, deter-
mined by confocal fluorescent micros-
copy; and
 • signal transduction pathways, such as 
MAPK, and phosphoinositide-3 (PI3) ki-
nase pathways.
In vivo tests would measure markers of inflam-
mation (e.g., BAL neutrophils, inflammatory 
cytokines and chemokines), fibrosis (colla-
gen, hydroxyproline), and proliferation (BrdU 
assay, hyperplasia) that precede pathology. 
Knockout mice or pathway inhibitors in rats 
may be used to confirm mechanistic pathways 
identified in vitro and develop biomarkers for 
disease initiation and progression. Potential 
biomarkers identified in in vitro and in vivo 
studies would be evaluated in human popula-
tions with known exposure to EMPs, and the 
type and extent of the relationships between 
the marker and clinical signs of disease could 
be determined.
3.5 Develop Information and 
Knowledge on Occupational 
Exposures to Asbestos 
Fibers and Other EMPs and 
Related Health Outcomes 
Many studies have been published concerning 
occupational exposures to asbestos fibers and as-
sociated health effects. These studies have formed 
a knowledge base that has supported increased 
regulation of occupational asbestos exposures 
and substantial reductions in asbestos use and 
asbestos exposures in the United States over the 
past several decades. But, as this Roadmap makes 
clear, much less is known about other types of 
mineral fibers and EMPs in terms of occupation-
al exposures and potential health effects.
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Research is needed to produce information on 
 • current estimates and, where possible, fu-
ture projections of numbers of U.S. work-
ers exposed to asbestos fibers;
 • levels of current exposures and nature of 
the exposures (e.g., continuous, short-term, 
or intermittent); and
 • the nature of any concomitant dust expo-
sures.
Similar research is needed to produce analo-
gous information about occupational expo-
sures to other EMPs. Research is needed to 
assess and quantify potential human health 
risks associated with occupational exposures 
to other EMPs, as well as to better understand 
and quantify the epidemiology of asbestos-
related diseases by using more refined indices 
of exposure. Research is also needed to pro-
duce improved methods and clinical guidance 
for screening, diagnosis, secondary prevention, 
and treatment of diseases caused by asbestos fi-
bers and other hazardous EMPs.
3.5.1 Assess Available Information 
on Occupational Exposures to 
Asbestos Fibers and Other EMPs 
A fully informed strategy for prioritizing re-
search on EMPs should be based on preliminary 
systematic collection and evaluation of available 
information on (1)  industries/occupations/job 
tasks/processes with exposure to various types 
of asbestos fibers and other EMPs; (2) numbers 
of workers exposed; (3) characteristics and lev-
els of exposures; and (4) associated concomitant 
particulate exposures. Such information could 
enable estimations of 
 • the overall distribution and levels of oc-
cupational exposures and an estimate of 
the total number of workers exposed to 
EMPs currently, in the past, and project-
ed in the future; and
 • the specific distributions and levels of ex-
posures to each particular type of EMP, 
as well as numbers of workers exposed to 
each type of EMP currently, in the past, 
and projected in the future.
To complement readily available information 
disseminated by the USGS on annual domestic 
production and importation of raw asbestos, 
data on the annual amounts of asbestos im-
ported into the United States in the form of any 
asbestos-containing products should be aggre-
gated and made easily accessible.
Additional efforts should be made to collect, re-
view, and summarize available occupational ex-
posure information and to collect and analyze 
representative air samples relating to various 
types of EMPs. For example, systematic com-
pilation of exposure data collected by OSHA, 
MSHA, NIOSH, state agencies, and private 
industry could contribute to an improved un-
derstanding of current occupational exposures 
to EMPs, particularly if there are opportunities 
to (re)analyze collected samples with use of en-
hanced analytical methods to better character-
ize the exposures (see Section 3.6). To help limit 
potential impact of sampling bias that may be 
inherent in the available EMP exposure data, 
these initial efforts should be supplemented 
with efforts to systematically identify, sample, 
and characterize EMP exposures through-
out U.S. industry. These exposure assessments 
should include workplaces in which a fraction 
of the dust comprises EMPs (i.e., mixed-dust 
environments), and occupational environments 
in which EMPs may not meet the current regu-
latory criteria to be counted (i.e., “short” fibers). 
With appropriate planning and resources, such 
efforts could be designed and implemented as 
ongoing surveillance of occupational exposures 
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to EMPs, with periodic summary reporting of 
findings. Representative EMP exposure data 
could help identify worker populations or par-
ticular types of EMPs warranting further study 
(i.e., more in-depth exposure assessment; medi-
cal surveillance; epidemiologic studies of par-
ticular types of EMPs, processes, job tasks, oc-
cupations, or industries; and toxicity studies of 
particular EMPs). Occupational exposure data 
should be collected and stored in a compre-
hensive database. Information similar to that 
described by Marchant et al. [2002] should be 
incorporated into the database to support these 
efforts. This could be accomplished in parallel 
with efforts to develop an occupational exposure 
database for nanotechnology [Miller et al. 2007] 
or efforts to develop a national occupational ex-
posure database [Middendorf et al. 2007].
3.5.2 Collect and Analyze Available 
Information on Health 
Outcomes Associated with 
Exposures to Asbestos Fibers 
and Other EMPs
The body of knowledge concerning human 
health effects from exposure to EMPs consists 
primarily of findings from epidemiological 
studies of workers exposed to asbestos fibers. 
There is general agreement that workers ex-
posed to fibers from any asbestiform amphi-
bole mineral would be at risk of serious ad-
verse health outcomes of the type caused by 
exposure to fibers from the six commercially 
exploited asbestos minerals. NIOSH com-
mented on the most recently proposed MSHA 
rule on asbestos (subsequently promulgated as 
a final rule), stating that “NIOSH remains con-
cerned that the regulatory definition of asbes-
tos should include asbestiform mineral fibers 
such as winchite and richterite, which were 
of major importance as contaminants in the 
Libby, MT, vermiculite” [NIOSH 2005]. To en-
sure a clear science base that might support a 
formal recommendation for control of occupa-
tional exposures to all asbestiform amphibole 
fibers, it would be reasonable to thoroughly 
review, assess, and summarize the available 
information on asbestiform amphiboles such 
as winchite, richterite, and fluoro-edenite that 
have not been commercially exploited. 
It will also be important to quantitatively de-
termine the health risks posed by EMPs from 
nonasbestiform amphiboles and to compare 
them to the risks posed by fibers from asbesti-
form amphiboles. If nonasbestiform amphibole 
EMPs are, in fact, associated with some risk, a 
quantitative risk assessment would be needed 
to understand the risks relative to those asso-
ciated with exposures to asbestos fibers. If new 
epidemiological and other evidence is sufficient 
to support such a risk estimate, that could lead 
to the development of risk management policies 
for nonasbestiform amphibole EMPs distinct 
from risk management policies for asbestos fi-
bers. Risk management policies that differ for 
asbestiform and nonasbestiform amphiboles 
would motivate the development and routine 
use of new analytical methods that differentiate 
asbestiform from nonasbestiform particles.
In addition to collecting and analyzing infor-
mation on health outcomes associated with ex-
posures to asbestiform EMPs and EMPs from 
nonasbestiform amphiboles, similar information 
related to other EMPs (e.g., erionite, wollastonite, 
attapulgite, and fibrous talc) should be collected 
for systematic analysis. Additional relevant in-
formation may be gleaned from epidemiological 
studies conducted on some SVFs (e.g., glass and 
mineral wool fibers, ceramic fibers). 
Surveillance and epidemiological studies gener-
ally have been circumscribed by the long latency 
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periods that characterize manifestations of either 
pulmonary fibrosis (e.g., as detected by chest ra-
diography or pulmonary function tests) or can-
cer caused by asbestos exposures. Modern medi-
cal pulmonary imaging techniques or bioassays 
of circulating levels of cytokines or other bio-
chemical factors associated with disease process-
es might be adaptable to better define early stages 
of asbestosis, and might provide a new paradigm 
for early detection of the active disease process. 
For example, positron emission tomographic im-
aging with use of tracers indicative of active col-
lagen synthesis can detect fibrogenic response in 
a matter of weeks after quartz dust challenge in a 
rabbit animal model [Jones et al. 1997; Wallace et 
al. 2002].
3.5.3 Conduct Selective 
Epidemiological Studies of 
Workers Exposed to Asbestos 
Fibers and Other EMPs
Statistically powerful and well designed epi-
demiological studies are typically very expen-
sive and time consuming, but they have been 
invaluable for defining associations between 
human health outcomes and occupational ex-
posures. In fact, the strongest human evidence 
indicating that, at a sufficient dose and with 
a sufficient latency, certain EMPs of thoracic 
dimension and high durability pose risks for 
malignant and nonmalignant respiratory dis-
ease has come from epidemiological studies of 
workers exposed to asbestos fibers. 
Outcomes from proposed research efforts 
outlined above in Section 3.5.2 may identify 
additional opportunities for informative epi-
demiological studies following the example 
of NIOSH researchers who have recently un-
dertaken a reanalysis of data from a prior epi-
demiological study of asbestos textile workers, 
after having more thoroughly characterized 
exposures with use of sample filters archived 
from that study [Kuempel et al. 2006]. Out-
comes from the approaches outlined above in 
Section 3.3.2 might also potentially identify 
opportunities for aggregate meta-analyses of 
data from multiple prior epidemiological stud-
ies, allowing an assessment of risks across vari-
ous types of EMPs. Recently published research 
illustrates the potential of such meta-analyses 
to contribute to an understanding of determi-
nants of disease caused by exposure to asbestos 
and related EMPs [Berman et al. 1995; Berman 
and Crump 2008b; Berman 2010].
Given the ongoing and widespread occupa-
tional and environmental exposure to Libby 
vermiculite, a more complete understanding of 
the mortality experience of the Libby occupa-
tional cohort could shed light on risks associ-
ated with exposure to the Libby amphibole, 
such as exposures at the World Trade Center 
disaster, as well as the health effects among the 
Libby community. Analyses of the Libby work-
er cohort continue and future analyses are en-
visioned, with the following aims: 
 • complete exposure-response modeling and 
occupational risk assessment for mesothe-
lioma and asbestosis, and
 • description of nonrespiratory outcomes 
(e.g., mortality with rheumatoid arthri-
tis and mortality from extrapulmonary 
 cancers).
Other research relating to Libby amphibole 
also continues. EPA and ATSDR have been en-
gaged in a program of research involving sev-
eral recent projects, including evaluation of
 • the relationship between radiographic ab-
normalities and lung function in Libby 
community residents, finding that diffuse 
pleural thickening on radiography was a 
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significant predictor of both restrictive and 
obstructive patterns on spirometry. 
 • the natural history of radiographic dis-
ease progression, observing an exposure- 
response relationship between cumulative 
fiber exposure and small opacity profu-
sion level on chest radiographs of Libby 
workers.
 • the effect of exposure to asbestos- containing 
Libby vermiculite at 28 processing sites in 
the United States. Activities included con-
ducting medical screening of former work-
ers and household contacts at six sites; a 
summary report is available at www.atsdr.
cdc.gov/asbestos/sites/ national_map.
 • cases of mesothelioma, asbestosis, and 
lung cancer among former workers and 
others with nonoccupational exposure 
associated with a vermiculite processing 
facility in northeast Minneapolis. 
 • disease progression in workers exposed 
to asbestos-containing vermiculite ore at 
a fertilizer plant in Marysville, Ohio. 
 • autoimmune conditions not classically 
associated with asbestos exposure and 
health effects associated with low-level 
exposure and childhood exposure. 
In addition, ATSDR continues to update its 
Tremolite Asbestos Registry (TAR) of individ-
uals exposed to vermiculite-associated asbes-
tiform amphibole in Libby. Opportunities for 
additional informative epidemiological studies 
relating to Libby amphibole could be pursued 
in the future, particularly if an EM-based job-
exposure matrix for workers exposed to the 
Libby amphiboles is developed, or if amphi-
bole exposures during commercial building 
and household construction renovation tasks 
were well-characterized. 
Large unstudied populations with sufficiently 
high exposure to commercial asbestos fibers 
are unlikely to be identified in developed coun-
tries such as the United States, where asbestos 
use has been markedly curtailed and where oc-
cupational exposures have been strictly regu-
lated in recent decades. Nevertheless, some 
developing countries (where asbestos use con-
tinues on a large scale and where exposures 
may be less regulated) may offer opportunities 
for de novo epidemiological studies that could 
contribute to a more refined understanding 
of the association of human health outcomes 
with occupational exposures to asbestos fibers 
and other EMPs. 
Opportunities for epidemiological studies of ex-
posed workers might be sought in other coun-
tries where medical registry data and historical 
or current workplace sampling data are available 
(e.g., in China, where epidemiological studies 
of another occupational dust disease, silicosis, 
have been collaboratively conducted by Chinese 
and NIOSH researchers [Chen et al. 2005]). 
Opportunities may also exist in other coun-
tries for epidemiological studies of nonworker 
populations exposed to asbestos in ways not 
encountered in more developed countries. For 
example, regular whitewashing of the interiors 
of homes has, in more than one country, been 
shown to be fraught with hazard. In parts of 
Greece and Turkey and in New Caledonia, the 
local earthen material traditionally used for 
whitewashing homes was predominantly com-
posed of tremolite asbestos, resulting in high 
rates of nonmalignant pleural plaques [Con-
stantopoulos et al. 1987], lung cancer [Luce et 
al 2000; Menvielle et al. 2003], and malignant 
mesothelioma [Sakellariou et al. 1996; Senyiğit 
et al. 2000]. The whitewashing work, including 
crushing of the dry material before addition of 
water, was typically done by women with small 
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children in tow, placing both sexes at risk of 
intermittent heavy exposures very early in life 
[Sakellariou et al. 1996]. This, along with the 
longer-term and lower-level exposures associ-
ated with inhabiting homes whitewashed with 
this asbestos-containing material, represents 
an exposure pattern very different from the oc-
cupational exposures to asbestos studied in the 
Unites States and other industrialized countries. 
Results of epidemiological studies of workers 
exposed to EMPs, such as from nonasbesti-
form amphibole minerals or minerals in talc 
deposits, have provided limited evidence of 
an association between occupational exposure 
and lung cancer or mesothelioma. It will be 
important to establish a priori criteria to en-
able results of epidemiological studies or meta-
analyses to be used to indicate whether or not 
occupational exposure to EMPs from nonas-
bestiform amphibole minerals or minerals in 
talc deposits is associated with a risk level that 
warrants preventive intervention. Clearly lay-
ing out these criteria and assessing the feasi-
bility of conducting necessary studies should 
be done by a panel of knowledgeable experts. 
Laboratory research will undoubtedly shed 
much light on the issue of potential human 
health risks associated with specific physico-
chemical characteristics of EMPs. Still, where 
such studies are not only feasible but also likely 
informative, there is reason to consider further 
epidemiological studies of worker populations 
exposed to EMPs from nonasbestiform amphi-
boles. These may be conducted either de novo 
or through updating of prior studies for more 
complete follow-up of health outcomes and/or 
through reanalyzing archived exposure sam-
ples for development of more specific knowl-
edge concerning etiologic determinants and 
quantitative risk.
Other studies worthy of consideration include 
these:
 • Epidemiological studies of worker pop-
ulations incidentally exposed to EMPs 
from fibrous minerals, including asbesti-
form minerals (e.g., those associated with 
Libby vermiculite);
 • Epidemiological studies of populations ex-
posed to other less-well-studied EMPs (e.g., 
wollastonite, attapulgite, and erionite); and 
 • Meta-analyses of data from multiple epi-
demiological studies of various worker 
populations, each exposed to EMPs with 
somewhat different attributes (such as 
EMP type or dimensions), to better define 
specific determinants of EMP-associated 
adverse health outcomes for purposes of 
risk assessment. 
The following criteria should be considered in 
selecting and prioritizing possible populations 
for epidemiological study: (1) type of EMP ex-
posure (e.g., mineral source, chemical compo-
sition, crystalline structure, surface character-
istics, and durability); (2)  adequate exposure 
information (e.g., EMP concentrations and 
[bivariate] EMP dimensions); (3)  good work 
histories; (4) sufficient latency; (5) number of 
workers needed to provide adequate statisti-
cal power for the health outcome(s) of interest; 
and (6) availability of data on other potentially 
confounding risk factors. Priority should be 
placed on epidemiological studies with poten-
tial to contribute to the understanding of EMP 
characteristics that determine toxicity, includ-
ing type of mineral source (e.g., asbestiform 
mineral habit vs. other fibrous mineral habit 
vs. blocky mineral habit) and morphology and 
other aspects of the airborne EMPs (e.g., di-
mensions [length and width], chemical com-
position, crystalline structure, surface charac-
teristics, and durability).
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In addition to epidemiological studies that 
address etiology and that quantify exposure- 
related risk, epidemiological studies can be 
used to better understand the pathogenesis of 
lung diseases caused by asbestos fibers and oth-
er EMPs. For example, appropriately designed 
or reconstructed epidemiological studies could 
be used to assess the relationship between the 
physicochemical properties of EMPs, lung fi-
brosis, and lung cancer. 
3.5.4 Improve Clinical Tools and 
Practices for Screening, 
Diagnosis, Treatment, and 
Secondary Prevention of 
Diseases Caused by Asbestos 
Fibers and Other EMPs
Given the huge human and economic impact of 
asbestos-related disease and litigation, Congress 
has considered asbestos-related legislation on 
several occasions in recent years. To date, bills 
with provisions to require private industry to 
fund an asbestos victims’ trust fund have not 
succeeded in Congress. Most recently, the Ban 
Asbestos in America Act, which was passed by 
the U.S. Senate in 2007 but was not acted on 
in the House of Representatives, would have 
authorized and funded a network of asbestos-
related disease research and treatment centers 
to conduct studies, including clinical trials, on 
effective treatment, early detection, and preven-
tion [U.S. Senate 2007]. This bill also called for 
the establishment of a mechanism for coordi-
nating and providing data and specimens re-
lating to  asbestos-caused diseases from cancer 
registries and other centers, including a recently 
funded virtual biospecimen bank for mesothe-
lioma [Mesothelioma Virtual Bank 2007]. 
Various research objectives relevant to clinical 
aspects of asbestos-related diseases are worthy 
of pursuit by NIOSH and other federal agen-
cies, along with their partners, to improve 
screening, diagnosis, secondary prevention, and 
treatment. These include but are not limited to 
the following objectives: 
 • Continue to develop and validate techni-
cal standards for the assessment of digital 
chest radiographs with the ILO classifica-
tion system. The ILO system for classifying 
chest radiographs of the pneumoconioses 
is widely used as a standard throughout the 
world. Although initially intended for use 
in epidemiological studies, the ILO system 
is now also commonly used as a basis for 
describing severity of disease in clinical 
care and for awarding compensation to 
individuals affected by nonmalignant dis-
eases of the chest caused by asbestos and 
other airborne dusts. To ensure that digital 
chest radiographic methods used in future 
clinical and epidemiological studies can 
be compared with past studies based on 
conventional film radiography, there is a 
critical need to continue ongoing research 
to validate use of the ILO system for clas-
sification of digital chest images.
 • Develop and promote standardized as-
sessment of nonmalignant dust-induced 
diseases, including asbestos-related pleu-
ral and parenchymal disease, on comput-
ed tomography (CT) images of the chest. 
Over the past several decades, CT scan-
ning of the chest has been increasingly 
used for assessing chest disease, and high-
resolution CT scanning is often done in 
clinical settings. Although approaches for 
standardizing classifications of CT im-
ages for dust-related diseases have been 
proposed, none have yet been widely ad-
opted or authoritatively promoted. 
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 • Develop, validate, and promote standard-
ization of approaches for assessment of 
past asbestos exposures by measurement 
of asbestos bodies and uncoated fibers, 
particularly in samples collected noninva-
sively (e.g., sputum). Various approaches 
for quantifying fiber burden have been 
used for research and clinical purposes, but 
results are often difficult or impossible to 
compare across different studies because of 
lack of standardization and the differential 
rates of biopersistence and translocation of 
various types of asbestos fibers. 
 • Develop and validate biomarkers for as-
bestosis, lung cancer, and mesothelioma 
to enable more specific identification of 
those at risk or early detection of disease 
in those previously exposed to asbestos. 
For example, noninvasive bioassays for 
mesothelioma warrant further research 
before they can be considered ready for 
routine application in clinical practice. 
 • Develop and/or adapt emerging medi-
cal imaging techniques to better define 
stages of asbestosis, or to provide a new 
paradigm for early detection or grading 
of the active disease process. For example, 
positron emission tomographic (PET) 
imaging using tracers indicative of active 
collagen synthesis can detect pulmonary 
fibrogenic response in a matter of weeks 
after quartz dust challenge in a rabbit ani-
mal model [Jones et al. 1997; Wallace et al. 
2002]. This holds promise for noninvasive 
approaches for earlier clinical detection 
and more sensitive surveillance and epide-
miological studies, that to date have been 
circumscribed by the long latency periods 
that characterize pulmonary fibrosis asso-
ciated with asbestos exposure (e.g., as de-
tected by conventional chest radiography).
 • Develop new treatment options to reduce 
risk of malignant and nonmalignant disease 
among those exposed to asbestos and to ef-
fectively treat established  asbestos-induced 
disease. For example, many widely used 
anti-inflammatory drugs exert their effect 
by inhibiting cyclooxygenase-2 (COX-2), 
an enzyme that is induced in inflammatory 
and malignant (including premalignant) 
processes. Promising results of laboratory 
and case-control epidemiological studies 
have led to clinical trials of COX-2 inhibi-
tors as adjuvant therapy to enhance treat-
ments for various types of cancer. Research 
is warranted to determine whether these 
drugs can reduce the risk of asbestos-relat-
ed malignancies in exposed individuals. 
 • Authoritatively and regularly update and 
disseminate clear clinical guidance for 
practitioners, based on expert synthesis 
of the available literature.
3.6 Develop Improved 
Sampling and Analytical 
Methods for Asbestos 
Fibers and Other EMPs
There are important scientific gaps in under-
standing the health impacts of exposure to 
EMPs. Changes in how EMPs are defined for 
regulatory purposes will likely have to be ac-
companied by improvements to currently used 
analytical methods or development and appli-
cation of new analytical methods. An ability to 
differentiate between fibers from the asbestos 
minerals and EMPs from their nonasbestiform 
analogs in air samples is an important need, es-
pecially for mineral-specific recommendations 
(e.g., occupational exposure limits). However, 
overcoming this obstacle may be difficult be-
cause of (1) the lack of standard criteria for the 
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mineralogical identification of airborne EMPs 
and (2) technical difficulties in generating test 
aerosols of size-specific EMPs representative of 
worker exposures so that sampling and analyt-
ical methods can be tested and validated.
Improvements in exposure assessment meth-
ods are needed to increase the accuracy of the 
methods used to identify, differentiate, and count 
EMPs captured in air-sampling filter media. Un-
til new analytical methods are developed and 
validated, it will be necessary to investigate the 
various proposals that have been made to modify 
current analytical methods, such as those dis-
cussed in Section 3.6.2, and additional modifica-
tions to the current analytical methods. 
Manual microscopy methods are labor- intensive 
and error-prone. Automated analyses would 
permit examination of larger sample fractions 
and improve the accuracy of particle classifica-
tion. Developing a practical method that accu-
rately counts and sizes all EMPs could improve 
risk assessments and exposure assessments done 
in support of risk management. Automated 
methods could reduce operator bias and inter-
laboratory variability, providing more consis-
tent results for risk assessments.
Some barriers to improving current analytical 
methods have been identified. Increasing the 
optical resolution of PCM analysis may help 
to increase counts of thinner asbestos fibers. 
However, any increases in optical microscopy 
resolution will not be sufficient to detect all as-
bestos fibers. In addition, any improvements in 
counting EMPs (e.g., an increase in the number 
of EMPs observed and counted) will need to 
be evaluated by comparing them with counts 
made by the current PCM method. The use of 
electron microscopy (EM) would improve the 
capability to detect thin fibers and also provide 
a means to identify many types of minerals.
However, the routine use of EM would
 • require the development of standardized 
analytical criteria for the identification of 
various EMPs; 
 • require specialized experience in micros-
copy and mineral identification; 
 • increase analytical costs; and 
 • potentially increase the lag time between 
collecting the sample and obtaining results. 
In some workplace situations, such as in con-
struction, increases in the time needed to ana-
lyze samples and identify EMPs could poten-
tially delay the implementation of appropriate 
control measures to reduce exposures.
Several potential sampling and analytical im-
provements are currently under study. Some 
of the studies are aimed at improving the ac-
curacy of current techniques used for moni-
toring exposures to asbestos. One such study 
is evaluating the use of thoracic samplers for 
the collection of airborne EPs, and another 
concerns the use of gridded coverslips for 
PCM analyses. The proposed use of gridded 
coverslips for sample evaluation can aid in the 
counting of asbestos and other EMPs and can 
provide a means for “recounting” fibers at spe-
cific locations on a filter sample. Another study 
is evaluating the proposed ASTM method to 
determine whether interoperator variability of 
differential counting (to distinguish fibers of 
asbestos minerals from other EMPs) is within 
an acceptable range. 
Research to develop new methods is warranted. 
One such research area could be development 
of methods that would permit assessment of 
the potential biopersistence (e.g., durability) of 
EMPs collected on air sampling filters prior to 
their evaluation by PCM or other microscopic 
methods. If durability is deemed biologically 
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relevant, then an exposure assessment limited 
to the durable EMPs collected on a sample 
would help to reduce possible analytical in-
terferences caused by other, nondurable EMPs 
and may eliminate the need for mineral identi-
fication. Another such area would be improve-
ment in EM particle identification techniques, 
such as field emission SEM and the capabil-
ity to determine the elemental composition 
of EMPs with an SEM equipped with EDS. A 
third research area, largely conceptual at this 
time, would be development of techniques to 
more accurately reflect internal dose by quan-
tifying or estimating the number of particles 
likely to be produced by splitting of asbestos-
fiber bundles deposited in the lung.
Modifications of current analytical methods 
and development of new analytical methods 
will require an assessment of their implica-
tions for worker health protection (e.g., how 
do the results using improved or new methods 
relate to human risk estimates based on counts 
of EMPs made by PCM?). To ensure that rel-
evant toxicological parameters (e.g., dose, di-
mension, durability, and physicochemical pa-
rameters) are incorporated in the analysis and 
measurement, any changes in analytical meth-
ods should be made in concert with changes in 
how asbestos fibers or other EMPs are defined. 
3.6.1 Reduce Interoperator and 
Interlaboratory Variability of 
the Current Analytical Methods 
Used for Asbestos Fibers 
To ensure the validity of EMP counts on air 
samples, it is important to ensure consistency 
in EMP counts between and among analysts. 
Microscopy counts of EMPs on air sample fil-
ters are based on only a small percentage of 
the surface area of the filters, and the counting 
procedures require the analyst to make deci-
sions on whether each observed particle meets 
specified criteria for counting. Interlaboratory 
sample exchange programs have been shown to 
be important for ensuring agreement in asbes-
tos fiber counts between laboratories [Crawford 
et al. 1982]. Unfortunately, microscopists from 
different laboratories are unlikely to view exact-
ly the same fields, and this alone accounts for 
some of the observed variation in fiber counts 
between microscopists. A mechanism to allow 
recounts of fibers from the exact same field ar-
eas would remove this variable and allow a bet-
ter assessment of the variation attributable to 
microscopists in analyzing samples. 
A technique is under development for improv-
ing the accuracy of PCM-based fiber-counting 
by allowing the same sample fields to be ex-
amined by multiple microscopists or by the 
same microscopist on different occasions [Pang 
et al. 1984, 1989; Pang 2000]. The method in-
volves the deposition of an almost transparent 
TEM grid onto the sample. Included with the 
grid are coordinates that allow relocation of 
each grid opening. Photomicrographs of typical 
grid openings superimposed on chrysotile and 
amosite samples have been published [Pang et 
al. 1989]. Slides prepared in this manner have 
been used in a Canadian proficiency test pro-
gram for many years. The main errors affecting 
the counts of various types of fibers (e.g., chrys-
otile, amosite, and SVF) have been evaluated 
by examining large numbers of slides by large 
numbers of participants in this program. A re-
cently developed scoring system for evaluating 
the performance of microscopists is based on 
errors compared with a reference value defined 
for each slide by the laboratory in which they 
were produced [Pang 2002]. A statistical analy-
sis of the intragroup precision in this study was 
able to identify those analysts who were outliers 
[Harper and Bartolucci 2003]. In a pilot study, 
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the pooled relative standard deviations, without 
the outliers, met the requirements for an un-
biased air-sampling method. Further study is 
needed to validate these findings and to identify 
other techniques that can reduce interlabora-
tory and interoperator variability in counting 
asbestos fibers and other EMPs by PCM. 
Reference slides made from proficiency test 
filters from the American Industrial Hygiene 
Association (AIHA) have been created and cir-
culated to laboratories and individual micros-
copists recruited from AIHA laboratory qual-
ity programs [Pang and Harper 2008; Harper 
et al. 2009]. The results illustrate an improved 
discrimination of fiber counts when the pro-
ficiency test materials have a more controlled 
composition. These reference slides have also 
been evaluated in Japan, the United Kingdom, 
and elsewhere in Europe. Further research will 
be useful in determining the value of these 
slides for training purposes.
3.6.2 Develop Analytical Methods 
with Improved Sensitivity 
to Visualize Thinner EMPs 
to Ensure a More Complete 
Evaluation of Airborne 
Exposures
Most PCMs can visualize EMPs with widths 
>0.25 µm, which is the approximate lower 
resolution limit when the microscope is oper-
ated at a magnification of 400× and calibrated 
to NIOSH 7400 specifications [NIOSH 1994a]. 
However, higher-end optical microscopes can 
resolve thinner widths, and, for crocidolite, 
they may resolve widths as thin as 0.1 µm.
Improvement in the optical resolution may be 
possible with use of an oil-immersion 100× ob-
jective with a numerical aperture of 1.49. Also, 
the use of 15× eyepiece oculars would help im-
prove the visibility of small particles and thin 
EMPs in samples. However, using oil immer-
sion has several drawbacks. When exposed to 
air for more than a few hours, the oil on the 
slide dries and its optical properties change. 
Also, the oil cannot be wiped off because the 
cover slip is likely to be moved and thus ruin 
the sample. For these reasons, using oil immer-
sion does not permit recounts or further analy-
sis for quality control purposes and is not an 
attractive alternative.
Other methods may also allow for increased 
resolution with optical microscopes. Anecdotal 
information on the use of PCM with dark- 
medium (DM) objectives, presented at a meet-
ing in November 2007, suggests that analysts 
using DM objectives could resolve more blocks 
of the Health and Safety Executive/National 
Physical Laboratory (HSL/ULO) test slide‡‡ 
than are allowable for the method and pro-
duced higher counts of chrysotile fibers than 
expected [Harper et al. 2009]. The implication 
is that using DM objectives can resolve thinner 
chrysotile fibers than the accepted method. This 
methodology should be explored further to de-
termine its resolution and potential application 
in asbestos exposure assessment.
As stated previously, because risk estimates for 
workers exposed to asbestos fibers have been 
‡‡ The HSE/NPL Mark II or HSL/ULO Mark III Phase 
Shift Test Slide checks or standardizes the visual de-
tection limits of the PCM. The HSL/ULO Test Slide 
consists of a conventional glass microscope slide with 
seven sets of parallel line pairs of decreasing widths. 
The microscope must be able to resolve the blocks of 
lines in accordance with the certificate accompanying 
the slide. Only slides where at least one block of lines is 
intended to be invisible should be used. Microscopes 
that resolve fewer or greater numbers of blocks than 
stated on the certificate cannot be used in NIOSH 
Method 7400.
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based on counts made by the current PCM 
method, counts made with improved optical 
microscope resolution capabilities would not 
be directly comparable to current occupational 
exposure limits for airborne asbestos fibers. 
Additionally, the findings that asbestos fibers 
thinner than 0.1 µm are most associated with 
mesothelioma and that optical microscopes 
cannot resolve fibers <0.1 µm in width suggest 
that alternatives to PCM should be researched.
TEM can resolve asbestos fibers with widths 
less than ~0.01 µm, which effectively detects the 
presence of all asbestos fibers and other EMPs 
collected on airborne samples. Both TEM and 
SEM provide greater resolution for detecting 
and sizing EMPs. Both methods also provide 
capability for mineral identification (TEM us-
ing selected area X-ray diffraction [SAED], and 
TEM and SEM using EDS or WDS for elemen-
tal analysis). The cost of using TEM and/or SEM 
for routine analysis of all samples would be con-
siderably higher than PCM analysis and the 
turnaround time for analysis would be substan-
tially longer. In addition, any routine use of EM 
methods for counting and sizing asbestos fibers 
or other EMPs would require formal evaluation 
of interoperator and interlaboratory variability. 
SEM is now a generally available method that 
can routinely resolve features down to ~0.05 
µm, an order of magnitude better than optical 
microscopes. Field emission SEM is now com-
mercially available and further increases this 
resolution. In vitro or short-term or long-term 
animal model studies can now utilize these EM 
imaging technologies to characterize EMPs 
for studies of etiology and disease mechanism. 
EM analyses of EMP size and composition can 
be supplemented with analysis of surface el-
emental composition by scanning Auger spec-
troscopy or X-ray photoelectron spectroscopy. 
Investigation is needed to determine whether 
SEM-backscatter electron diffraction analysis 
can be adapted to EMP crystallographic analy-
ses equivalent to TEM-SAED capability. The 
ease of sample preparation and data collection 
for SEM analysis in comparison with TEM anal-
ysis, along with an SEM advantage in visualizing 
EMP and EMP morphology (e.g., surface char-
acteristics), provides reason to reevaluate SEM 
methods for EMP characterization and mineral 
identification for field and laboratory sample 
analysis.
3.6.3 Develop a Practical Analytical 
Method for Air Samples to 
Differentiate Asbestiform 
Fibers from the Asbestos 
Minerals and EMPs from Their 
Nonasbestiform Analogs 
A recently published ASTM method for dis-
tinguishing other EMPs from probable as-
bestos fibers uses PCM-determined morpho-
logic features to differentiate asbestos fibers 
from other EMPs [ASTM 2006]. The proposed 
method has several points of deviation from 
existing PCM methods. It uses a new grati-
cule that has not been tested for conformance 
with the traditional graticule used in standard 
PCM analysis of asbestos air samples. It speci-
fies additional counting rules to classify par-
ticles, and there are few data to show these 
rules provide consistently achievable or mean-
ingful results. Also, only limited data are avail-
able to show interoperator,  intraoperator, or 
 interlaboratory variation. These issues must be 
addressed before the method can be consid-
ered acceptable. NIOSH researchers are cur-
rently addressing these issues. Specific aims of 
the project are
 • to determine the effect of using the tradi-
tional Walton-Beckett graticule and the 
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new RIB graticule on the precision of mea-
suring fiber dimensions; and
 • to determine the interlaboratory variation 
of the proposed method for determining 
particle identities by observing morpho-
logical features of individual particles.
Anticipated outcomes of these ongoing re-
search projects include a measure of method 
precision, which will help to determine wheth-
er the method meets the requirements of regu-
latory and other agencies. 
Although EM may currently not be suitable for 
routine analysis of samples of airborne EMPs, 
EM techniques used to characterize and iden-
tify minerals (e.g., differentiating between as-
bestos fibers and other EMPs) should be fur-
ther investigated and evaluated to determine 
whether results are reproducible by multiple 
microscopists and laboratories.
3.6.4 Develop Analytical Methods to 
Assess Durability of EMPs
Although research has been conducted to deter-
mine the ability of biological assays to evaluate 
the biopersistence of EMPs in the lung, there is 
a need to consider how the assessment of EMP 
durability might be incorporated into the evalu-
ation of air samples containing a heterogeneous 
mix of EMPs. Research with several types of 
glass fibers and some other SVFs indicate that 
they dissolve in media at different rates de-
pending on the pH and that they dissolve more 
rapidly than chrysotile and amphibole asbes-
tos fibers [Leineweber 1984]. Chrysotile fibers 
have been shown to dissolve at a rate that varies 
not only with the strength of the acid, but also 
with the type of acid. Amphibole asbestos fibers 
have been shown to be more resistant to disso-
lution than chrysotile fibers. Research suggests 
that the rate of dissolution in the lungs for most 
EMPs appears to be strongly dependent on their 
chemical composition, surface characteristics, 
and dimension. 
The selective dissolution of EMPs might be a 
useful approach for eliminating specific types 
of EMPs or other particles collected on air sam-
ples prior to analysis (e.g., microscopic count-
ing). The removal of interfering EMPs prior to 
counting could potentially eliminate the need 
for additional analysis to identify EMPs on the 
sample. Selective dissolution of samples to re-
move interferences is well established in NIOSH 
practice for other analytes. NIOSH Method 5040 
for diesel exhaust has an option for using acidi-
fication of the filter sample with hydrochloric 
acid to remove carbonate interference [NIOSH 
2003a]. Silicate interferences for quartz by in-
frared spectroscopic detection are removed by 
phosphoric acid digestion in NIOSH Method 
7603 [NIOSH 2003b]. Although selective disso-
lution might be accomplished for some EMPs, 
research will be necessary to develop and char-
acterize a procedure that would correlate resid-
ual EMP counts to the results of toxicity studies.
3.6.5 Develop and Validate Size-
selective Sampling Methods 
for EMPs
For measuring airborne concentrations of non-
elongate particles in the workplace, conventions 
have been developed for sampling the aerosol 
fractions that penetrate to certain regions of the 
respiratory tract upon inhalation: the inhalable 
fraction of particulate that enters into the nose 
or the mouth; the thoracic fraction that pene-
trates into the thorax (i.e., beyond the larynx); 
and the respirable fraction that reaches the al-
veoli of the lung. The thoracic convention is rec-
ognized by NIOSH and other organizations that 
recommend exposure limits, and NIOSH has 
94 NIOSH CIB 62 • Asbestos
established precedence in applying it in RELs 
(e.g., the REL for metalworking fluid aerosols 
[NIOSH 1998]).
Asbestos fibers currently are collected for mea-
surement by standard sampling and analytical 
methods (e.g., NIOSH Method 7400 [NIOSH 
1994a], in OSHA ID–160 [OSHA 1998], in 
Methods for the Determination of Hazardous 
Substances (MDHS) 39/4 [HSE 1995], and in 
ISO 8672 [ISO 1993]). In these methods, air 
samples are taken by means of a membrane fil-
ter housed in a cassette with a cowled sampling 
head. Early studies [Walton 1954] showed that 
the vertical cowl excludes some very coarse 
particles because of elutriation, but its selection 
characteristics should have little effect on the 
collection efficiency for asbestos fibers. Howev-
er, when Chen and Baron [1996] evaluated the 
sampling cassette with a conductive cowl used 
in sampling for asbestos fibers, they found in-
let deposition was higher in field measurements 
than predicted by models.
Unlike the WHO [1997], NIOSH has not rec-
ommended an upper limit for width of asbestos 
fibers to be counted because airborne asbestos 
fibers typically have widths <3 µm. The absence 
of an upper width criterion for the NIOSH 
Method 7400 A rules has generated criticism 
that some EMPs counted by this method may 
not be of thoracic size. Others have recom-
mended NIOSH Method 7400 B rules for the 
sampling and analysis of various types of fibers 
and EPs, including asbestos fibers [Baron 1996], 
because the B rules specify an upper limit of 
3 µm for EP width. However, Method 7400 B 
rules have not been field- tested for occupational 
exposures to asbestos and many types of EPs.
Two separate but complementary investigations 
have examined the performance of thoracic sam-
plers for EMPs [Jones et al. 2005; Maynard 2002]. 
Thoracic samplers allow the collection of air-
borne particles that meet the aerodynamic defi-
nition of thoracic-size EMPs (i.e., with physical 
widths equal to or less than 3 µm for the typical 
length distributions of fibers of silicate compo-
sition), collecting only those EMPs considered 
most pathogenic. The results of studies have in-
dicated that penetration of some thoracic sam-
plers is independent of EMP length, at least up to 
60 µm, indicating that the samplers’ penetration 
characteristics for an EP aerosol should be no dif-
ferent than that of an isometric aerosol. In a study 
be Jones et al. [2005], the relative ability of the 
thoracic samplers to produce adequately uniform 
distributions of EPs on the surface of the mem-
brane filter was also tested. On the basis of results 
of these studies, two samplers appeared to meet 
the criteria of minimal selection bias with respect 
to EP length and uniform distribution on the col-
lection filters. However, neither of these samplers 
has been tested under conditions of field use. 
NIOSH is currently evaluating these two thoracic 
samplers and the traditional cowled sampler in 
three different mining environments. The results 
from these studies have been published [Lee et al. 
2008; Lee et al. 2010], and each of the samplers 
gave fiber concentrations in proportion to their 
fiber loading rates, which is consistent with pre-
vious reports [Cherrie et al. 1986]. Thus, alterna-
tive samplers cannot be recommended until the 
impact of this effect on the established risk analy-
sis has been evaluated.
3.7 From Research to 
Improved Public Health 
Policies for Asbestos Fibers 
and Other EMPs 
Section 3 of this Roadmap proposes several 
strategic goals and associated objectives for a 
 multidisciplinary research program on asbestos 
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fibers and other EMPs. In summary, accom-
plishing these goals is intended to (1)  further 
elucidate the physicochemical properties that 
contribute to their pathogenicity; (2)  improve 
existing analytical tools and develop new ana-
lytical tools for identifying and measuring ex-
posures to EMPs with use of metrics that reflect 
the important determinants of toxicity (e.g., 
dimension and composition); (3) better define 
the nature and extent of occupational expo-
sures to EMPs and their relationships to EMP-
related health outcomes among exposed worker 
populations; and (4)  improve clinical tools for 
screening, diagnosis, secondary prevention, and 
treatment of EMP-related diseases. 
Results of much of the research to date (e.g., 
animal and human studies with asbestos and 
other EMPs) are readily available and should 
be considered in developing the research pro-
gram, including the specification of minerals 
to be studied. Much of this evidence supports 
the important role of particle dimension as a 
determinant of lung deposition and retention 
and the concomitant role of particle composi-
tion and crystalline structure as a determinant 
of durability and biopersistence. Despite this 
body of research, several fundamental issues 
are not clearly understood, and a broad sys-
tematic approach to further toxicological and 
epidemiological research would help to reduce 
remaining uncertainties. Although long, thin 
asbestos fibers clearly cause respiratory dis-
ease, the role of unregulated short (i.e., <5 μm) 
asbestos fibers is not entirely clear. It also re-
mains unclear to what extent each of the vari-
ous physicochemical parameters of asbestos 
fibers is responsible for respiratory disease out-
comes (e.g., asbestosis, lung cancer, and meso-
thelioma) observed in asbestos-exposed indi-
viduals. Limited evidence from studies with 
other EMPs confirms the importance of par-
ticle dimension and biopersistence in causing 
a biological response. However, uncertainty 
remains as to whether the respiratory disease 
outcomes for workers exposed to asbestos fi-
bers can be anticipated for workers exposed to 
other EMPs of thoracic size and with elemental 
compositions similar to asbestos. 
Another important effort that can inform devel-
opment of the research program will involve a 
systematic collection and review of available in-
formation on (1) industries and occupations with 
exposure to EMPs; (2) airborne exposure in these 
industries and occupations; and (3) numbers of 
workers potentially exposed in these industries 
and occupations. Additional relevant minerals 
and mineral habits identified should also be con-
sidered for study. The minerals identified through 
these efforts should be carefully and comprehen-
sively characterized with respect to both struc-
ture and elemental composition. In the charac-
terization of minerals, consideration should also 
be given to (1)  purity, (2)  particle morphology 
(range of dimensions and sizes), (3) surface area, 
(4) surface chemistry, and (5) surface reactivity. 
Care must be taken to ensure that a sufficient 
amount of the studied material is available, not 
only for current studies but also as reference ma-
terial for possible future studies. The information 
developed from all of these efforts should be en-
tered into a database, which can serve as a tool 
for selection of minerals for testing and valida-
tion of toxicological tests, as well as to assist in 
identification of worker populations for possible 
epidemiological studies. 
An objective of the proposed research is to 
achieve a level of mechanistic understanding 
that can provide a basis for developing biologi-
cally based models for extrapolating results of 
animal inhalation and other types of in vivo 
studies to predict risks to worker health asso-
ciated with exposure conditions typically en-
countered in workplaces. Little is known about 
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the mechanisms by which asbestos fibers and 
some other EMPs cause lung cancer, mesothe-
lioma, and nonmalignant respiratory diseases. 
As these mechanisms become understood, 
biologically based models can be developed to 
extrapolate from exposure-dose-response rela-
tionships observed in animals to estimates of 
disease risk in exposed humans. In addition, 
such studies would provide (1) an opportunity 
to measure molecular and cellular outcomes 
that can be used to determine why one animal 
species responds differently from another and 
(2) information on EMP characteristics associ-
ated with eliciting or potentiating various bio-
logical effects. The outcomes of these studies can 
then be evaluated in subsequent experiments to 
provide (1) risk assessors with a useful under-
standing of the various disease mechanisms by 
which animals respond to EMP exposures; and 
(2) regulatory agencies and industrial hygiene 
and occupational health professionals with in-
formation needed to implement appropriate 
exposure limits and risk management programs 
for monitoring worker exposure and health. 
It is anticipated that it may be difficult to find 
populations of workers that are exposed to EMPs 
with characteristics (e.g., dimension, composi-
tion) of interest that are sufficiently large to pro-
vide adequate statistical power, and where expo-
sures are not confounded or where confounding 
can be effectively controlled in the analysis. 
NIOSH retains exposure information and, in 
some cases, personal air sample filters collected 
and archived from past epidemiological studies 
of workers exposed to asbestos. Such existing 
data might be used to update and extend find-
ings from these studies. Where appropriately bal-
anced epidemiological studies can be identified, 
it may be possible to conduct meta-analyses to 
investigate important EMP characteristics. The 
analysis of archived samples may help to elucidate 
how more detailed characteristics of exposure 
(e.g., particle dimension) relate to disease out-
comes. New epidemiological (retrospective and 
prospective) studies should not be undertaken 
unless feasibility studies (e.g., preliminary assess-
ments of study population size, exposure laten-
cies, records of exposure, and confounders) have 
been appropriately considered. 
Because the opportunities for informative epi-
demiological studies are likely to be limited, 
it will be necessary to complement them with 
toxicological testing, and an integrated ap-
proach to toxicological research will be needed 
to understand how various types of EMPs in-
duce disease. Where epidemiological studies of 
new cohorts are possible, or where epidemio-
logical studies of previously studied cohorts 
can be updated, attempts should be made to 
link their results with those of toxicological 
studies to assess the ability of various types 
of toxicological testing to predict health out-
comes in humans. Toxicological testing should 
be done with attention to collecting more spe-
cific information, including: (1) physical char-
acteristics (e.g., dimension); (2) chemical com-
position; (3) in vitro acellular data (dissolution, 
durability); and (4) in vitro/in vivo cellular data 
(e.g., cytotoxicity, phagocytosis, chromosomal 
damage, mediator release). 
To help elucidate which physicochemical prop-
erties are important for inducing a biological ef-
fect, it may be necessary to generate exposures 
to EMPs of specific dimensions and composi-
tion. Several approaches are being pursued by 
NIOSH to overcome technological difficulties 
in generating sufficient quantities of well-char-
acterized and dimensionally restricted EMPs. 
Efforts to generate mineral samples of appropri-
ate particle-size dimensions by grinding tech-
niques have met with some success but have 
not consistently generated EMPs in restricted 
size ranges of interest or in sufficient quantity 
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to enable toxicity testing. Another approach has 
used a fiber size classifier [Deye et al. 1999], but 
this has not provided large enough quantities of 
EMPs for long-term inhalational exposure stud-
ies in animals. NIOSH researchers are currently 
evaluating the possibility of developing a fiber 
size classifier with increased output to generate 
much larger quantities of particles in restricted 
size ranges for toxicological testing.
An outcome of the proposed research programs 
should be an understanding of the relationships 
between and among the results of human obser-
vational studies and in vitro, short-term in vivo, 
and long-term in vivo experimental studies. 
Any research undertaken should be designed 
to ensure that results can be interpreted and 
applied within the context of other studies. For 
example, EMPs used in long-term animal inha-
lation studies should also be tested in in vitro/in 
vivo assay systems so that findings can be com-
pared. The results of such experiments can help 
to develop and standardize in vitro/in vivo assay 
systems for use in predicting the potential toxic-
ity of various types of EMPs. 
Government agencies, other organizations, 
and individual researchers have already recom-
mended similar research strategies for evaluat-
ing the toxicity of mineral and synthetic fibers 
[Greim 2004; ILSI 2005; Mossman et al. 2007; 
Schins 2002; Vu et al. 1996]. These published 
strategies should be used as a foundation for 
developing a research program. 
Some research and improvements in sampling 
and analytical methods used to routinely assess 
exposures to EMPs can be done in the short 
term, and because the results of the toxicological 
studies provide a clearer understanding of EMP 
characteristics that determine toxicity, it will be 
necessary to ensure that the measurement tech-
niques used in evaluating workplace exposures 
incorporate the exposure metrics used in deter-
mining the dose-response effect found in animal 
studies. The development of such exposure mea-
surement techniques should (1) reduce the sub-
jectivity inherent in current methods of particle 
identification and counting, (2) closely quantify 
EMPs on the basis of characteristics that are im-
portant to toxicity, and (3) reduce cost and short-
en turnaround times in comparison with current 
EM methods. 
Toxicological, exposure assessment, and epide-
miological research should be conducted with 
the overarching goal of developing informa-
tion necessary for risk assessments. Although 
a framework for mineralogical research is not 
provided in this Roadmap, research provid-
ing a better understanding of mineralogical 
physicochemical properties will help inform the 
risk assessment process. Improved risk assess-
ments and analytical methodology are needed 
to inform the development of new and revised 
occupational exposure limits for control of ex-
posures associated with the production of EMP-
caused disease. 
For those individuals who have an asbestos-
related disease or are at high risk of developing 
an asbestos-related disease, research is needed 
to improve methods and clinical guidance for 
screening, diagnosis, secondary prevention, and 
treatment of EMP-caused diseases. The devel-
opment and validation of biomarkers of disease 
and improved lung-imaging technologies can 
lead to earlier diagnosis of asbestos-related dis-
ease. It will also be important to advance knowl-
edge on how to effectively treat EMP-caused 
diseases, especially malignant mesothelioma, 
which is fatal in most cases. Accomplishing the 
goals of early diagnosis and development of 
treatment options can improve the quality and 
quantity of life for those who develop asbestos-
related disease.

99NIOSH CIB 62 • Asbestos
4 The Path Forward
Developing an interdisciplinary research pro-
gram and prioritizing research projects to 
implement the research agenda envisioned in 
this Roadmap will require a substantial invest-
ment of time, scientific talent, and resources 
by NIOSH and its partners. However, achiev-
ing the proposed goals will be well worth the 
investment because it will improve the quality 
of life of U.S. workers by preventing workplace 
exposure to potentially hazardous EMPs, and it 
will reduce future healthcare costs. As with any 
strategic approach, unintended and unforeseen 
results and consequences will require program 
adjustments as available resources change, in-
formation is produced, and time goes on.
4.1 Organization of the 
Research Program
To ensure that the scientific knowledge created 
from implementation of this Roadmap is ap-
plied as broadly as possible, NIOSH plans to 
partner with other federal agencies, such as the 
Agency for Toxic Substances and Disease Reg-
istry (ATSDR), the Consumer Product Safety 
Commission (CPSC), the Environmental Pro-
tection Agency (EPA), the Mine Safety and 
Health Administration (MSHA), the National 
Institute of Standards and Technology (NIST), 
the National Institute of Environmental Health 
Sciences (NIEHS), the National Toxicology 
Program (NTP), the Occupational Safety and 
Health Administration (OSHA), and the Unit-
ed States Geological Survey (USGS), as well as 
with labor, industry, academia, practitioners, 
and other interested parties including interna-
tional groups. Partnerships and collaborations 
will be used to help focus the scope of the re-
search to be undertaken, enhance extramural 
research activities, and assist in the develop-
ment and dissemination of educational materi-
als describing the outcomes of the research and 
their implications for occupational and public 
health policies and practices.
Some of the next steps in development will in-
volve organizing study groups with representa-
tives from federal agencies, industry, academia, 
and workers’ organizations to identify  specific 
priorities for the programs developed within 
the overarching research framework. Study 
groups should be assembled from among the 
partners to identify specific research elements 
needed to address the information gaps and 
data needs outlined in this Roadmap. Although 
it may be appropriate to organize separate 
study groups around the scientific disciplines 
needed to conduct the research—such as epi-
demiology, toxicology, exposure assessment, 
mineralogy, and particle characterization and 
analysis—and to conduct the risk assessments, 
each of the study groups will need to include 
members from other disciplines to ensure the 
multidisciplinary nature of the research is con-
sidered and addressed. Also important will be 
coordination between and among study groups 
to ensure the efforts in the various research 
areas are complementary and move toward 
common goals and the eventual development 
of sufficient information for risk assessment. 
These study groups should be maintained over 
the lifetime of the research program to oversee 
and help guide the research. An independent 
group could provide oversight of the overall 
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research effort, periodically reviewing the vari-
ous discipline-specific research programs to 
help ensure that the most appropriate research 
is accomplished in a timely and coordinated 
manner and to help maintain the scientific 
quality of the research.
4.2 Research Priorities
The key issues discussed in Section 2.10 include 
several research needs: (1) for the asbestos min-
erals, development of a clearer understanding of 
the important dimensional and physicochemi-
cal determinants of pathogenicity; (2) for other 
EMPs, such as those from nonasbestiform hab-
its of the asbestos minerals and erionite, devel-
opment of a deeper understanding of the de-
terminants of toxicity; and (3) development of 
analytical methods that can differentiate EMPs 
and quantify airborne exposures to EMPs. To 
begin addressing these issues, infrastructure 
projects should be developed and initiated with 
input from the study groups.
One such infrastructure project is the develop-
ment of a standardized set of terms that can be 
used to clearly and precisely describe minerals 
and other scientific concepts. This is needed to 
help with the planning of research projects and 
to effectively communicate research results. 
This effort should involve representatives from 
each of the relevant scientific disciplines.
Another infrastructure project that should be 
considered at the onset of prioritizing research 
is the development of criteria and logistics for 
establishing a mineral reference repository. Ini-
tially, representative samples from the known 
asbestos deposits should be procured and care-
fully and comprehensively characterized. If 
samples of these repository minerals are fur-
ther processed in the course of conducting re-
search, the processed materials will need to be 
fully characterized as well. Concomitant with 
this characterization effort should be the devel-
opment of a mineralogical research effort ad-
dressing issues pertaining to the identification 
of minerals that might be found on airborne 
samples collected at various workplace environ-
ments and to develop further and deeper under-
standing of mineralogical properties that may 
contribute to the toxicity of particles. 
One of the earliest research efforts will be pre-
liminary systematic collection and evaluation 
of available information on (1)  industries/oc-
cupations/job tasks/processes with exposure to 
various types of asbestos fibers and other EMPs, 
(2) numbers of workers exposed, (3) character-
istics and levels of exposures, and (4) associated 
particulate exposures. The knowledge generated 
from these efforts will be needed to identify the 
EMPs that workers are exposed to and worker 
populations that have the potential to be includ-
ed in epidemiological studies. In addition to as-
certaining EMP exposures and EMP-exposed 
populations in the United States, networking 
and other tools should be used to identify po-
tential international populations for epidemio-
logical studies. Representative samples of the 
EMPs identified through these efforts should 
be procured, characterized, and included in the 
mineralogical reference repository. After thor-
ough characterization, these samples can be 
classified and prioritized for use in the toxico-
logical studies. 
A part of this early effort should be the devel-
opment of a comprehensive and integrated 
public-use information management system to 
warehouse (1) the mineral characterization in-
formation generated on the reference samples; 
(2) data generated from hazard and health sur-
veillance activities; (3) information on the min-
erals tested and the methods used, as well as 
the results of toxicological studies; and (4)  the 
data gathered from epidemiological and other 
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surveillance investigations. By having the re-
sults of previous studies available in the infor-
mation management system, it could be used to 
promote the development of an efficient, non-
duplicative research program. It could also be 
a resource for data exploration and additional 
analyses of accumulated results. 
After comprehensive review of current knowl-
edge and the available data in the above- 
described information management system, 
the study groups should identify specific aims 
and plan, prioritize, and conduct mineralogi-
cal, toxicological, epidemiological, and clinical 
research within the general framework laid out 
in this Roadmap. Early results will inform the 
need for later research and will dictate changes 
in priorities and directions needed to accom-
plish the overall goals of the research program. 
Ongoing research and study on improvements 
of the analytical methods currently used for 
regulatory purposes should be independent of 
other research. However, as surveillance and 
exposure assessment efforts proceed, research 
on analytical methods should advance the ca-
pability to identify and characterize worker ex-
posures and to measure relevant exposure pa-
rameters identified by toxicological research. 
Eventually, after determinants of EMP toxic-
ity are more fully elucidated, research should 
increasingly focus on sampling and analytical 
methods that can be routinely used in compli-
ance exposure assessment. 
4.3 Outcomes
NIOSH will promote integration of the re-
search goals set forth in this Roadmap into 
the industry sector–based and research-to- 
practice-focused National Occupational Re-
search Agenda (NORA), a national program 
involving both the public and private sectors. 
The goals and objectives of this Roadmap 
can be substantially advanced through robust 
public-private sector partnership.
The ideal outcome of a comprehensive research 
program for asbestos fibers and other EMPs 
would be to use the results to develop recom-
mendations to protect workers’ health that are 
based on unambiguous science. Optimally, such 
recommendations may specify criteria, such as 
a range of chemical composition, dimensional 
attributes (e.g., ranges of length, width, and as-
pect ratio), dissolution rate/fragility parameters, 
and other factors that can be used to indirectly 
assess the toxicity of EMPs. It would be particu-
larly advantageous if the results of the research 
could be used to devise a battery of validated 
in vitro or short-term in vivo assays with suf-
ficient predictive value to identify EMPs war-
ranting concern on the basis of their physical 
and chemical properties, without the need for 
comprehensive toxicity testing and/or epide-
miological evaluation of each individual EMP. 
Newly identified EMPs could be compared to 
the criteria to determine a likelihood of toxic-
ity. Coherent risk management approaches for 
EMPs that fully incorporate a clear understand-
ing of the toxicity could then be developed to 
minimize the potential for EMP-related disease 
outcomes among exposed workers. 
Although it is beyond the scope of this Road-
map, exploration of the extent to which a 
health-protective policy for EMPs could be ex-
tended to SVFs and other manufactured ma-
terials, such as engineered carbon nanotubes 
and nanofibers, is warranted. It has been noted 
that elongate nanoscale particles (e.g., single-
walled and multiwalled carbon nanotubes) 
cause interstitial fibrosis in mice [Shvedova et 
al. 2005; Porter et al. 2009] and that peritone-
al exposure of mice to carbon nanotubes has 
been reported to induce pathological responses 
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similar to those caused by asbestos, suggesting 
potential for induction of mesothelioma [Po-
land et al. 2008]. Recommendations have been 
made elsewhere to systematically investigate 
the health effects of these manufactured nano-
materials within the next five years [Maynard 
et al. 2006; NIOSH 2008b]. Integrating results 
of nanoparticle toxicity investigations with the 
results of the research program developed as a 
result of this Roadmap may lead to a broader 
and more fundamental understanding of the 
determinants of toxicity of EPs.
Working toward achieving the goals delineated 
in this Roadmap is consonant with NIOSH’s 
statutory mission to generate new knowledge 
in the field of occupational safety and health 
and to transfer that knowledge into practice for 
the benefit of workers. Advancing knowledge 
relevant for use in protecting workers from 
adverse health effects arising from exposure 
to asbestos fibers and other EMPs is the ulti-
mate goal. Though further scientific research 
conducted by NIOSH will continue to focus on 
the occupational environment, NIOSH intends 
to pursue partnerships to ensure that scientific 
research arising from this Roadmap will com-
prise an integrated approach to understanding 
and limiting EMP hazards incurred not only in 
work settings, but also in the general commu-
nity and the general environment. 
As information becomes available from re-
search activities, NIOSH plans to assist in the 
development and dissemination of educational 
materials describing the outcomes of the re-
search and their implications for occupational 
and public health policies and practices.
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6 Glossary
6.1 NIOSH Definition of 
Potential Occupational 
Carcinogen
Potential Occupational Carcinogen means any 
substance, or combination or mixture of sub-
stances, which causes an increased incidence of 
benign and/or malignant neoplasms, or a sub-
stantial decrease in the latency period between 
exposure and onset of neoplasms in humans 
or in one or more experimental mammalian 
species as the result of any oral, respiratory or 
dermal exposure, or any other exposure which 
results in the induction of tumors at a site other 
than the site of administration. This definition 
also includes any substance which is metabo-
lized into one or more potential occupational 
carcinogens by mammals.
6.2 Definitions of New Terms 
Used in this Roadmap
Countable elongate mineral particle: A particle 
that meets specified dimensional criteria and is to 
be counted according to an established protocol. 
A countable elongate mineral particle under the 
NIOSH REL for Airborne Asbestos Fibers and Re-
lated Elongate Mineral Particles is any asbestiform 
fiber, acicular or prismatic crystal, or cleavage frag-
ment of a covered mineral that is longer than 5 µm 
and has a minimum aspect ratio of 3:1 on the basis 
of a microscopic analysis of an air sample using 
NIOSH Method 7400 or an equivalent method.
Covered mineral: A mineral encompassed by a 
specified regulation or recommended standard. 
Under the NIOSH REL for Airborne Asbestos 
Fibers and Related Elongate Mineral Particles, 
covered minerals include those minerals hav-
ing the crystal structure and elemental com-
position of the asbestos varieties (chrysotile, 
riebeckite asbestos [crocidolite], cummingtonite- 
grunerite asbestos [amosite], anthophyllite 
asbestos, tremolite asbestos, and actinolite as-
bestos) or their nonasbestiform analogs (the 
serpentine minerals antigorite and lizardite 
and the amphibole minerals contained in the 
cummingtonite-grunerite mineral series, the 
tremolite-ferroactinolite mineral series, and the 
glaucophane-riebeckite mineral series).
Elongate mineral particle (EMP): Any min-
eral particle with a minimum aspect ratio of 
3:1. This Roadmap is focused on EMPs that are 
of inhalable, thoracic, or respirable size, as de-
scribed below in Section 6.2. 
Elongate particle (EP): Any particle with a 
minimum aspect ratio of 3:1. The research de-
scribed in this Roadmap is focused on EPs that 
are of inhalable, thoracic, or respirable size, as 
described below in Section 6.2.
6.3 Definitions of 
Inhalational Terms
Inhalable particulate matter: Particles that 
deposit anywhere in the respiratory tract.
This varies by species, but for humans such 
matter can be approximated as those particles 
captured according to the following collection 
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efficiency, regardless of sampler orientation with 
respect to wind direction: 
IPM(dae) = 0.5 (1 + exp[−0.06 dae]) ± 10; for 
0 < dae ≤ 100 µm
Where IPM(dae) = the collection efficiency 
and dae is the aerody-
namic diameter in µm. 
[ACGIH 1999]
Respirable particulate matter: Particles that 
deposit anywhere in the gas-exchange re-
gion of the lung. This varies by species, but 
for humans such matter can be approximated 
as those particles captured according to the 
following collection efficiency: RPM(dae) = 
IPM(dae)[1−F(x)]
Where F(x) = cumulative probability func-
tion of the standardized nor-
mal variable, x. 
x = ln(dae/4.25 µm)/ln(1.5) [ACGIH 1999]
Thoracic particulate matter: Particles that 
deposit anywhere within the lung airways and 
the gas-exchange region. This varies by species, 
but for humans such matter can be approxi-
mated as those particles captured according to 
the following capture efficiency: TPM(dae) = 
IPM(dae)[1−F(x)]
Where F(x) = cumulative probability func-
tion of the standardized nor-
mal variable, x 
x = ln(dae/11.64 µm)/ln(1.5) [ACGIH 1999]
6.4 Definitions of General 
Mineralogical Terms 
and Specific Minerals
Definitions from several sources are provided in 
the following tables for many of the mineralogical 
terms used in this Roadmap. Definitions of 
some terms in this table differ. Also, definitions 
of these same terms, as used by various authors 
whose work has been cited in this Roadmap, 
may vary from those provided here. It is not 
possible to know and/or provide each of the 
variant definitions.
6.5 References for Definitions 
of General Mineralogical 
Terms, Specific Minerals, 
and Inhalational Terms
ACGIH (American Conference of Governmental 
Industrial Hygienists) [1999]. Particle size–selective 
sampling for particulate air contaminants. Vincent 
JH, ed. Cincinnati, OH: ACGIH.
American Geological Institute [2005]. Glos-
sary of Geology, 5th ed. Neuendorf KKE, Mehl 
JP, Jackson JA, eds. Alexandria, VA: American 
Geological Institute.
Leake BE, Woolley AR, Arps CES, Birch WD, 
Gilbert CM, Grice JD, Hawthorne FC, Kato A, 
Kisch HF, Krivovichev VG, Linthout K, Laird J, 
Mandarino JA, Maresch WV, Nickel EH, Rock 
NMS, Schumacher JC, Smith DC, Stephenson 
NCN, Ungaretti L, Whittaker EJW, Youzhi G 
[1997]. Nomenclature of the amphiboles: re-
port of the Subcommittee on Amphiboles of 
the International Mineralogical Association 
Commission on new minerals and mineral 
names. Can Mineral 35:219–246.
NIOSH [1990a]. Comments of the National 
Institute for Occupational Safety and Health 
on the Occupational Safety and Health Admin-
istration’s Notice of Proposed Rulemaking on 
Occupational Exposure to Asbestos, Tremolite, 
Anthophyllite, and Actinolite. OSHA Docket 
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No. H-033d, April 9, 1990 [http://www.cdc.
gov/niosh/review/public/099/pdfs/Asbestos-
Testimony_April%209_1990.pdf]. Date ac-
cessed: December 17, 2009.
U.S. Bureau of Mines [1996]. Dictionary of 
mining, mineral, and related terms. 2nd ed 
[http://xmlwords.infomine.com/USBM.htm]. 
Date accessed: December 18, 2009.
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